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1. ETIOLOGY OF COLIFORM MASTITIS  
 
1.1. Escherichia coli, a specific environmental pathogen  
 
Escherichia coli is a Gram-negative, non-spore-forming rod, which belongs to the family 
Enterobacteriaceae. Gram-negative bacteria have a cell wall that typically consists of three 
layers, the cytoplasmic membrane, the peptidoglycan layer and the outer membrane (Fig. 1). The 
outer cell membrane contains phospholipids, membrane proteins and lipopolysaccharide (LPS). 
Lipopolysaccharide comprises lipid-A, the lipopolysaccharide core and repeated polysaccharide 
units, called O-antigens (Fig. 2) (Cullor, 1996). Lipid-A is the lipophilic, inner part of LPS, 
which causes the toxic effects of LPS, also known as endotoxin (Cullor, 1996; Hogan and Smith, 
2003). On the outer surface, bacteria may have fimbriae, which protrude from the cell wall. The 
surface may also be covered with a thick polysaccharide layer, called a capsule. Based on the 
different structures of O-antigens, K-antigens (capsular) and H-antigens (flagellar), E. coli can 
be divided into O:H:K serotypes (Cullor, 1996).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Schematic illustration of the cell wall components of Gram-negative bacteria.  
 
Cytoplasm 
 
Inner cell membrane 
Peptidoglycan 
 
Lipoprotein 
 
Outer cell 
membrane 
 
Flagellae 
 
Pili 
  
- 6 -  
Escherichia coli is part of the normal intestinal flora of humans and animals, and is the 
most common facultative anaerobic bacterial species in the gut. The bacteria are constantly 
excreted in the faeces to the environment. Pathogenic E. coli bacteria can cause intestinal and 
extra-intestinal infections in mammalian and avian hosts (Cullor, 1996; Nagy and Fekete, 1999). 
Infections of the gastrointestinal tract may lead to various kinds of diarrhoeic diseases, which, in 
case of Shiga toxin, may even progress to systemic haemolytic uremic syndrome in humans and 
oedema disease in pigs (Cullor, 1996). Escherichia coli is the predominant cause of urinary tract 
infection in humans, and also causes invasive diseases, such as bacteraemia and meningitis, in 
humans and animals (Cullor, 1996).  
 
 
 
 
 
 
 
 
 
Figure 2. Schematic diagram of the structure of LPS. Various monosaccharides are present. The 
number (n) of repeating subunits in the O-antigen is quite variable and may be > 20 (based on 
Tobias et al., 1999). 
 
 Escherichia coli strains involved in acute clinical mastitis have, however, no specific 
virulence factors (Lehtolainen, 2004). Over the last decades, several potential virulence factors 
have been studied in bovine mastitis isolates from clinical cases of E. coli mastitis. No specific 
O-serotypes could be associated with bovine mastitis, and only serum resistance could 
consistently be identified as a possible virulence factor of importance, with a prevalence of 64 to 
100% depending on the study. Other potential virulence factors, such as adhesins (F17-fimbriae, 
S and P fimbriae), toxins (heat-stable toxin (ST), heat-labile toxin (LT), Shiga-like toxins (slt), 
cytotoxic necrotising factors (CNF) 1 and 2, Vero-toxin), hemagglutination, colicin V, K-
antigen, invasiveness, presence of capsule, aerobactin, TraT and attaching and effacing capacity 
(eae) have extensively been studied, but could not be identified in a consistent number of strains.  
 Colonies on agar have a smooth or rough appearance. Smooth colonies are characterised 
by a shiny surface and an entire edge. They have developed polysaccharide side chains as part of 
their LPS outer membrane. In contrast, rough forms appear as dry, wrinkled colonies, which 
have lost their polysaccharide side chains by mutation. 
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O-antigen 
Polysaccharide 
Core 
Outer Core Inner Core 
Lipid A 
Lipid 
Monosaccharide Phosphate Fatty Acid 
Pathogenesis, severity prediction and treatment of E. coli mastitis: a review 
- 7 -  
 
1.2. Incidence and severity of E. coli mastitis in high-yielding dairy cows 
 
Mastitis incidence is the frequency of newly occurring events in a population over a 
given time period (Smith, 1999). Throughout the lactation cycle, two distinct periods of 
increased mastitis incidence occur, namely the periparturient period, from 2 weeks before 
calving until peak lactation (8 weeks), and around drying-off (Natzke, 1981; Burvenich et al., 
2000) (Fig. 3).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Incidence of clinical mastitis throughout the lactation cycle. Two distinct peak 
moments occur, namely the periparturient period and late lactation – drying-off period 
(Burvenich et al., 2000, based on results of Natzke, 1981). Time is represented in the X-axis, 
incidence of clinical mastitis in the Y-axis. The different segments are respectively 
mammogenesis (), periparturient period (), lactation () and involution (). The transition 
period () goes from mammogenesis over colostrogenesis to milk secretion during early 
lactation.  
 
 Acute mastitis is an udder inflammation characterised by its sudden onset with visible 
signs of abnormal milk (Smith, 1999). When all cases of acute coliform mastitis during the entire 
lactation are considered, a significant percentage occurs before peak lactation (Erskine et al., 
1988). Twenty-five % of the cases of clinical coliform mastitis occur in the first two weeks of 
lactation. However, when the first month of lactation is considered, this percentage increases to 
45% and to 60% in the period before peak lactation at 8 weeks post-partum (Erskine et al., 1988; 
Burvenich et al., 2000) (Fig. 4).   
CALVING DRYING-OFF 
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 The severity of the disease is, however, quite variable throughout the lactation cycle 
(Burvenich et al., 2000). During the transition period and in early lactation (until 8 weeks post-
partum), a variable degree of self-curing can be observed with moderate to severe clinical 
responses, whereas during mid- and late lactation, a moderate reaction with a high degree of self-
curing is apparent. Dry cows are very resistant to clinical coliform mastitis (Hill, 1981; 
Todhunter et al., 1991a; Vandeputte-Van Messom et al., 1993; Shuster et al., 1996; Burvenich et 
al., 2000) (Fig. 5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Incidence of clinical coliform mastitis during the periparturient period until peak 
lactation (Burvenich et al., 2000, based on results of Erskine et al., 1988). Twenty-five % of the 
cases of clinical coliform mastitis already occur in the first 2 weeks of lactation. This increases 
to 45% after 4 weeks and 60% at peak lactation (8 wks). Time is represented in the X-axis, 
cumulative percentage of cases of clinical coliform mastitis in the Y-axis. The different 
segments are respectively mammogenesis (), periparturient period (), lactation () and 
involution (). The transition period () goes from mammogenesis over colostrogenesis to 
milk secretion during early lactation.  
 
Multiple reports on incidence of E. coli mastitis in low SCC herds are available 
(Schukken et al., 1989; Barkema et al., 1998; Surayasathaporn et al., 2000; de Haas et al., 2002). 
Most research on increased risk for clinical mastitis in low bulk milk SCC has been performed in 
The Netherlands. Except for Surayasathaporn et al. (2000), who observed an incidence for E. 
coli mastitis of 42.8% in a low bulk milk SCC herd, in most other studies the incidence of 
clinical mastitis due to E. coli was around 20% (Schukken et al., 1989; Barkema et al., 1998; de 
Weeks post-partum 
 8 
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Haas et al., 2002). The incidence of E. coli mastitis was little higher in multiparous cows 
(21.5%) as compared to primiparous cows (16.7%) (de Haas et al., 2002). The distribution of 
cases of E. coli mastitis throughout lactation was similar for primiparous and multiparous cows, 
with 50% of all cases occurring within 56 and 61 days of lactation, and 75% of all cases due to 
E. coli within 118 and 123 days of lactation, respectively (de Haas et al., 2002).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Severity of clinical coliform mastitis throughout the lactation cycle (Burvenich et al., 
2000). Time is represented in the X-axis, disease severity in the Y-axis. The different segments 
are respectively mammogenesis (), periparturient period (), lactation () and involution 
(). The transition period () goes from mammogenesis over colostrogenesis to milk secretion 
during early lactation.  
 
1.3. Economical impact of coliform mastitis 
 
Accurate estimation of the actual costs and the economic impact of mastitis in general, 
and E. coli mastitis in particular, is difficult (Esslemont and Kossaibati, 1997). Mastitis can 
occur in many different forms; however, a distinct difference in clinical course can be defined 
based on the stage of lactation and the cow’s parity. The greatest loss caused by clinical mastitis 
is due to lost milk production, which originates from two different sources, namely the reduced 
milk yield and milk withdrawal because of drug use. As for E. coli mastitis, which occurs 
frequently during early lactation, these losses can be serious. The prevalence of mild, severe and 
fatal mastitis in dairy practice was assumed to be 70, 29 and 1%, respectively (Blowey, 1986). In 
mild cases of clinical mastitis, reduced milk yield seems to be the most important financial loss, 
whereas in severe cases veterinary costs become almost as high as the cost due to the reduction 
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in milk yield due to the prolonged negative effects of mastitis on the secretory epithelium 
(Esslemont and Kossaibati, 1997). In fatal cases of clinical mastitis, major costs are attributed to 
replacement costs for dairy heifers (Table 1). 
 
Table 1. Costs of clinical mastitis in dairy cows (adapted from Esslemont and Kossaibati, 1997).  
 
 Mild (70%) Severe (29%) Fatal (1%) 
 Unit Cost (€) Unit Cost (€) Unit Cost (€) 
Drugs  15.8  39.8  54.8 
Herdsman’s time (min)  15 1.9     
Discarded milk (l)  80 28.8 120 43.2   
Reduced milk yield (l) 247 74.1 450 135.0   
Veterinarian’s time (min)   50 94.0 135 244.9 
Increased risk of culling (%)   20 231.0   
Cost of fatality      3021.9 
DIRECT COSTS  120.6  543.0  3321.6 
 
The determining parameter for the total cost of mastitis in a dairy herd is, however, the 
number of animals affected by the disease per 100 animals present in the herd. In a British 
survey of 90 dairy herds, the average number of cases per 100 cows per year was 37.4, although 
a very wide range existed between the best herds in the study (2.8 cases per 100 cows) and the 
worst herds (215.4 cases per 100 cows). Taking this into account, mastitis is considered the most 
important production disease in terms of reduced profitability with an average yearly cost of € 
35.9 per cow on an average herd (Esslemont and Kossaibati, 1997).  
 
2. PATHOGENESIS 
 
2.1. Virulence factors of E. coli 
 
Escherichia coli, involved in bovine coliform mastitis, is part of the normal intestinal 
flora of dairy cows. The strains isolated from bovine mastitis are essentially not different from 
strains isolated from bovine faeces (Nemeth et al., 1994). This supports the hypothesis that 
mastitic E. coli are simply opportunistic pathogens. Nevertheless, several studies have been 
performed to identify potential virulence factors of E. coli associated with bovine coliform 
mastitis (Linton and Robinson, 1984; Sanchez-Carlo et al., 1984; Barrow and Hill, 1989; Hogan 
et al., 1990; Nemeth et al., 1991; 1994; Thomas et al., 1992; Fang et al., 1993; Pohl et al., 1993; 
Lipman et al., 1995; Cray et al., 1996; Kaipainen et al., 2002). However, only LPS, the 
endotoxin originating from the bacterial outer cell membrane, has been shown to be a consistent 
virulence factor in all E. coli strains isolated from bovine coliform mastitis. Lipopolysaccharide 
Pathogenesis, severity prediction and treatment of E. coli mastitis: a review 
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is a potent inducer of inflammatory cytokines (Shuster et al., 1993) and is released by bacteria 
during growth and killing (Burvenich, 1983). The second most important virulence characteristic 
of bovine mastitis isolates is their serum resistance (Carroll and Jasper, 1977; Sanchez-Carlo et 
al., 1984; Valente et al., 1988; Barrow and Hill, 1989; Nemeth et al., 1991; 1994; Fang and 
Pyörälä, 1996), and 64 to 100% of the strains were reported to be resistant. Two specific 
structures on the outer cell membrane, TraT – a cell surface-exposed lipoprotein – and K1 – a 
capsular antigen –, have been assumed to act in concert to inhibit the correct assembly or 
membrane insertion of the membrane attack complex of the complement system (Sukupolvi and 
O’Connor, 1990). No relation between both TraT and K1, and serum resistance could, however, 
be established (Nemeth et al., 1991; Kaipainen et al., 2002).  
In order to colonise the mammary gland and induce mastitis, invading bacteria should be 
able to proliferate in normal and abnormal mastitis milk (Fang et al., 1993), which means that it 
may be necessary for the bacterial strains to adapt to changing growth conditions. Escherichia 
coli has improved growth capacity in abnormal mastitis milk, which could be explained through 
the presence of growth-enhancing nutrients, although elevated antibacterial activities during 
mastitis would rather inhibit bacterial growth (Fang et al., 1993). In vivo adhesion of E. coli to 
the epithelial surface of the mammary gland is thought to be unimportant during the initial phase 
of infection (Bramley et al., 1979), because in healthy udders collagen or fibronectin are not 
exposed. Recent in vitro experiments, using epithelial cell cultures (Döpfer et al., 2000) or tissue 
explant cultures (Thomas et al., 1992), have found indications for in vitro adhesion to mammary 
epithelial cells. However, strains in one study were isolated from recurrent cases of coliform 
mastitis (Döpfer et al., 2000), and a continuous epithelial cell line of MAC-T-cells was used. 
Thomas et al. (1992) only observed in vitro adhesion of E. coli when epithelial surface was 
damaged and underlying tissues, containing fibronectin and collagen, were displayed.      
Although over 100 serotypes of E. coli have been recognised, no specific O-serotypes 
have been conclusively related to bovine E. coli mastitis (Linton and Robinson, 1984). 
Nevertheless, intramammary challenge with E. coli 487 caused more severe clinical signs of 
mastitis than did E. coli 727 (Todhunter et al., 1991b; Hogan et al., 1992; 1995; 1999). In 
accordance with E. coli strains causing extra-intestinal diseases in humans, hemagglutination and 
hemolysis of erythrocytes have been considered as virulence factors in bovine mastitis (Hogan et 
al., 1990), because they enable the bacteria to increase iron availability. However, neither of both 
characteristics was related to duration or severity of bovine intramammary infection from which 
the bacteria were isolated (Hogan et al., 1990).  
Further research related to the presence of F17 fimbriae, genes encoding for enterotoxins 
(LT and ST1), verotoxins and cytotoxic necrotising factors (CNF1 and CNF2), attaching and 
  
- 12 - 
effacing capacity (eae), Shiga-like toxin (slt) I and II, and heat-stable enterotoxin did not add 
substantial evidence on the presence of multiple virulence factors in E. coli involved in bovine 
coliform mastitis (Pohl et al., 1993; Lipman et al., 1995; Cray et al., 1996). 
 
2.2. Cow factors that influence the outcome of the disease 
 
2.2.1. Polymorphonuclear leukocytes and their role in mammary defence 
 
Once environmental bacteria, such as E. coli, have passed the first functional barrier 
against invasion, formed by the teat canal, they are able to proliferate in the milk at the level of 
the teat and udder cistern. However, milk is not the ideal growth medium, mainly due to the 
presence of several inhibitory factors, such as lysozyme, lactoferrin, and phagocytic cells, 
originating from the blood. The polymorphonuclear leukocyte (PMN) and macrophage are the 
functional phagocytic cells of the body. The resident cells in the normal healthy mammary gland 
are predominantly macrophages, followed by lymphocytes, whereas only a small portion of 
PMN (10-15%) is present (Dulin et al., 1982; Östensson et al., 1988; Leitner et al., 2000; Pillai et 
al., 2001). 
In the healthy mammary gland, PMN migrate from the blood circulation through the 
endothelial gaps in the mammary epithelium to the milk compartment. Directed migration of 
PMN into the mammary gland is stimulated by nursing or milking (Paape et al., 1992), 
supplying the normal sterile mammary gland with a constant source of fresh PMN (Paape and 
Wergin, 1977). Once in the mammary gland, PMN start to phagocytose fat globules and casein, 
which induces an activated status of the cells, finally leading to a progressive exhaustion of 
cellular functionality, as can be observed with milk PMN chemiluminescence (CL) (Mehrzad et 
al., 2001b). 
Polymorphonuclear leukocytes have several receptors on their cell membrane, which 
serve in the process of directed migration from the blood into the milk compartment, called 
diapedesis. Rolling and attachment of PMN to the endothelium is the first step in the recruitment 
process and is accomplished by interaction between L-selectin on PMN and its ligand on the 
endothelial cells (Kishimoto and Rothlein, 1994). Subsequently, the β2-integrins are responsible 
for a strong and sustained attachment, followed by transendothelial PMN migration into the 
extracellular matrix and through the mammary gland epithelium. The respective role of the two 
subunits, namely CD11b and CD18, in the migration process has recently been studied using an 
in vitro diapedesis model (Smits et al., 2000). Migration across the endothelium is almost 
completely dependent on CD18 and to a lesser extent on CD11b, whereas the diapedesis across 
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the mammary epithelial barrier is more dependent on CD11b. Migration across the collagen of 
the extracellular matrix was partly dependent on CD18, but completely independent of CD11b 
(Smits et al., 2000).  
Following diapedesis through the blood-milk barrier, functionality of milk PMN has 
been shown to be decreased (Mehrzad et al., 2001b). This was not only attributed to the 
ingestion of fat globules and casein from the milk environment (Paape et al., 2003). In vitro 
diapedesis showed a reduction in phagocytosis and oxidative burst activity following migration 
across a mammary epithelial cell layer (Smits et al., 1999). The migration process also 
influenced the appearance of programmed cell death or apoptosis in PMN following migration. 
In vitro migration through a collagen-coated membrane induced an apoptotic response, which 
was downregulated by the addition of a monolayer of endothelial cells, but negated by a 
mammary epithelial cell monolayer (Van Oostveldt et al., 2002a). It was suggested that L-
selectin might play an important role in the PMN apoptosis-inducing effect after in vitro 
migration through the collagen-coated membrane inserts (Van Oostveldt et al., 2002a), whereas 
CD11b/CD18 could induce an attenuation of the rate of apoptosis after migration through the 
blood-milk barrier (Smits et al., 2000).  
During the periparturient period, a temporary change in several blood PMN 
characteristics and functions has been described: oxidative burst activity (Moreira da Silva et al., 
1998), L-selectin (Monfardini et al., 2002), acyloxyacyl hydrolase (AOAH) (Dosogne et al., 
1998a); whereas β2-integrins (CD11a, CD11b, CD11c and CD18) did not change over time 
(Diez-Fraile et al., 2003a).  
Acyloxyacyl hydrolase is thought to be one of the mechanisms responsible for the local 
intramammary detoxification of released LPS (Dosogne et al., 1998a), besides the recognition 
and uptake of LPS by the LPS-binding protein (LBP) / cluster of differentiation (CD) 14 system 
(Thomas et al., 2002). Following intramammary endotoxin challenge with high inoculum doses, 
clinical signs were less pronounced as compared to intravenous endotoxin challenge (Lohuis et 
al., 1988b). This suggests that endotoxemia as such is not the major cause of systemic clinical 
signs following LPS or E. coli mastitis. Following E. coli challenge, few peaks of LPS have been 
detected in circulation (Dosogne et al., 2002). In contrast, significant differences in circulating 
concentrations of TNF-α have been observed between moderate and severe responding animals 
(Hoeben et al., 2000a). This suggests that animals with E. coli mastitis rather suffer from 
mediator shock than from endotoxemia (Hoeben et al., 2000a; Dosogne et al., 2002). However, 
under practical circumstances bacteraemie has been described in a substantial number of cows 
with acute clinical mastitis (Wenz et al., 2001). A significant difference in potential bacteraemie 
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existed between mild-moderate and severe responders, with as much as 42% of the severe 
responders having positive bacterial cultures.  
Subsequently, endothelial cells of the blood vessel walls in the mammary gland are 
activated, leading to an increased margination, attachment and migration into the mammary 
gland tissue under the chemotactic guidance of locally produced chemoattractants, such as 
activated complement fragment 5 (C5a) and interleukin-8 (IL-8) (Shuster et al., 1997; Rainard, 
2003). Meanwhile, an increase in mammary blood flow can also be observed (Dhondt et al., 
1977), providing the mammary gland with a larger amount of fresh reactive blood PMN. Once 
the inflammation actively eliminates the invading pathogens from the mammary gland, several 
regulatory mechanisms to limit the inflammation and the associated local epithelial damage are 
enhanced. During E. coli mastitis, an increase in programmed cell death has been observed (Van 
Oostveldt et al., 2002c), whereas the margination decreases through a downregulation of L-
selectin (Monfardini et al., 1999). Moreover, in vitro induction of PMN apoptosis through 
addition of LPS or TNF-α resulted in a decreased phagocytic and oxidative burst capacity, 
which could also play a role in the resolution of inflammation (Van Oostveldt et al., 2002b). 
Nevertheless, functional activity of the viable blood PMN is enhanced during experimental E. 
coli mastitis, as the number of circulating PMN with unstimulated respiratory burst activity is 
higher (Van Oostveldt et al., 1999). Within the mammary gland, PMN oxidative burst, as 
quantified through CL, is higher in severely diseased animals (Mehrzad, 2002), which could 
explain the larger, long-lasting decrease in milk production in the affected quarters of these 
animals.  
At the mammary gland level, activated PMN recognise, phagocytose and kill bacteria 
through their oxygen-dependent and oxygen-independent bactericidal mechanisms (Burvenich et 
al., 2003). Finally, they become apoptotic and are taken up by macrophages, without release of 
their toxic compounds into the surrounding environment (Paape et al., 2003).  
 
2.2.2. Hormonal and metabolic profile during the periparturient period 
 
During the periparturient period, hormonal and metabolic profile of the high-yielding 
dairy cow undergoes some tremendous changes which are mainly related to the process of 
calving, with its associated hormonal regulation, and the initiation of milk production, the 
lactogenesis, which changes metabolic demands quite abruptly. Besides the sudden decrease in 
progesterone, there is a rise in oestrogen, and cortisol peaks on the day of calving. Freshly calved 
cows meanwhile undergo a decrease in energy balance, characterised by increased blood 
concentrations of β-hydroxybutyrate (BHBA) and non-esterified fatty acids (Hoeben et al., 
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2000b), in conjunction with a slight and short-lasting dip in glucose (Moreira da Silva et al., 
1998; Hoeben et al., 2000b).  
High concentrations of progesterone and to a lesser extent oestrogen have been shown to 
decrease blood PMN oxidative burst activity (Moreira da Silva, 1996). β-hydroxybutyric acid 
has been shown to have a direct negative effect on circulating blood PMN function (Hoeben et 
al., 1997c), but an indirect inhibiting effect on bone marrow progenitor cloning in vitro has also 
been reported (Hoeben et al., 1999). Taking these findings into account, the previously described 
depression in PMN functions can easily be explained. 
However, the described hormonal and metabolic changes all occur within the same 
period, which makes a causal interpretation difficult. Using mammectomy, Kimura et al. (1999) 
showed two major factors affecting the changes in PMN functionality, namely the process of 
calving and its related hormonal changes on the one hand, and the onset of lactation, the 
lactogenesis, on the other hand. Eliminating the second factor, decreased PMN functionality 
could still be demonstrated as an effect of parturition alone (Kimura et al., 1999).  
 
2.2.3. Severity of experimentally induced E. coli mastitis 
 
A clear distinction must be made between risk factors for severe clinical mastitis and 
severity determining factors. Risk factors are parameters or characteristics which have a 
causative relation with the occurrence of severe clinical mastitis. There are, however, no 
possibilities to manipulate these factors. In contrast, severity determining factors are mechanisms 
or parameters which can actively be changed or manipulated, resulting in a different outcome of 
the course of clinical E. coli mastitis.  
Several studies have identified the number of PMN in blood immediately prior to 
infection as an important risk factor in the pathogenesis of mastitis (Hill, 1981; Kremer et al., 
1993c; Dosogne et al., 1997). It has been shown that a decreased number and function of blood 
PMN predisposes cows to a severe clinical response to intramammary E. coli challenge 
(Burvenich et al., 1994). A large pool of circulating PMN is apparently required for an effective 
resistance against intramammary infections (Heyneman et al., 1990; Sordillo and Peel, 1992; 
Kremer et al., 1993c; van Werven et al., 1999), and considerable difference can be observed in 
the number of blood PMN or white blood cells (WBC) before infection between moderate and 
severe responding animals following E. coli challenge (Heyneman et al., 1990; Sordillo and 
Peel, 1992; Kremer et al., 1993c; van Werven et al., 1997) (Table 2). 
Many of these functions are associated with the maturity of the circulating PMN 
(Moreira da Silva et al., 1998; Van Merris et al., 2002), although the dramatic hormonal and 
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metabolic changes that occur around parturition and at onset of lactation can also influence these 
functions (Dosogne et al., 1999; Hoeben et al., 1999). The circulating number of PMN represents 
a dynamic balance between cells that disappear from the circulation through margination and 
diapedesis on the one hand, and the rate at which cells are introduced from the bone marrow or 
by demargination. Within an individual animal, the number of blood PMN seems to be relatively 
constant. High coefficients of correlation (r = 0.68 to 0.83) could be observed between blood 
PMN number during 5 consecutive days before experimental challenge (van Werven et al., 
1997). Moreover, older cows (> 4 parities), which have been shown to be more susceptible to 
coliform mastitis, had significantly lower numbers of circulating PMN on the day of challenge as 
compared to young animals (2nd parity). This discrepancy was confirmed by the course of the 
bacterial counts in the infected quarters, where younger animals had a much lower peak bacterial 
count (≈ 105 CFU/ml) in comparison with the older animals (≈ 108 CFU/ml) (van Werven et al., 
1997). However, no data are available on the inflammatory response in primiparous cows. 
 
Table 2. Number of WBC or PMN in blood (x 106/ml) of severe and moderate responding cows 
immediately before infection. 
 
Reference Cell Type Severe Moderate 
Heyneman et al., 1990 PMN 2.3 3.2 
Kremer et al., 1993c WBC 5.7 7.8 
Sordillo and Peel, 1992 WBC 6.1 7.8 
van Werven et al., 1997 WBC 10.5 12.5 
 
Modulation of the number of circulating PMN available for intramammary defence 
against invading pathogens has been performed (Jain et al., 1971; Paape et al., 1986). 
Administration of an equine anti-bovine leukocyte serum resulted in neutropenia in all treated 
cows. Following intramammary Aerobacter aerogenes challenge, neutropenic cows only 
developed slight udder swelling and little leukocytosis in milk, resulting in a massive 
intramammary proliferation of A. aerogenes within 30 h post-infusion. Subsequently, a large 
amount of endotoxin was generated, which resulted in an extreme inflammatory reaction, 
leading to necrosis and irreversible tissue damage (Jain et al., 1971). In contrast, the insertion of 
an intramammary device induced a permanent moderate recruitment of PMN into the mammary 
gland, resulting in significant higher milk SCC. The continuous PMN activation in the mammary 
gland resulted in a lower number of acute clinical mastitis cases as compared to the control 
animals (Paape et al., 1986).  
In contrast to the number of circulating PMN, the pre-infection adhesion molecule 
expression is not a good predictor for the ability to recruit leukocytes to an intramammary 
infection during the periparturient period (Burvenich et al., 1994). Nevertheless, cows with a 
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higher CD11c/CD18 and a lower CD11b/CD18 expression on their blood PMN before infection 
typically showed less severe disease symptoms (van Werven et al., 1997).  
During intramammary infection, it is of importance that a high number of circulating 
PMN can reach the site of infection within reasonable time, and therefore, an optimal 
chemotaxis and diapedesis of these cells is the determining step for the final outcome of coliform 
mastitis during early lactation (Burvenich et al., 1994). Pre-infection in vitro PMN chemotaxis 
was higher in moderately diseased animals than in severely diseased cows (Kremer et al., 1993a; 
van Werven et al., 1997). The same difference was observed by Shuster et al. (1996) when 
comparing the inflammatory response of early and mid-lactating dairy cows. In vivo, rapid influx 
of PMN into the infected quarters occurred in moderate responders, resulting in efficient 
suppression of bacterial growth, whereas in severe responders excessive bacterial growth 
appeared to be related to a delayed diapedesis of PMN into the glands (Vandeputte-Van Messom 
et al., 1993). Therefore, it can be concluded that one of the most important risk factors for a 
severe clinical response is a slow migration of PMN from the blood into the infected mammary 
gland (Table 3). 
 
Table 3. Chemotactic differential (ratio of chemotactic versus (vs.) random migration) of blood 
PMN of severe and moderate responding cows immediately before infection. 
 
Reference Lactation Stage Severe Moderate 
Kremer et al., 1993a early 3.5 6.4 
Shuster et al., 1996 early / mid 0.5 0.7 
van Werven et al., 1997 early 2.9 3.2 
 
 In contrast to the previously described functions and characteristics of blood PMN, 
phagocytosis does not seem to be critically reduced during early lactation, and therefore, no 
significant correlation with severity of E. coli mastitis could be observed (Dosogne et al., 1997). 
However, a significant correlation between the number of PMN (number of circulating PMN * 
% phagocytic PMN) and the severity of clinical mastitis existed in that study, which confirms 
the importance of a high number of immunologically active cells in the circulation for an 
effective resistance against intramammary infections by E. coli during the periparturient period 
(Burvenich et al., 1994).  
 The oxidative burst activity of blood PMN following phagocytosis is, however, an 
important predictive parameter for the clinical outcome of experimentally induced E. coli 
mastitis (Heyneman et al., 1990). The competence of PMN to generate reactive oxygen species  
following stimulation with opsonised particles prior to infection was negatively correlated with 
severity of subsequently induced E. coli mastitis.  
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 Binding and detoxification of LPS is strictly controlled upon entrance in the body: after 
binding to the serum-derived LBP, the complex is recognised by CD14 on macrophages and 
PMN, and subsequently internalised for further metabolisation by enzymes, such as 
phosphatases and hydrolases. In milk, the number of PMN expressing CD14 and their receptor 
density is significantly higher as compared to blood PMN (Paape et al., 1996), and the 
expression of CD14 molecules on PMN was not significantly reduced during the periparturient 
period (Dosogne et al., 1998a). The average AOAH activity, however, was reduced during this 
period (Dosogne et al., 1998a). No relation could be observed between pre-infection blood PMN 
AOAH activity and severity following experimental E. coli challenge (Dosogne et al., 2000). It 
can therefore be concluded that AOAH activity is not a good marker to predict the final outcome 
of clinical coliform mastitis.  
 Neutrophil alkaline phosphatase (NAP) activity increased during experimentally induced 
E. coli mastitis, which may suggest this enzyme plays a role in the pathogenesis of the disease. 
During mastitis, NAP activity was much higher in severe responders (van Werven et al., 1998), 
and was associated with an increased percentage of immature PMN, suggesting a higher 
production in these cells (Heyneman and Burvenich, 1992; van Werven et al., 1998). Despite the 
association of NAP activity and severity during infection, no relation between pre-infection NAP 
activity and outcome of clinical E. coli mastitis could be observed (van Werven et al., 1998). 
 Besides its role as a parameter for milk quality and udder hygiene, milk SCC can also be 
considered as a potential risk factor for mastitis, as a high SCC in milk of healthy cows during 
early lactation protected against severe clinical symptoms during subsequent experimental E. 
coli challenge (van Werven, 1999). In a comparative study between early and mid-lactating 
cows, Shuster et al. (1996) also observed lower SCC in the cows during early lactation. 
Moreover, within early lactating cows, a significant lower pre-infection SCC has been reported 
in severe responders (Hirvonen et al., 1999; Vandeputte-Van Messom et al., 1993) (Table 4). 
Nevertheless, a high degree of variation can be observed in pre-infection milk SCC between 
different studies. 
 
Table 4. Somatic cell count (cells/ml) of severe and moderate responding cows immediately 
before infection. 
 
Reference Lactation Stage Severe Moderate 
Hirvonen et al., 1999 early 10,000 35,000 
Shuster et al., 1996 early / mid 20,000 63,000 
Vandeputte-Van Messom et al., 1993 early 99,630 132,720 
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 In conclusion, several parameters associated with number and function of blood PMN 
have shown predictive capacity in relation to the outcome (moderate/severe) of experimentally 
induced E. coli mastitis. Besides the absolute number of circulating PMN, their chemotactic 
migratory capacity, diapedesis and oxidative burst activity have a significant impact on 
subsequent outcome of intramammary infection.  
 
2.3. Role of complement, LPS-binding protein and soluble CD14 
 
2.3.1. Complement system and its role in the innate defense 
 
The complement system plays an important role in the innate immunity against 
microorganisms through its various functions. Proteins of the complement system are not only 
able to lyse micro-organisms and erythrocytes, as initially thought; they also play a role in 
recognition and ingestion of micro-organisms by phagocytes. Complement can contribute at 
three pivotal steps of phagocytosis, which is an essential defence mechanism against mastitis 
(Craven and Williams, 1985; Burvenich et al., 1994), namely the opsonisation of bacteria 
through deposition of complement fragments at the bacterial surface, which are recognised by 
phagocyte receptors; chemotactic attraction of phagocytes to the site of inflammation; and 
priming or activation of ingestion and/or intracellular killing of pathogens (Rainard, 2003). 
Moreover, the elements of the complement system are important operators in the initiation and 
control of inflammation (Frank and Fries, 1991). The concentrations of complement components 
in milk in different physiological situations have amply been studied. Complement component 
C1q is known to be relatively deficient, whereas C3 is present in relative abundance. Until now, 
the origin of the complement components found in bovine milk is essentially a matter of 
speculation (Rainard, 2003). Although transudation of complement proteins is likely to 
contribute to the total amount of complement present in normal healthy milk, this route of supply 
is probably limited due to the relative impermeability of the mammary epithelium. This may be 
one of the main reasons for the lack of C1q, the largest component (900 kDa) in normal milk 
(Rainard and Poutrel, 1995). During mastitis, the selective blood-milk barrier is damaged, which 
enables complement components to temporarily exudate to the affected mammary glands 
together with other plasma proteins, such as serum albumin and fibrinogen. The concentration of 
C5 in milk can be highly variable between cows during inflammation (Rainard and Poutrel, 
2000), although plasma C5 concentrations in these animals were quite comparable. In milk from 
uninflamed, uninfected quarters, generated C5a concentrations range from 0.6 ng/ml to 20 ng/ml 
(Rainard and Poutrel, 2000), whereas in milk from quarters affected by clinical E. coli mastitis 
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C5a concentrations can exceed 50 ng/ml (Shuster et al., 1997). In normal healthy milk, little 
complement-dependent bactericidal activity is present. The low level of the bactericidal activity, 
possibly due to low concentrations of immunoglobulins for most mastitis pathogens in this milk, 
can be increased by systemic immunisation of cows against a defined pathogen (Korhonen et al., 
2000). In contrast to normal milk, milk derived from mastitis affected quarters exhibits 
pronounced bactericidal and haemolytic complement-mediated activity (Rainard, 2003), which is 
highly correlated with the magnitude of inflammation. Following injury, damage or infection, 
complement activation results in the production of pro-inflammatory mediators C4a, C3a and 
C5a, of which C5a is the most biologically relevant peptide in relation to PMN (Rainard, 2003). 
Complement fragment C5a has various biological functions: increased vascular permeability, 
potent chemoattractant for PMN, basophils, macrophages and lymphocyte subpopulations, 
modulation of phagocyte receptor for opsonins, increased oxidative metabolism, release of 
eicosanoids and degradative enzymes, and stimulation of cytokine synthesis (Damereau, 1987; 
Frank and Fries, 1991; Tomlinson, 1993).  
 
2.3.2. LPS-binding protein and sCD14 recognise and neutralise LPS 
 
The early innate immune response is considered to be the first line of defence against 
infectious diseases. The principal challenge of the host is to detect the pathogen within a 
reasonable time; and rapidly mount a defensive response to limit the pathogen growth in order to 
obtain a total elimination of the pathogen, if possible. Within the first line of defence, the 
leukocytes, such as macrophages and PMN, are the predominant cell types. They can 
phagocytose and kill the pathogens and concurrently co-ordinate additional host responses 
through the synthesis of a wide range of inflammatory mediators and cytokines (Aderem and 
Underhill, 1999). An important aspect of the innate defence system is the ability to recognise a 
large number of potential pathogens with a limited number of available receptors. An additional 
problem is the tendency of pathogens to mutate. However, the host has tried to overcome this by 
the development of receptors, recognising conserved motifs on pathogens. These motifs have 
essential roles in the biology of the invading agents, and are therefore not subjected to high 
mutation rates (Aderem and Ulevitch, 2000). Janeway and Medzhitov (1998) have defined these 
patterns as pathogen-associated molecular patterns (PAMP’s), and their respective binding sites 
on the phagocytes as pattern-recognition receptors.  
In Gram-negative bacteria, LPS is the most important PAMP, and the most essential 
structural feature governing interactions with the innate immune system is known as lipid A. 
Lipid A is composed of a diglucosamine backbone, containing ester-linked and amide-linked 
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long-chain fatty acids. Lipopolysaccharide is released from the outer membrane of the Gram-
negative cell membrane by actively growing, damaged and dead bacteria (Petsch and Anspach, 
2000). The pattern-recognition receptors on the phagocytes for this PAMP are LBP and CD14, 
which enhance the inflammatory response mediated by Toll-like receptors (TLR); and TLR-4 
and TLR-2, which recognise LPS and initiate the inflammatory response (Aderem and Ulevitch, 
2000).  
Lipopolysaccharide, a constituent of the outer membrane of Gram-negative bacteria, is 
apparently one of the major toxins responsible for initiating the pathophysiological cascade 
resulting in sepsis or a systemic inflammatory response (Rietschel et al., 1996). LPS-binding 
protein recognises bacterial LPS and transfers it to CD14, thereby enhancing internalisation of 
LPS or host cell stimulation. Therefore, LBP can be considered as an opsonin, whereas CD14 is 
an opsonic receptor for complexes of LBP-LPS or LPS-containing particles, such as Gram-
negative bacteria. Lipopolysaccharide-mediated stimulation of CD14-positive cells, such as 
monocytes, macrophages and PMN, is enhanced 100 to 1,000-fold when LBP is added to a 
serum-free system. Although CD14 alone can efficiently interact with LPS, the presence of LBP 
has been demonstrated to increase not only the association rate, but also the association constant 
of LPS with CD14 by three orders of magnitude (Thomas et al., 2002). In addition, LBP can 
catalytically transfer monomeric LPS from LPS aggregates onto membrane-associated CD14 
(mCD14) or soluble CD14 (sCD14) molecules (Tobias et al., 1993; Hailman et al., 1994), which 
has been suggested a major advantage compared to binding proteins, such as  
bactericidal/permeability-increasing protein (Tobias et al., 1997).  
Therefore, LBP participates in the pathogenesis of sepsis (Schumann et al., 1990; 
Mathison et al., 1992), although it is unclear why the host would release large quantities of LBP 
during acute inflammation, thereby further enhancing LPS-induced cytokine secretion. However, 
it has been demonstrated that the acute phase LBP has a protective effect against LPS and 
bacterial infection; and may represent a physiologic defence mechanism against Gram-negative 
infection (Lamping et al., 1998).  LPS-binding protein not only mediates binding of LPS to 
CD14, but also the binding of whole Gram-negative bacteria to CD14 leading to phagocytosis 
and subsequent clearance of bacteria (Lengacher et al., 1996). This LBP-mediated CD14-
dependent phagocytic uptake of bacteria could be a mechanism for improved survival following 
bacterial infection.  
In vitro, high concentrations of LBP have been shown to block the LPS-induced 
stimulation of a murine macrophage cell line, both in the absence and in the presence of murine 
serum (Lamping et al., 1998). The LBP dependency in this cell culture system was of bipolar 
nature. Addition of murine LBP at concentrations corresponding to the constitutive murine LBP 
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levels resulted in an increased secretion of TNF-α in vitro, whereas high LBP concentrations, 
simulating the acute phase rise of LBP, resulted in a pronounced decrease in TNF-α response 
(Lamping et al., 1998). A somehow bipolar nature of biological activity has been described for 
CD14, another protein involved in LPS recognition. In vitro, intermediate concentrations of 
sCD14 increased the LBP dependent stimulation of PMN, whereas high concentrations of 
sCD14 inhibited the PMN activation (Hailman et al., 1996), and protected against the toxic 
properties of LPS (Haziot et al., 1995). It can be concluded that LBP and sCD14 in vivo both 
seem to protect from LPS toxicity and bacteraemie if elevated, although in vitro both proteins 
seem to contribute to LPS recognition and LPS-mediated cell stimulation (Lamping et al., 1998). 
This bipolar physiologic defence mechanism could have potential applications in therapeutic 
intervention strategies during sepsis or Gram-negative infections, using a natural host defence 
mechanism against overstimulation by bacterial products (Lamping et al., 1998) (Fig. 6).  
In the bovine, only a few studies have been performed in order to elucidate the kinetics 
and the role of sCD14 and LBP during LPS-induced or Gram-negative mastitis (Bannerman et 
al., 2003; Lee et al., 2003a). Lee et al. (2003a) followed sCD14 concentrations throughout 
lactation and observed the highest concentrations (11.4 ± 0.17 µg/ml) of milk sCD14 during the 
transitional period. Intermediate concentrations (± 5.5 µg/ml) were present during early (5-100 d 
post-partum) and late lactation (> 200 d post-partum), and lowest concentrations (4.6 ± 0.27 
µg/ml) were found in mid-lactating animals. Increased sCD14 concentration was associated with 
higher SCC, although sCD14 concentration in subclinically infected quarters did not differ from 
sCD14 concentration in healthy mammary glands. Upon induction of acute LPS mastitis, milk 
sCD14 rapidly increased to reach maximal levels between 12 and 24 h post-challenge (Lee et al., 
2003a). Possible sources of sCD14 in milk were postulated to be blood serum leakage through 
the damaged blood-milk barrier or cells present in the mammary gland. Milk sCD14 appeared 
much later than the initial breakdown of the blood-milk barrier, as indicated by the increase in 
serum albumin concentrations, ruling out the first possibility. Bovine PMN have been 
demonstrated capable of releasing sCD14 into milk upon contact with LPS. Moreover, the 
increase in sCD14 paralleled the increase in SCC following LPS challenge. It is therefore most 
likely that the PMN influx into the inflamed mammary gland induces the increase in milk sCD14 
(Lee et al., 2003a).  
 
 
 
Figure 6. An overview of the association of LPS with cells mediated by (LBP) and CD14 (based 
on Tobias et al., 1999). 
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Following intramammary LPS challenge, peak fever, a marker of the acute phase 
response, preceded LBP increase both in blood and milk (Bannerman et al., 2003). The increase 
in milk LBP paralleled increments of sCD14 levels. From a host perspective, the simultaneous 
increase of both molecules should be considered advantageous, because they act in concert to 
facilitate activation of the host defence mechanisms by presenting LPS to the transmembrane 
LPS receptor, TLR-4 (Bannerman and Goldblum, 2003). However, maximal levels of IL-8 were 
already observed before increases in either LBP or sCD14, which suggests that initial host cell 
activation can take place in the presence of only basal levels of sCD14 and LBP (Bannerman et 
al., 2003). In contrast to sCD14, LBP increases in the affected glands occur coincidently with the 
disruption of the blood-milk barrier, as indicated by the rise in serum albumin concentration 
(Bannerman et al., 2003), which is in accordance with the fact that LBP is of hepatic origin and 
is already present in plasma at high concentrations before the onset of increases in milk. 
During the initial phase of inflammation, sCD14 mediates the activation of non-CD14-
bearing cells, including epithelial cells (Frey et al., 1992). Low concentrations of LPS-
recombinant bovine sCD14 (rbosCD14) have been demonstrated to induce IL-8 transcription in 
vitro in mammary ductal epithelial cell cultures (Wang et al., 2002). Interleukin-8 is an 
important early chemotactic factor, inducing a massive influx of leukocytes, predominantly 
PMN into the infected mammary gland (Shuster et al., 1997). A delay in leukocyte recruitment 
after intramammary coliform infections resulted in 10 times more bacteria (Erskine et al., 1989), 
indicating the importance of a rapid and early inflammatory reaction in protecting the host from 
overwhelming bacterial infections. Indeed, delayed leukocyte recruitment was not only 
associated with overwhelming bacterial growth, but could also be related with increased severity 
of the inflammatory reaction (Vandeputte-Van Messom et al., 1993). Therefore, the signalling 
role of sCD14 during the early stage of infection, inducing activation of mammary epithelial 
cells with the production of IL-8, is an essential step in innate host defence (Wang et al., 2002). 
Recently, biological functionality of rbosCD14 has been demonstrated in a mouse mastitis model 
using experimental E. coli challenge (Lee et al., 2003b). Intramammary administration of 
rbosCD14 reduced TNF-α production by phagocytes in milk, possibly by competition with 
mCD14 for LPS. Moreover, rbosCD14 administration reduced the number of E. coli, most likely 
through an early infiltration of PMN, induced by activation of epithelial cells with the rapid 
production of IL-8 upon infection (Lee et al., 2003b).    
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2.4. Recurrent intramammary E. coli infections in the bovine 
 
Intramammary infections caused by E. coli are commonly considered to be limited in 
duration. Sometimes, the micro-organisms may even be eliminated before or shortly after the 
onset of clinical symptoms (Hogan et al., 1989). Therefore, the host defence system appears to 
eliminate E. coli efficiently (Hill et al., 1978), especially when the intramammary infection 
occurs late in lactation (Hill and Shears, 1979). Recurrent clinical mastitis caused by E. coli in a 
cow that experiences persistent intramammary infection is known to exist, but is considered to 
be exceptional (Hogan et al., 1989; Lam et al., 1996). It has been observed that quarters with 
recurrent clinical episodes of mastitis caused by E. coli were infected by the same E. coli strain, 
as confirmed by serotyping and deoxyribonucleic acid (DNA) polymorphism patterns with REP 
(= repetitive extragenic palindromic) and ERIC (= enterobacterial repetitive intergenic 
consensus) primers (Lipman et al., 1994). The estimated occurrence of episodes of clinical 
mastitis during persistent intramammary infection caused by E. coli within the same quarter 
ranged from 4.77% (Döpfer et al., 1999), over 7.5% (Hogan et al., 1989) to 9.1% (Lam et al., 
1996), depending on the study design and confirmation techniques used. The E. coli bacteria 
causing persistent intramammary infection may survive intracellularly after invading the udder 
epithelial cells (Döpfer et al., 1999), which is, however, in contrast with the general perception 
that strains of E. coli from mastitis cases are non-invasive for the udder epithelial cells (Linton et 
al., 1979; Sanchez-Carlo et al., 1984; Valente et al., 1988) and mainly opportunistic 
environmental pathogens (Nemeth et al., 1994). A limited number of E. coli strains from 
recurrent mastitis has been studied with respect to adhesion and invasion mechanisms towards 
mammary epithelial cells (Döpfer et al., 2000; 2001). Besides occurrence of persistent 
intramammary infection in the same quarter, multiple cases of recurrent mastitis in different 
quarters of the same cow with the same genotype of E. coli occurred (Döpfer et al., 1999). 
Possible explanations could be that 1) cows were re-infected with the same strain from the 
environment, 2) quarters were infected simultaneously but showed clinical symptoms of mastitis 
at different times, or 3) transmission of E. coli from one quarter to another occurred (Döpfer et 
al., 1999).  
Recently, it was observed that quarters infected with an enterobacterial organism during 
the last third of the dry period were more likely to develop mastitis due to the same pathogen 
than were uninfected quarters in the subsequent lactation cycle (Bradley and Green, 2000). 
Previously, the ability of infections acquired during the dry period to remain quiescent within the 
udder until calving, subsequently causing clinical mastitis in early lactation, has been illustrated 
(McDonald and Anderson, 1981). The dry period has been implicated as a crucial period for 
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acquisition of new coliform intramammary infections (Todhunter et al., 1991a), with more than 
60% of all new intramammary infections occurring at that time. Although, it has been suggested 
that the dry gland is highly resistant to enterobacterial infection as a result of the high levels of 
lactoferrin; more recent research, applying polymerase chain reaction (PCR) DNA fingerprinting 
techniques, has shown that the mammary gland is not resistant to the acquisition of new 
enterobacterial intramammary infections (Bradley and Green, 2000). Multiple aspects should be 
taken into account concerning this new phenomenon, such as potential pathogen adaptation and 
changed host susceptibility (Bradley and Green, 2001a). Few intramammary enterobacterial 
infections appeared to persist throughout the entire dry period (Bradley and Green, 2001b).  
 
3. EXPERIMENTAL INFECTION MODELS 
 
Several experimental infection models for the induction of intramammary E. coli infection 
have been explored throughout the years in an attempt to mimic naturally occurring E. coli 
mastitis. During natural intramammary infection, bacteria have to overcome the physical barrier 
formed by the teat canal and its keratinisation before they can enter the teat sinus and start to 
proliferate in the milk. External contamination of the teat ends with a bacterial suspension of E. 
coli did, however, not induce acute clinical mastitis (Vandeputte-Van Messom et al., 1992). In 
order to obtain an intramammary infection following bacterial exposure, researchers passed the 
physical barrier of the teat canal by direct infusion of the bacterial suspension or the bacterial 
cell wall compounds, such as endotoxin, into the teat and gland sinus.   
 
3.1. Lipopolysaccharide model 
 
Lipopolysaccharide (endotoxin) is a component of the Gram-negative cell wall, and is 
composed of three basic subunits: 1) the O-polysaccharide, providing serospecificity for Gram-
negative bacteria, 2) the lipid moiety, generally called lipid A, which is considered to be the 
toxic component of the cell wall, and 3) the R core, consisting of hexoses, hexamines, and 
heptose, which acts as a bridge between the O-polysaccharide and the lipid (Westphal, 1975). 
The extraction of LPS from Gram-negative bacteria can be performed through different methods 
(Burvenich, 1983): 1) trichloracetic acid (Boivin-extraction), 2) diethylene glycol, 3) phenol / 
water (Westphal-extraction), 4) water / ether, 5) phenol / chloroform / petroleumether and 
butanol. Most commercially available endotoxin preparations are prepared by the Boivin- or 
Westphal-extraction (Burvenich, 1983). Boivin-extracted LPS contains some protein and 
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possesses therefore much stronger antigenic properties. In contrast, Westphal-extracted LPS 
contains some peptides, nucleic acids and sugar residues.  
The toxicity of LPS is determined by two of its subunits. Lipid A, the lipid moiety of 
LPS, is identical for LPS originating from different Gram-negative bacterial species. Primary 
toxicity is due to the lipid A fraction of the LPS, whereas secondary toxicity is related to 
antigen-antibody reactions, mainly directed against the sugar residues on the O-polysaccharide, 
which are weakly antigenic. Host hypersensitivity determines the impact of secondary LPS 
toxicity. A longer O-polysaccharide chain with more sugar residues has higher immunogenic 
properties and can therefore result in more pronounced secondary toxicity (Burvenich, 1983).   
Intramammary LPS challenge is frequently used to study inflammation in the bovine 
mammary gland, mainly due to its resemblance to E. coli challenge (Lohuis et al., 1988b; 
1988c). Nevertheless, some fundamental differences exist between both challenge models. In the 
LPS model, peak fever is reached within 6 h post-challenge, depending on the infused dose of 
LPS, and is accompanied by acute local and systemic clinical symptoms (Lohuis et al., 1988b), 
although no depression in reticulorumen motility could be observed following intramammary 
LPS challenge. Duration of clinical symptoms and general illness in the LPS model is limited, 
and therefore, quarter milk production is only temporarily depressed and rapidly returns to pre-
infection values (Hoeben et al., 2000a; Mehrzad et al., 2001a). In contrast to earlier assumptions, 
general clinical symptoms following intramammary LPS challenge are not due to LPS resorption 
into circulation, but mediated through locally produced and systemically active inflammatory 
cytokines (Dosogne et al., 2002).  
Throughout the years, a wide range of LPS inoculum doses, varying from 0.0001 (van 
der Vliet et al., 1989) to 20,000 µg (Frost et al., 1984), has been applied, although currently used 
doses appear in a more narrow range of 100 to 1,000 µg per quarter (Table 5). The tendency to 
use a specific LPS inoculum dose or range of doses also seems to be research group-related. In 
contrast to the wide variety of applied inoculum doses, only a small selection of strains was used 
for the extraction and preparation of LPS (Table 6). 
A general trend in LPS-induced mastitis is the use of multiparous cows (78.3 %) during 
the mid-lactation stage (Table 7-8). Although in many, predominantly older studies, neither 
parity group nor stage of lactation are defined, the most recent research reports on endotoxin-
induced mastitis provide more detailed information on the experimental animals and conditions 
applied in the studies. Taking into account that cow factors may determine the outcome of 
mastitis (Burvenich et al., 2003), the trend towards a more standardised choice of experimental 
animals is positive and should be encouraged at all levels.  
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Table 5. LPS inoculum dose for intramammary endotoxin challenge. 
 
LPS inoculum dose References 
100 pg van der Vliet et al., 1989 
1 ng Persson et al., 1993 
10 ng Persson et al., 1993; Schultze, 1981; Verheijden et al., 1982 
100 ng Mattila et al., 1985; Persson et al., 1993; Schultze, 1981 
1 µg Needs and Anderson, 1984; Persson et al., 1993; Persson-Waller, 
1997; Schultze et al., 1978; Schultze, 1981; Schultze and Bright, 
1983; Verheijden et al., 1982 
2 µg Hopster et al., 1998; Salih and Anderson, 1979 
5 µg Giri et al., 1984; Persson, 1990; Persson et al., 1992a; Sladek and 
Rysanek, 2001 
10 µg Anderson et al., 1986a; 1986b; 1986c; Anderson and Hunt, 1989; 
Barrett et al., 1997; Brownlie, 1979; Brownlie et al., 1979; Giri et 
al., 1984; Guidry et al., 1983; Ishikawa and Shimizu, 1983; Lohuis 
et al., 1989; Mattila et al., 1987; Mattila and Frost, 1989; Morkoc et 
al., 1993; Moussaoui et al., 2002; Needs and Anderson, 1984; Paape 
et al., 1996; Prin-Mathieu et al., 2002; Raulo et al., 2002; Shuster 
and Harmon, 1992; Shuster et al., 1991a; 1991b; 1993; Verheijden et 
al., 1982  
12.5 µg Gorewit, 1993 
15 µg Bouchard et al., 1999 
20 µg Kaartinen et al., 1990; Persson and Hallén-Sandgren, 1992; Persson 
et al., 1992a; Persson-Waller, 1997 
25 µg Giri et al., 1984; Gorewit, 1993 
50 µg Carroll et al., 1974; Jain and Lasmanis, 1978; Jain et al., 1978; 
Mueller et al., 1983; Oliver, 1991; Östensson, 1993; Persson-Waller 
et al., 2003; Saad and Östensson, 1990 
100 µg Bannerman et al., 2003; Brooker et al., 1981; Chaiyotwittayakun et 
al., 2002; Frost et al., 1984; Giri et al., 1984; Guidry et al., 1983; 
Jackson et al., 1990; Kaartinen et al., 1988; Lappalainen et al., 1988; 
Lohuis et al., 1988a; 1990b; 1991; Mattila et al., 1985; Schmitz et 
al., 2004; Shuster and Harmon, 1991; Verheijden et al., 1982; Ziv et 
al., 1998 
200 µg Carroll et al., 1965; Jain et al., 1972 
500 µg Blum et al., 2000; Carroll et al., 1974; Diez-Fraile et al., 2003b; 
Dosogne et al., 2002; Hoeben et al., 2000a; Lefcourt et al., 1993; 
Mehrzad et al., 2001a; Paape et al., 1974; Van Oostveldt et al., 
2002c; Yagi et al., 2002 
750 µg Jain et al., 1972 
900 µg Brooker et al., 1981 
1 mg Brooker et al., 1981; DeGraves and Anderson, 1993; Dhondt et al., 
1977; Frost et al., 1984; Kassa et al., 1986; Tyler et al., 1992; 1993; 
1994a; 1994b; Verheijden et al., 1982; Welles et al., 1993; Ziv et al., 
1983 
3 mg Dhondt et al., 1977 
5 mg Brooker et al., 1981; Carroll et al., 1974; Frost et al., 1984; Jain et 
al., 1969 
10 mg Verheijden et al., 1982; Ziv et al., 1976 
15 mg Ziv and Jochle, 1981 
20 mg Carroll et al., 1965 
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Table 6. Strain diversity used to prepare endotoxin for intramammary inoculation. 
 
Strain References 
Aerobacter aerogenes Carroll et al., 1965 
E. coli undefined Fox et al., 1981; Jain et al., 1969; 1972; Oliver and Smith, 1982; 
Oliver, 1991; van der Vliet et al., 1989 
E. coli B117 :O8 Brooker et al., 1981; Frost et al., 1984 
E. coli O111 :B4 Bannerman et al., 2003; Blum et al., 2000; Chaiyotwittayakun et al., 
2002; Diez-Fraile et al., 2003b; Hoeben et al., 2000a; Kaartinen et 
al., 1988; Lappalainen et al., 1988; Lohuis et al., 1988a; 1989; 
1990a; 1991; 1992; Mattila et al., 1985 ; Mehrzad et al., 2001a; 
Tyler et al., 1992; 1993; 1994a; 1994b; Van Oostveldt et al., 2002c; 
Verheijden et al., 1982; Welles et al., 1993; Yagi et al., 2002 
E. coli O128 :B12 Lefcourt et al., 1993; Mattila et al., 1985; Schultze, 1981; Schultze 
and Bright, 1983; Sladek and Rysanek, 2001 
E. coli O26 :B6 Anderson et al., 1986a; 1986b; 1986c; Anderson and Hunt, 1989; 
Barrett et al., 1997; Carroll et al., 1974; DeGraves and Anderson, 
1993; Dhondt et al., 1977; Jain and Lasmanis, 1978; Jain et al., 
1978; Morkoc et al., 1993; Moussaoui et al., 2002; Mueller et al., 
1983; Paape et al., 1974; 1996; Prin-Mathieu et al., 2002; Schmitz et 
al., 2004; Schultze et al., 1978; Schultze, 1981; Ziv and Jochle, 
1981; Ziv et al., 1976; 1983; 1998  
E. coli O55 :B5 Bouchard et al., 1999; Brooker et al., 1981; Brownlie, 1979; 
Brownlie et al., 1979; Frost et al., 1984; Giri et al., 1984; Gorewit, 
1993; Guidry et al., 1983; Hopster et al., 1998; Ishikawa and 
Shimizu, 1983; Jackson et al., 1990; Kaartinen et al., 1990; Mattila 
et al., 1987; 1989; Needs and Anderson, 1984; Persson-Waller et al., 
2003; Raulo et al., 2002; Salih and Anderson, 1979; Schultze, 1981; 
Shuster and Harmon, 1991; 1992; Shuster and Kehrli, 1995; Shuster 
et al., 1991a; 1991b; 1993 
E. coli O157 Lohuis et al., 1990a 
S. typhimurium SH4809 Kassa et al., 1986; Östensson, 1993; Persson, 1990; Persson and 
Hallén-Sandgren, 1992; Persson et al., 1992a; 1992b; 1993; 
Persson-Waller, 1997; Saad and Östensson, 1990 
 
 
Table 7. Frequency and percentage of LPS mastitis studies in different cow parity groups.  
 
Parity group Frequency Percentage 
undefined 6 7.0 
primiparous 10 11.5 
multiparous 62 71.3 
primiparous-multiparous 7 8.0 
variable 2 2.2 
TOTAL 87 100 
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Table 8. Frequency and percentage of LPS mastitis studies in different stages of lactation.  
 
Parity group Frequency Percentage 
undefined 19 22.0 
early 13 15.0 
mid 23 26.4 
late  4 4.6 
dry 7 8.0 
variable 7 8.0 
early-mid 4 4.6 
mid-late 8 9.2 
late-dry 1 1.1 
early-mid-late 1 1.1 
TOTAL 87 100 
 
 Most frequently, 1 or 2 quarters are challenged with LPS (86.6 %) (Fig. 7).  
 
 
 
 
 
 
 
 
 
Figure 7. Percentage of LPS mastitis studies inoculating 1, 2, 3 or 4 quarters of each dairy cow. 
 
In conclusion, experimental endotoxin mastitis is mostly induced through a single dose 
administration. This is in contrast with the more dynamic release of LPS in the E. coli mastitis 
model, where LPS is released during growth and subsequent killing of the inoculated bacteria 
over a much longer time interval (Petsch and Anspach, 2000). Therefore, the model is suitable in 
the study of inflammatory kinetics, without major health risk for the experimental animals with 
respect to persistent clinical disease, as is occasionally observed following E. coli challenge. 
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3.2.   Escherichia coli model 
 
The E. coli mastitis model is the more realistic approach for an experimental 
intramammary infection, as it can be observed in field cases. The most important difference with 
the previously described LPS mastitis model is the occurrence of a continuous release of LPS 
during bacterial growth and killing (Burvenich, 1983; Petsch and Anspach, 2000), although an 
initial delay in this release can occur. Intramammary inoculation is performed in one or more 
quarters, leaving the other quarters as negative controls during inflammation (Fig. 8). The 
distribution of the number of inoculated quarters with live E. coli bacteria is comparable to the 
previously discussed LPS model.   
 
 
 
 
 
 
 
 
Figure 8. Percentage of E. coli mastitis studies inoculating 1, 2, 3 or 4 quarters of each dairy 
cow. 
 
 Inflammatory characteristics and kinetics related to experimentally induced E. coli 
mastitis are mainly influenced by the initial inoculum dose. When low numbers of bacteria are 
inoculated, several hours of bacterial growth are needed before initiation of an inflammatory 
response (Shuster et al., 1996; Riollet et al., 2000), whereas inoculation of high numbers of 
bacteria rapidly induce local and systemic clinical symptoms (Vandeputte-Van Messom et al., 
1993; Hoeben et al., 2000a; Dosogne et al., 2002). Therefore, it is not easy to clearly define the 
exact time point when peak fever and maximal systemic and local clinical symptoms are 
reached. A major clinical difference between the LPS and the E. coli mastitis model is the 
pronounced suppression of reticulorumen motility, which can only be observed in the E. coli 
challenge model (Verheijden et al., 1982; Lohuis et al., 1988b). 
For induction of intramammary challenge, a great variety of strains has been used, 
however, only a few have regularly been applied (Table 9).  
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Table 9. Strain diversity of coliform bacteria used for intramammary challenge. 
 
Strain References 
Aerobacter aerogenes Jain et al., 1969 
A. aerogenes 2414-1 Carroll et al., 1973; Zia et al., 1987 
A. aerogenes 2413-2 Carroll et al., 1973 
Klebsiella K644 Carroll et al., 1973 
Klebsiella K-6 Carroll et al., 1973 
K. pneumoniae Bramley and Neave, 1975 
E. coli 12795 Carroll et al., 1973 
E. coli Harmon et al., 1976 
E. coli S-16 Carroll et al., 1973 
E. coli Lilly Carroll et al., 1973 
E. coli 1128 Schultze et al., 1978 
E. coli McDonald 487 Hogan et al., 1994b; Shuster et al., 1996; 1997 
E. coli 727 Barrett et al., 1997; Hogan et al., 1994a; 1995; Scaletti et al., 2003; 
Smith et al., 1999; Tomita et al., 2000; Weiss et al., 2004 
E. coli B117:O8 Frost et al., 1980; 1982 
E. coli FT238 Pyörälä et al., 1994 
E. coli O157 Dosogne et al., 1997; Kremer et al., 1993a; 1993b; 1993c; Lohuis et 
al., 1990b; Roets et al., 1999; van Werven et al., 1997  
E. coli O5 Griel et al., 1975 
E. coli P4:O32 Anderson et al., 1985; Blum et al., 2000; Dosogne et al., 2002; 
Heyneman et al., 1990; Heyneman and Burvenich, 1992; Hill et al., 
1978; Hoeben et al., 2000a; Monfardini et al., 1999; Riollet et al., 
2000; Shpigel et al., 1997; Van Oostveldt et al., 2002c; Vandeputte-
Van Messom and Burvenich, 1993; Vandeputte-Van Messom et al., 
1993 
E. coli Saskatchewan Sordillo and Babiuk, 1991; Sordillo and Peel, 1992 
 
Throughout the years, different inoculum doses have been used from 5 CFU (Schultze et 
al., 1988) up to 1.8 x 1010 CFU (Frost et al., 1980), although currently used inoculum doses were 
2 x 102 to 1 x 104 CFU (Carroll et al., 1973; Fox et al., 1981; Frost et al., 1982; Heyneman et al., 
1992; Vandeputte-Van Messom et al., 1993; Hoeben et al., 2000a) (Table 10). Inoculum doses 
above 1 x 104 CFU per quarter have mainly been used in older studies. Another remarkable 
observation is that American mastitis research groups predominantly inoculate low numbers (< 
100 CFU) of E. coli into the mammary gland, whereas European investigators prefer to use 
higher numbers ( > 100 CFU). Therefore, care should be taken when study results in terms of 
inflammatory kinetics are compared between both types of experimental design for reasons 
discussed earlier.  
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Table 10. Inoculum doses used for experimental intramammary inoculation with coliform 
bacteria.  
 
Inoculum dose (CFU) References 
< 20 Schultze et al., 1978 
21-30 Hogan et al., 1994b; Scaletti et al., 2003; Schultze et al., 1978; 
Shuster et al., 1996; 1997 
31-50 Barrett et al., 1997; Frost et al., 1982; Hill et al., 1978; Riollet et al., 
2000; Sordillo and Babiuk, 1991; Sordillo and Peel, 1992 
51-100 Carroll et al., 1973; Hogan et al., 1994a; 1995; Smith et al., 1999; 
Tomita et al., 2000; Weiss et al., 2004 
101-500 Carroll et al., 1973; Frost et al., 1982; Griel et al., 1975; Harmon et 
al., 1976; Shpigel et al., 1997; Van Oostveldt et al., 2002c 
501-1,000 Anderson et al., 1985; Carroll et al., 1973; Dosogne et al., 1997; 
Kremer et al., 1993a; 1993b; 1993c; Roets et al., 1999; Shpigel et 
al., 1997; van Werven et al., 1997 
1,001-10,000 Anderson et al., 1985; Blum et al., 2000; Bramley and Neave, 1975; 
Carroll et al., 1973; Dosogne et al., 2002; Griel et al., 1975; 
Heyneman et al., 1990; Heyneman and Burvenich, 1992; Hill et al., 
1978; Hoeben et al., 2000a; Lohuis et al., 1990b; Monfardini et al., 
1999; Pyörälä et al., 1994; Vandeputte-Van Messom and Burvenich, 
1993; Vandeputte-Van Messom et al., 1993; Zia et al., 1987 
10,001-100,000 Bramley and Neave, 1975; Carroll et al., 1973 
100,001-1,000,000 Bramley and Neave, 1975; Carroll et al., 1973; Hill et al., 1978 
> 1,000,001 Carroll et al., 1973; Jain et al., 1969; Frost et al., 1980 
 
 Experimentally induced E. coli mastitis has mainly been studied in multiparous animals 
(84.5 %), whereas the immune response in primiparous cows (6.7 %) has hardly been explored 
(Table 11). In contrast to LPS mastitis which was predominantly studied in mid-lactation, E. coli 
challenge has mainly been performed in early lactation animals (66.7 %) (Table 12).  
 
Table 11. Frequency and percentage of E. coli mastitis studies in different cow parity groups.  
 
Parity group Frequency Percentage 
undefined 2 4.4 
primiparous 3 6.7 
multiparous 30 66.7 
primiparous-multiparous 8 17.8 
variable 2 4.4 
TOTAL 45 100 
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Table 12. Frequency and percentage of E. coli mastitis studies in different stages of lactation.  
 
Parity group Frequency Percentage 
undefined 4 8.9 
early 28 62.3 
mid 3 6.7 
late  4 8.9 
dry 0 0 
variable 2 4.4 
early-mid 1 2.2 
mid-late 2 4.4 
late-dry 0 0 
early-mid-late 1 2.2 
TOTAL 45 100 
 
4. DIAGNOSIS AND TREATMENT OF E. COLI MASTITIS 
 
4.1. Diagnosis 
 
Coliform mastitis affects the quality of milk, may induce partial or total loss of milk 
production capacity in the affected quarters or can even result in a life-threatening situation for 
the diseased animal. Therefore, rapid and correct diagnosis of the etiological agent of clinical 
mastitis should be performed. Knowledge on risk factors and severity determining factors may 
assist in the recognition of a clinical case as being due to E. coli.   
 
4.1.1.  Clinical and bacteriological diagnosis 
 
Clinical diagnosis, consisting of inspection and visual examination of the diseased 
animal, the affected quarter and the changes in milk composition, does not systematically result 
in a correct etiological diagnosis. Appearance of mastitis with acute or peracute clinical signs 
and watery mammary secretions with flakes is indicative of an intramammary E. coli infection, 
although bacteriological sampling of clinical mastitis cases only resulted in 16.2% E. coli 
cultures (Schukken et al., 1989). If the absence of bacteria in culture would also be considered as 
E. coli, a total of 39.1% of the clinical cases would be due to E. coli (Schukken et al., 1989). 
Therefore, etiological diagnosis solely based on clinical parameters is assumed to be difficult to 
take the appropriate therapeutic measures to combat acute clinical mastitis. It is clear that further 
steps should be taken to identify the etiological agent through bacteriological examination or 
molecular identification methods. 
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An alternative to clinical diagnosis may be provided by cow-side tests, such as 
ColiMast or LiMast, which help to identify the etiological agent responsible for the clinical 
case. In the ColiMast cow-side test, coliforms are identified by means of a visual colour 
change. Reliable and specific results were obtained within 12 h (Rogerson et al., 2000). A 
disadvantage of the ColiMast test is that negative results are difficult to interpret, as presence 
of coliforms below the detection limit also leads to absence of colour change. The LiMast test 
can be used in cows with moderate to severe clinical symptoms, but detection is also limited to 
Gram-negative organisms (Yazdankhah et al., 2001). An advantage of the LiMast  cow-side 
test is its speed (results within 15 min), although the same disadvantage remains present as 
pointed out for the ColiMast test.  
From a therapeutic point of view, the differential diagnosis of clinical mastitis is 
essential, since the optimal treatment differs between Gram-positive and Gram-negative bacterial 
infection in the mammary gland (Yazdankhah et al., 2001). Therefore, a rapid procedure (less 
than 5 min) for differentiation between Gram-positive and Gram-negative mastitis was 
developed. Although the method has a high detection limit (1 x 106 CFU/ml), application in the 
diagnosis of moderate or severe clinical mastitis is possible (Yazdankhah et al., 2001). As mild 
to moderate mastitis caused by coliforms should not be treated with antibiotics, this procedure 
provides valuable information to limit the excessive use of antibiotics in these clinical cases with 
a high degree of self-curing.   
 Bacteriological examination is considered to be the ‘golden standard’ for routine 
detection and identification of major mastitis pathogens (IDF, 1971). From a practical point of 
view, however, bacteriological diagnosis of clinical mastitis is labour-intensive and time-
consuming (Riffon et al., 2001), although the final result can be considered reliable and 
informative, especially for future treatment decision on the same dairy farm. Nevertheless, it has 
been demonstrated that early detection procedures enhance cure rates and reduce the time 
required to return to normal milk production when coupled with an appropriate antimicrobial 
therapy (Milner et al., 1997).  
 
4.1.2.  Milk SCC and compositional changes 
 
According to International Dairy Federation (IDF) recommendations, mastitis diagnosis 
should be based on the SCC (Hillerton, 1999). Normal healthy milk SCC mainly consists of 
macrophages, in addition to PMN, epithelial and mononuclear cells (Dulin et al., 1982; 
Östensson et al., 1988). The proportion of PMN increases from ± 10% in healthy milk to more 
than 90% during intramammary infection, and therefore, contribution of PMN to the total milk 
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SCC has been proposed as an indicator of mastitis (Kelly et al., 2000). This approach would 
provide more information on the health status of the mammary quarters (Östensson et al., 1988), 
but further applications did not occur mainly due to practical limitations.  
Milk SCC threshold for the diagnosis of mastitis has been reduced from 500,000 to 
200,000 cells/ml, and recently a threshold of 100,000 cells/ml was even suggested (Hillerton, 
1999) for quarters to be considered as clinically healthy. This seems to be in agreement with 
SCC results recently obtained through meta-analysis (Djabri et al., 2002), suggesting an average 
SCC of 68,000 cells/ml in bacteriologically negative quarters. Minor pathogens only result in a 
slight increase of quarter SCC (110,000 to 150,000 cells/ml), whereas major pathogens induced 
more pronounced increases (350,000 cells/ml) (Djabri et al., 2002). Recently, SCC patterns have 
been associated with pathogen-specific cases of clinical mastitis. In that study, clinical E. coli 
mastitis was significantly associated with the presence of a short peak in SCC (de Haas et al., 
2004).  
Besides SCC, several compositional changes occur in milk during clinical mastitis 
(Kitchen, 1981; Östensson et al., 1988; Hamann and Krömker, 1997), such as decreased quarter 
milk yield, lactose, fat, long-chained fatty acids, total casein, α-lactalbumin, β-lactoglobulin, 
Ca2+, Mg2+, P2+, Zn2+ and potassium (K+), and increased whey proteins, serum albumin, 
immunoglobulins, proteose peptone, free fatty acids, short-chained fatty acids, sodium (Na+), 
chlorine (Cl-), lactate, lipase, lysozyme, N-acetyl-β-D-glucosaminidase, β-glucuronidase and 
plasmin activity (Pyörälä, 2003).  
 
4.1.3. Molecular identification methods 
 
Recently, a PCR technique was developed for simultaneous detection of several major 
mastitis pathogens (Riffon et al., 2001). The advantage of PCR, compared to bacteriology, lays 
in the possibility to use only nanograms of nucleic acid samples, allowing the elimination of 
bacterial culture, combined with rapidity (within 24 h results) and easy analysis. The detection 
limit of the assay is set at 5 x 103 CFU/ml of milk in the absence of a pre-PCR enzymatic step, 
which should be sensitive enough to be used as a diagnostic tool in bovine mastitis.  
 
4.2. Treatment 
 
Various preventive measures and management practices have been shown effective to 
decrease the incidence of coliform mastitis over the years. Nevertheless, a great need exists for 
therapeutic measures following the occurrence of acute or peracute coliform mastitis. Currently, 
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these measures include the use of antimicrobials, anti-inflammatory agents (steroidal and non-
steroidal) and additional treatments (frequent milk-out, oxytocin administration and fluid 
therapy) (Ziv, 1992).   
Until now, differential therapies, depending on the risk factors and severity determining 
factors associated with the specific case of acute mastitis, have not been established. The 
importance of severity estimation should be stressed in relation to subsequent outcome of the 
clinical disease. Early lactation and ketonemia should be considered important severity 
determining factors, in combination with higher parity number (Gilbert et al., 1993; Kremer et 
al., 1993c; Hoeben et al., 1997c; 2000b; van Werven et al., 1997).  
 
4.2.1.  Antimicrobial treatment of E. coli mastitis 
 
Local and systemic antibiotics are frequently used in the treatment of clinical E. coli 
mastitis in the field. Mastitis in general is currently the most frequent reason for antibiotic use in 
lactating dairy cattle (Gardner et al., 1990; Meek et al., 1986; Guterbock, 1995). Even though 
antibiotic treatment of mastitis has been performed for decades, our current knowledge about 
their actual efficacy is still very scarce. Conclusive data on mastitis treatment efficacy through 
antibiotics should not only be based on clinical field trials, but also consist of in vitro studies and 
experimentally induced mastitis studies (Shpigel, 2001). Antimicrobial drugs are assumed to 
exert their beneficial therapeutic effect via bactericidal or bacteriostatic action.   
In vitro studies on the potential effects of local and systemic antimicrobials on bovine 
blood and milk PMN functionality have demonstrated severe suppressive effects when PMN 
were exposed to relatively high concentrations of several antimicrobials (Hoeben et al., 1997a; 
1997b; 1998a; Dosogne et al., 1998b). In practice, these high doses could only be reached by 
prolonged multiple dose treatment schedules, mainly through a local administration route 
(Hoeben et al., 1998a). In these studies a wide range of antimicrobials (Table 13) was tested at 
different subtherapeutic, therapeutic and supratherapeutic concentrations. Several products had 
the spectrum required for treatment of infections with Gram-negative bacteria, such as E. coli 
mastitis (Hoeben et al., 1997a) (Fig. 9). All antibiotics, except sulphadiazin and enrofloxacin 
decreased CL at the highest concentration. The stimulatory effect of enrofloxacin might be due 
to a stimulation of the production of H2O2 (Hoeben et al., 1997a) (Fig. 10).   
Intravenous administration of enrofloxacin following experimentally induced E. coli 
mastitis in early lactating dairy cows did not result in an improved clinical condition (Hoeben et 
al., 2000a), as 2 animals in the treated group responded severely following intramammary 
challenge. Nevertheless, a significantly decreased number of bacteria (1:100) in the infected 
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quarters could be observed following systemic antimicrobial treatment at 10 h post-challenge 
(Monfardini et al., 1999). It is known that the administration of a bactericidal antibiotic during 
intramammary bacterial infection is a double-edged sword, on the one hand decreasing the 
number of bacteria in the affected quarters, on the other hand inducing a major release of LPS 
from the destroyed bacteria into the mammary gland compartment (Hoeben et al., 2000a). 
In a clinical field trial evaluating the efficacy of parenteral administration of procaine 
penicillin G, spiramycin and enrofloxacin, bacteriological cure rate in cows with mastitis caused 
by E. coli was 74% for those treated with penicillin G and 71% for the non-treated controls 
(Pyörälä and Pyörälä, 1998). Following experimentally induced E. coli mastitis, treatment with 
trimethoprim-sulphadiazin or colistin sulphate were apparently no more beneficial than no 
treatment (Pyörälä et al., 1994). Another study reported beneficial effects of cefquinome 
treatment on bacteriological cure rate following experimentally induced E. coli mastitis, whereas 
no beneficial effect on bacteriological cure rate was observed for ampicillin or cloxacillin 
administration (Shpigel et al., 1997). 
 
Table 13. Antimicrobial products tested in vitro for their influence on blood or milk PMN 
functionality, more specifically phagocytosis, oxidative burst activity or bactericidal activity 
(Hoeben et al., 1997a; 1997b; 1998a; Dosogne et al., 1998b).   
 
Antimicrobial Antibiotic group Local or systemic treatment 
ampicillin aminopenicillins S 
cephapirin 1st generation cephalosporins L / S 
chloramphenicol - S 
cloxacillin penicillinase-resistant penicillins L 
danofloxacin fluoroquinolones S 
dihydrostreptomycin macrolides S 
doxycyclin tetracyclins S 
enrofloxacin fluoroquinolones S 
erythromycin macrolides S 
lincomycin lincosamides S 
mecillinam β-lactam antibiotics L 
Na+-ceftiofur 3rd generation cephalosporins L / S 
neomycin macrolides S 
oleandomycin macrolides S 
oxytetracyclin tetracyclins S 
penicillin natural penicillins L / S 
spiramycin macrolides S 
sulphadiazin sulphonamides S 
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Figure 9. Chemiluminescence index (%) of isolated blood PMN incubated with some currently 
used antibiotics for the treatment of mastitis (Hoeben et al., 1998a). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. Chemiluminescence index (%) of isolated blood PMN incubated with some currently 
used antibiotics for the treatment of mastitis (Hoeben et al., 1997a; 1997b). 
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4.2.2.  Anti-inflammatory treatment of E. coli mastitis 
 
Glucocorticosteroids are very well known and widely used anti-inflammatory agents in 
the treatment of a variety of inflammatory processes, such as acute E. coli mastitis in the 
periparturient cow. Local and systemic administration of glucocorticosteroids is possible. Local 
administration reduces swelling and oedema in the affected tissue, whereas systemic 
administration can combat the symptoms of endotoxin shock (Phillips et al., 1987). However, 
both endogenous and exogenous glucocorticosteroids in high concentrations have been shown to 
suppress functions of circulating PMN (Hoeben et al., 1998b), although no adverse effects on in 
vitro PMN CL could be shown at therapeutic concentrations. Attention has to be paid to possible 
immunodepressive effects of glucocorticosteroids after repeated and local administration. It is 
therefore advisable to avoid the regular use of these drugs during inflammation in vivo and to 
limit potential administration under controlled circumstances (Hoeben et al., 1998b). 
Furthermore, inhibitory effects of glucocorticosteroids on bone marrow progenitor cells were 
recently reported (Hoeben et al., 1999). The inhibitory effect on in vitro cultured bovine bone 
marrow progenitors not only appeared at supratherapeutic, but already at physiological 
concentrations.  
Non-steroidal anti-inflammatory drugs (NSAID’s) are known for many years for their 
anti-inflammatory, antipyretic and analgesic effects. They generally prevent the formation of 
inflammatory mediators by cyclo-oxygenase (COX) inhibition and reduction of prostaglandin E2 
(PGE2) production in the brain. Under experimental conditions, NSAID’s have been shown to 
have some beneficial effects (reduced rectal temperature, decrease in quarter inflammation,…), 
combined with a reduced concentration of inflammatory mediators in milk and plasma 
(Anderson et al., 1986a; 1986b; Lohuis et al., 1989; Ziv, 1992). A major disadvantage of most 
experimental studies evaluating NSAID efficacy is the use of an LPS model, in which animals 
rapidly return to normal milk production, therefore lacking to show any beneficial effects on 
milk production, rate of return to production or survival (Shpigel, 2001).  
Recently, NSAID efficacy was evaluated in the field (Shpigel et al., 1994; 1996). 
Ketoprofen significantly improved recovery in clinical mastitis, increasing the odds ratio for 
recovery by as much as 7 (Shpigel et al., 1994). In contrast, phenylbutazone and dipyrone only 
increased odds ratio to 2.42 and 1.71, respectively (Shpigel et al., 1996). Therefore, ketoprofen 
can be recommended as an adjunctive therapy in the treatment of Gram-negative clinical mastitis 
in dairy cows (Shpigel et al., 1994).  
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4.2.3. Additional treatments 
 
Several non-antibiotic methods have been suggested for the treatment of clinical 
mastitis, such as frequent milk-out with or without oxytocin administration, fluid therapy, 
hydrotherapy, intramammary infusions of saline, antihistamines, diuretics, hot and cold packing, 
hypertonic saline infusion and ultrasonic therapy (Roberson et al., 2004). Only two of the most 
relevant and practical supportive treatments will be discussed here. 
Frequent milk-out was encouraged as a possible treatment for mastitis as early as 1869 
by Sloan (1869), who claimed that the bad milk should be drawn three to four times a day, for by 
remaining in the bag, it tends to increase the inflammation. Since then, the practice of frequent 
milk-out, often facilitated by the administration of oxytocin, has been encouraged, although no 
scientific reports on potential beneficial effects are available (Leininger et al., 2003). 
Theoretically, frequent milk-out should have beneficial effects on clinical and bacteriological 
cure of E. coli mastitis, based on the fact that released and accumulated endotoxin in the affected 
mammary gland would more frequently be removed (Morin et al., 1998; Roberson et al., 2004). 
Therefore, from a practical point of view, this strategy was frequently recommended in the past 
(Eberhart et al., 1987). Recently, two studies compared non-treated controls to cows treated by 
frequent milk-out with oxytocin administration in field cases (Roberson et al., 2004) or 
experimentally induced  E. coli challenge (Leininger et al., 2003). Neither of both studies could 
show beneficial effects of frequent milk-out on the clinical or bacteriological cure rate of the 
affected animals. This is, however, not surprising as frequent milk-out is rather difficult during 
acute E. coli mastitis due to severe swelling of the affected quarter.  
Fluid therapy is widely recommended for the treatment of severe clinical E. coli mastitis, 
although very little published information assessing its efficacy is available (Green, 1998). In 
practice, several problems can arise when deciding upon a fluid therapy regimen: 1) oral fluid 
administration alone is probably of little benefit as gastro-intestinal mobility and function are 
depressed during severe clinical mastitis, resulting in a poor absorption of the administered 
fluids, 2) no field data are available which indicate improved survival rates following a fluid 
therapy regimen. Even though no direct clinical benefit would be proven, fluid therapy may 
nevertheless support the general clinical condition of the treated animal (Green, 1998).  
Essentially, two types of intravenous fluid therapy with practical application are 
available: isotonic and hypertonic fluid therapy. Isotonic solutions contain 0.9% NaCl and are 
administered in large quantities (50 to 100 ml/kg body weight per 24 h), with a fast rate of 
administration in the first hours of therapy (50 ml/kg). In contrast, hypertonic solutions contain 
much higher concentrations of NaCl (7.2%) and are administered concomitantly with an ad 
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libitum provision of water. The principal effect of hypertonic saline is thought to be an increase 
in preventricular load, and hence an increased plasma volume and blood pressure, leading to a 
general improvement in tissue perfusion (Green, 1998).   
 
5. PREDICTION OF THE SEVERITY OF EXPERIMENTALLY INDUCED E. 
COLI MASTITIS 
 
The variability in the severity of clinical signs of acute coliform mastitis is due to the 
physiological quality of the PMN. The quality seems to be determined by factors acting at the 
level of the bone marrow, the blood and the mammary gland. It is therefore reasonable and 
logical to assume that it could be possible to predict the severity of acute mastitis during early 
lactation through measurement of circulating PMN activity (Burvenich et al., 1999).  
The predictability of the number of circulating PMN as a marker for mastitis 
susceptibility was limited to the moment immediately before infection (Kremer et al., 1993b) 
(Table 14), although the correlation coefficient between the number of circulating leukocytes 
immediately before infection (d0) was +0.81 with d-1, +0.83 with d-2, and +0.74 with d-5 (van 
Werven et al., 1997).  
 
Table 14. Correlation between pre-infection parameters determined immediately prior to 
inoculation (d0), and at d+1, 2, 5, and 6 before inoculation and severity of E. coli mastitis 
characterised by bacterial growth in infected quarters (AUC) (Kremer et al., 1993b). 
 
Pre-infection parameter days before infection r P 
number of PMN in blood 0 -0.71 * 
 1 -0.61  
 2 -0.61  
 5 -0.22  
 6 .  
chemotactic differential of WBC 0 -0.83 *** 
 1 -0.90 *** 
 2 -0.88 *** 
 5 -0.55  
 6 -0.16  
chemotactic differential of PMN 0 -0.60  
 1 -0.72 * 
 2 -0.74 ** 
 5 -0.92 *** 
 6 0.13  
 
Besides a high number of circulating PMN, a fast migration of these cells into the 
affected mammary gland upon bacterial infection is critical for the outcome of coliform mastitis 
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during early lactation (Hill, 1981). Chemotaxis of PMN isolated from blood was negatively 
correlated with bacterial growth in the milk of the infected quarters (Lohuis et al., 1990b). 
Moreover, PMN isolated from blood of cows with severe clinical signs of mastitis had a 
significantly lower pre-infection chemotactic activity than cows with moderate symptoms of 
mastitis (Kremer et al., 1993a). During 2 consecutive days before infection, the chemotactic 
activity in severely diseased animals was only about 50% of the normal chemotactic activity, as 
measured in moderate responders. This resulted in a significant predictive capacity of the 
chemotactic differential towards severe clinical mastitis (Table 14). 
In another study (van Werven et al., 1997), the predictive value of PMN chemotaxis, 
phagocytosis, oxidative burst and CD11/CD18 adhesion molecules for severity of acute clinical 
mastitis was evaluated (Table 15). Of all the investigated markers in the circulation, PMN 
chemotaxis predicted best the outcome of experimentally induced E. coli mastitis.  
 
Table 15. Correlation between assessments immediately prior to inoculation (d0), and at d+1, 2, 
3, 4 5, and 6 before inoculation for values of chemotaxis, phagocytosis, oxidative burst, and 
CD11/CD18 molecule expression on PMN isolated from blood (van Werven et al., 1997).  
 
  Pre-infection PMN functionality and characteristics 
day chemotaxis phagocytosis oxidative 
burst 
CD11a 
expression 
CD11b 
expression 
CD11c 
expression 
-6 0.53 . 0.30 0.73 0.69 0.24 
-5 0.75 0.50 . . . . 
-4 0.66 0.86 0.70 0.78 0.89 0.33 
-3 0.59 . . . . . 
-2 0.35 0.84 0.85 0.47 0.80 0.68 
-1 0.05 0.77 0.84 0.46 0.31 0.91 
 
 Besides these risk factors for a severe clinical mastitis following intramammary E. coli 
challenge, predictive capacity could also be attributed to several severity determining factors. It 
is obvious from previously presented data that the incidence of severe clinical mastitis is much 
higher during early lactation, compared to the other stages of lactation and the dry period 
(Erskine et al., 1988; Burvenich et al., 2000). Moreover, severe reactions have mainly been 
observed in older animals in negative energy balance (Kremer et al., 1993c; Vandeputte-Van 
Messom et al., 1993; van Werven et al., 1997), whereas little is known on severity of the clinical 
response in primiparous cows. 
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6. CONCLUSIONS 
 
 In conclusion, the knowledge on the pathogenesis of E. coli mastitis has expanded 
greatly during the last 20 years. In contrast to infectious mastitis, the incidence and severity of E. 
coli mastitis is mainly due to cow factors, whereas bacterial virulence factors only play a minor 
role in the disease. Moreover, the circumstances under which moderate and severe clinical 
responses appear have extensively been studied in experimental E. coli mastitis models. In 
practice, however, the etiological diagnosis of E. coli mastitis is still problematic, and therefore, 
the availability of a practical severity scoring should help the clinician to estimate the cow’s 
clinical response and the related treatment prognosis. An attitude change is needed in order to 
successfully establish this innovative approach towards treatment of acute coliform mastitis.  
 However, to be able to make a reliable prognosis, several severity determining factors 
remain unexplored, such as the parity or age of the affected animals. Until now, older cows are 
supposed to be more susceptible to severe clinical coliform mastitis, but data on primiparous 
cows remain scarce. Taking into account the rapid turnover of dairy cows in our dairy herds, 
knowledge on resistance against or severity during intramammary E. coli infection of a large 
proportion of animals in the dairy herd, the primiparous cows, remains insufficient.  
 If an age-related resistance would exist, further questions towards the efficacy of 
therapeutic or prophylactic strategies remain unanswered. It would therefore be of interest to 
evaluate some of these strategies in an experimental E. coli model.  
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Review of literature clearly indicates the important role of PMN in the pathogenesis of 
E. coli mastitis, particularly in the elimination of E. coli itself and the released LPS. Therefore, it 
is obvious that small changes in PMN functionality, e.g. diapedesis and oxidative burst, could 
have a tremendous impact on the pathogenesis of subsequent E. coli mastitis (Heyneman et al., 
1990; Vandeputte-Van Messom et al., 1993). From this perspective, the experimental 
investigation of these factors is of interest to quantify the inflammatory reaction. However, in the 
past, PMN functionality during different stages of lactation and experimentally induced 
challenge has mainly been studied in the blood, although the site of infection is situated at the 
level of the mammary gland. Epidemiological studies have shown an association between low 
bulk milk SCC and an increased incidence of coliform mastitis (Schukken et al., 1989a; 1989b; 
Barkema et al., 1999). The role of the resident cells in the healthy bovine mammary gland with a 
low SCC and the effect of external bacterial contamination during milk sample collection on the 
PMN functions remain unclear.  
Until now, practical treatment of E. coli mastitis remains problematic. Standard therapy 
includes antibiotics, although efficacy and treatment success have never been fully established 
(Shpigel, 2001). Of major importance is the fact that intramammary infections with Gram-
negative bacteria only occur as clinical mastitis, whereas Gram-positive bacteria can have a 
clinical, subclinical or chronic course of infection. Therefore, there is an urgent need for 
improved prognosis of the course of clinical disease, mainly to discriminate between moderate 
cases, which have a high degree of self-curing and do not require treatment, and severe 
responders, which require rapid and efficient intervention with general supportive therapy and 
anti-inflammatory drugs. Risk factors for the development of severe clinical E. coli mastitis are 
limited to the stage of lactation (Burvenich et al., 1994; 2003), whereas parity or age of the cow 
have hardly been studied (Gilbert et al., 1993; van Werven et al., 1997). Nevertheless, some 
indications for differences in susceptibility between primiparous and multiparous cows have 
recently been found (Mehrzad et al., 2002). In the context of modern farm management, related 
with a relatively high turn-over of the dairy cow population, no information is available on 
resistance against clinical E. coli mastitis for a significant proportion of the farm population, 
namely the primiparous cows.  
Using an experimental intramammary E. coli challenge model to obtain information on 
inflammatory reaction kinetics in primiparous cows, it could also be of interest to evaluate 
possible modulatory effects of inoculum dose, NSAID treatment and prophylactic vaccination 
against the endotoxin. General perception would link an increased inoculum dose to more 
pronounced disease symptoms, whereas practically used therapeutic or prophylactic measures 
are usually thought to accelerate resolution or to protect from severe clinical symptoms.  
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Figure 1. Schematic drawing of the hypothesis and objectives of this thesis. Left pathway: study 
of the effect of external bacterial contamination on cellular response of resident cells in milk (*) 
(p. 69). Right pathway: following intramammary E. coli infection, bacterial growth and lysis 
leads to the release of LPS, which interacts with the resident cells in milk. Binding of LPS by 
LBP/sCD14 induces a cellular response, which changes resident milk cell characteristics and  
elicits an inflammatory response resulting in changes in milk secretion. (**) Effect of parity is 
studied through intramammary challenge of primiparous cows (p. 125), (***) the modulatory 
effects of a variation in inoculum dose (p. 145), inhibition of prostaglandin synthesis (p. 167) 
and vaccination against the endotoxin (p. 189) on the inflammatory reaction (mild-moderate-
severe) in primiparous cows are subsequently studied. 
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In this thesis, the effect of external bacterial contamination through milk sampling on 
several pre-infection milk related parameters was studied. Moreover, the inflammatory reaction 
kinetics of primiparous cows were evaluated in an intramammary E. coli challenge model and 
possible modulatory effects were studied. Specific objectives were: 
1. to evaluate the effect of milk sampling technique on cellular response of resident 
cells in low SCC milk of high-yielding dairy cows. 
2. to determine the influence of lactation number on the inflammatory reaction 
following intramammary E. coli challenge. 
3. to study modulation of a moderate inflammatory reaction through a variation in 
inoculum dose, inhibition of prostaglandin synthesis and vaccination against the 
endotoxin in primiparous cows following intramammary E. coli challenge.  
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INTRODUCTION 
 
Milk SCC is generally considered to be an important parameter for mastitis detection 
because inflammation of the mammary gland results in an influx of somatic cells, predominantly 
PMN, from the blood into the mammary gland (Burvenich et al., 1994). It is of importance that 
evaluation of animals, based on pre-infection milk parameters, can be performed under 
standardised conditions. Cows with low milk SCC have been suggested to be more susceptible to 
intramammary infection (Kehrli and Shuster, 1994). Although the important role of blood PMN 
in the pathogenesis of mastitis is well described, the contribution of resident milk cells to the 
intramammary defence mechanism is not well characterised. In healthy cows, the number, 
differential count and function of leukocytes within the mammary gland could contribute to the 
defence against invading pathogens. Both artificially induced (Vandeputte-Van Messom et al., 
1993; Shuster et al., 1996) as well as naturally occurring (Nickerson et al., 1990) increased SCC 
have been shown to exert a protective effect against severe inflammatory response to 
intramammary infections.  
Bacterial contamination during sampling could influence various cell functions and may 
interfere with the interpretation of physiological effects on cell function. Bacteria or yeast have 
been used in assays of phagocytosis, intracellular killing or oxidative burst of stimulated cells 
(Paape and Pearson, 1979; Saad and Hageltorn, 1985; Saad, 1987; Hallén-Sandgren et al., 1991; 
Stevens et al., 1991; Smits et al., 1997). Paape and Pearson (1979) studied the influence of the 
isolation procedure of PMN in the milk on the variation of phagocytosis. They reported that the 
variation in milk PMN isolation technique accounted for only 1.5% of the total variation. The 
variability between duplicate determinations was 4.4% of the total variation.  
Not only milk cell function, but also the distribution of the different cell populations in 
milk has recently been considered a major point of interest. Although several flow cytometric 
differential leukocyte count methods for bovine milk have been described (Hageltorn and Saad, 
1986; Östensson et al., 1988; Redelman et al., 1988; Saad and Östensson, 1990), these methods 
have predominantly been developed for high SCC milk samples. In addition, little attention has 
been paid to the standardisation of sample preparation procedures. Milk sample processing 
varies from the use of centrifuged whole milk samples (Redelman et al., 1988) to dilution with a 
hypotonic buffer (Hageltorn and Saad, 1986; Östensson et al., 1988); and the temperature of 
milk sample collection, storage and processing have never been described in detail. Flow 
cytometric identification of bovine milk cells based on forward scatter (FS) and side scatter 
(SSC) is difficult because phagocytosis of milk components may alter both size and intracellular 
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granularity and cellular debris may interfere with the scatter pattern of normal cells. Therefore, 
most flow cytometric differential milk leukocyte count techniques are based on fluorescent 
labelling with monoclonal antibodies against CD molecules or DNA labelling (Hageltorn and 
Saad, 1986; Kelly et al., 2000; Leitner et al., 2000; Pillai et al., 2001). The cells in milk are end-
stage cells which have been activated by diapedesis and phagocytosis of milk fat and protein. 
Therefore, they are particularly sensitive to permeabilising agents, causing drastic alterations of 
the FS and SSC pattern.  
  The objectives of the present study are the validation of milk sample collection under 
aseptical conditions and the evaluation of the effect of bacterial contamination on pre-infection 
PMN functionality in vitro. Moreover, a differential leukocyte count method with minimal 
effects on milk cell morphology was developed in order to approach the original cellular 
composition of milk as close as possible. Therefore, alteration of cellular morphology was 
avoided by using a live cell permeable DNA labelling dye and optimising the collection, 
processing, storage and labelling conditions. 
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MATERIALS AND METHODS 
 
Experimental Animals 
All cows were free of intramammary infection. Mean milk SCC from each quarter was 
determined to be < 2 x 105 cells/ml. In part 1 of the study, 10 Holstein-Friesian cows were 
selected from the Ghent University dairy herd (Biocentrum Agri-Vet, Melle, Belgium). The 
parity of the cows ranged between 1 and 5. The cows were in early lactation (9 ± 3 days in 
lactation). In part 2 of the study, 13 healthy Holstein-Friesian cows were selected from the same 
dairy farm. For method development, cows (n = 6) in mid-lactation (150-210 days in lactation) 
were used. For method application, cows (n = 7) were in early lactation (22 ± 4 days in 
lactation). The parity of the cows ranged between 1 and 6. 
 
Milk Sampling  
In part 1 of the study, 3 different milk sampling techniques were compared: 1) a sterile 
teat cannula infusion apparatus (STER-SPL), 2) manual hand milking (MAN-SPL) and 3) 
quarter machine milking (CONT-SPL). Because of practical restrictions, the experiment was 
divided into 2 separate trials. In trial 1, STER-SPL was compared with MAN-SPL (n = 5). In 
trial 2, STER-SPL was compared with CONT-SPL (n = 5). In all three sampling techniques, the 
teat ends were thoroughly disinfected with 70% ethanol containing 0.5% chlorhexidin before 
sample collection. The same quarter was used to perform the different sampling techniques. 
During both trials, milk was first collected through STER-SPL, followed by one of both other 
techniques (MAN-SPL or CONT-SPL). For MAN-SPL,  a volume of 1,000 ml was milked into a 
sterile pyrex container (volume 1,500 ml, diameter opening 50 mm) by manual hand milking. 
For STER-SPL, a sterile and pyrogen-free cannula (L 7 cm, Ø 2 mm; Me.Ve.Mat, Deinze, 
Belgium) was inserted into the teat canal, which was then connected to the free end of an 
infusion set attached to a 2,000 ml sterile collection bag (Uripac; Vycon, Brussels, Belgium) 
(Fig. 1). For CONT-SPL, the same fraction of milk was collected using a quarter milking 
machine. All different milk samples were collected during morning milking at 0800 a.m. 
 
Transport of Milk Samples 
Milk samples were stored in a coolbox with active cooling immediately after sampling. 
The time interval between sampling and the arrival at the laboratory was kept as short as 
possible (max. 1 h).  
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Figure 1. The sterile sampling 
technique devices, namely: (A) 
sterile and pyrogen-free 
cannula (Me.Ve.Mat, Deinze, 
Belgium), (B) sterile infusion 
set and (C) sterile collection 
bag (Uripac; Vycon). 
 
 
Bacterial Contamination 
In part 1 of the study, bacteriological examination was carried out through plating of 10 
µl onto a Columbia agar with 5% sheep blood (Biokar Diagnostics, Beauvais, France) with a 
Transferpette (Brand GmbH, Wertheim, Germany). Subsequently, the milk was smeared out 
over the plate with a sterile plastic loop. Each sample was plated out in duplicate and incubated 
for 24 h at 37°C. Colony-forming units were counted using the plate counting method. Detection 
limit of the bacteriological method was 1 CFU per 20 µl or 50 CFU/ml milk. 
 
Somatic Cell Count and Milk Composition 
Somatic cell count was determined with a fluoro-opto electronic method (Fossomatic 
5000 cell counter; Foss Electrics, Hillerφd, Denmark). Milk fat, protein and lactose 
concentrations (mg/ml) were determined by mid-infrared photospectrometry (MilkoScan 4000; 
Foss Electrics). Glucose concentration (mg/l) was determined using an UV-method (D-Glucose; 
Roche Diagnostics, Brussels, Belgium) according to manufacturer’s instructions. 
 
Isolation of Resident Milk Cells for Analysis of Milk Cell Characteristics and Functionality 
The isolation of milk cells was performed as described by Paape et al. (1976) with some 
modifications. Phosphate buffered saline (PBS) solution (25 l) was prepared as follows: 5 l of 
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stock solution (5.5842 g KH2PO4, 37.2438 g Na2HPO4, 40.9 g NaCl, distilled H2O; pH adjusted 
to 7.5) was diluted to 25 l with distilled H2O and 180 g NaCl was added. The PBS solution was 
sterilised through filtration with a cellulose acetate filter (pore size 0.2 µm; Whatman, 
Maidstone, UK). Milk, diluted 2/1 with sterile PBS, was centrifuged (1,000 x g, 15 min, 4°C) 
and the cream was removed after the first centrifugation. The cell pellet was washed twice in 
PBS and the cells were finally resuspended in Hanks balanced salt solution (HBSS; Gibco Life 
Technologies, Paisley, UK) containing Ca2+ and Mg2+ supplemented with 0.1% bovine serum 
albumin  (BSA, low endotoxin; Sigma Chemicals, St. Louis, MO, USA) and 25 mM HEPES 
buffer (Sigma).  
During isolation, the cells were maintained on melting ice (1°C). Isolated cells were 
counted using an electronic particle counter (Coulter Counter Z2; Coulter Electronics Ltd., 
Luton, England) and viability was determined. The milk cells were resuspended to a 
concentration of 5 x 106 viable milk cells/ml with HBSS containing Ca2+ and Mg2+ supplemented 
with 0.1% BSA and 25 mM HEPES buffer.  
 
Viability, Apoptosis and Differential Counts of Isolated Milk Cells 
Milk PMN viability was determined by propidium iodide (PI) exclusion. Viable PMN 
having an intact cell membrane, are impermeable to PI (PI-negative); whereas necrotic PMN 
having a deficient cell membrane, are permeable to PI (PI-positive). Ten µl of PI (50 µg/ml 
PBS) was added to the cell suspension (400 µl) and analysed by flow cytometry (FACScan; 
Becton Dickinson Immunocytometry Systems, San José, USA). The PMN were gated, based on 
their FS and SSC, in accordance with the settings found through flow cytometric analysis of pure 
PMN populations (Mehrzad et al., 2001) (Fig. 2). 
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Figure 2. Flow cytometric analysis of isolated bovine milk PMN gated in the FS-SSC dot plot 
(A). Green fluorescence (FL-1) of PMN labelled with a monoclonal antibody specific against 
bovine granulocytes and with a secondary FITC-labelled antibody (B). Red fluorescence of PI-
incubated PMN selectively gated in the FS-SSC dot plot (C). Gate M1 is applied to determine 
the percentage of dead PMN (for the quantification of the viability).   
 
Milk PMN apoptosis was assessed by addition of annexin-V-FITC and PI according to 
Van Oostveldt et al. (1999) with slight modifications. Briefly, 50 µl of annexin-V-FITC/PI was 
added to the cell suspension and incubated for 10 min. After incubation, 300 µl of RPMI 1640 
(Gibco Life Technologies) were added and apoptosis was quantified through flow cytometry 
PMN
A 
B 
C 
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(FACScan). Polymorphonuclear leukocytes were again gated, based on their FS/SSC. Apoptotic 
PMN (programmed cell death) are also PI-negative (viable), but can be distinguished within the 
viable PMN population by their expression of phospholipid phosphatidyl-serine, binding with 
annexin-V-FITC, on their outer cell membrane (Fig. 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Flow cytometric analysis of isolated bovine milk PMN gated in the FS-SSC dot plot 
(A). Green fluorescence (FL-1) of annexin-V-FITC in the X-axis and red fluorescence (FL-2) 
from PI in the Y-axis of the flow cytometric analysis program (B). Cells in the lower left 
quadrant are negative for both fluorescent markers and are classified as living PMN. Cells in the 
lower right quadrant are positive for annexin-V-FITC (apoptosis marker), though negative for PI 
and are classified as apoptotic. Cells in the upper right quadrant are positive for both annexin-V-
FITC and PI and are classified as dead (necrotic).  
 
Differential counts of isolated milk cells were carried out as described by Dulin et al. 
(1988). Two hundred cells were counted on each of the smears and the percentages of 
lymphocytes-monocytes (LM), macrophages (MΦ) and PMN were determined. These data were 
used to correct intracellular killing and CL for the percentage of PMN in the isolated milk cells. 
 
PMN
A 
B 
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Neutrophil Function Tests 
Phagocytosis and intracellular killing of Staphylococcus aureus Newbould 305 was 
evaluated in a bacteriological assay according to Barta (1993) and Barrio et al. (2000) with few 
modifications for milk. The assay was run in duplicate in Eppendorf tubes (Netheler-Hinz 
GmbH, Hamburg, Germany) in a final volume of 1 ml with the following composition: 500 µl 
isolated cells (5 x 106 viable cells/ml), 100 µl S. aureus Newbould 305 suspension (1 x 108 
CFU/ml) and 400 µl pooled bovine serum diluted to a final concentration (v/v) of 5% 
(complement-inactivated, 56°C, 30 min). Control samples contained bacteria, HBSS and serum 
without PMN. The bacteria to PMN ratio was between 4:1 and 5:1.   
The results from the bacteriological assay were expressed as the percentages of killed (% 
killing) and phagocytosed (% phagocytosis) bacteria and were corrected for the percentage of 
PMN and MΦ in the samples of isolated milk cells as described by Dosogne et al. (2001).  
Luminol-enhanced PMA (phorbol 12-myristate 13-acetate) –stimulated cellular CL of 
milk PMN was quantified on isolated milk cells as described by Mehrzad et al. (1999). Non-
stimulated CL was compared with PMA-stimulated CL. The area under the curve (AUC) was 
calculated for the registrated impulse rate over a 30-min period. The CL response was corrected 
for 1,000 viable PMN.  
 
SYTO

13 Labelling 
A stock of SYTO13 (5 mM, Molecular Probes, Eugene, USA), a live cell permeable 
DNA labelling dye, in DMSO was stored at −18°C and diluted 1:40 with RPMI 1640 (Gibco 
Life Technologies) immediately before labelling, according to the manufacturer’s prescriptions. 
This corresponds with a final concentration of 200 nM in the samples. Two other dilutions 
(1:200 and 1:400; 40 and 20 nM final concentrations, respectively) were also evaluated with low 
SCC milk samples from 5 cows, but 1:40 was used for the standard procedure. Four hundred and 
ninety µl RPMI was added to the cell pellets (1 x 105 – 4 x 106 cells/ml), followed by 10 µl 
diluted SYTO13 solution. This mixture was incubated during 0, 5, 10, 20 and 30 min. A 10-min 
incubation period was necessary for optimal labelling of all cells (Table 5) and was further used 
for the standard differential leukocyte count procedure. 
 
Flow Cytometry and Cell Sorting 
A flow cytometer (FACScan) equipped with an argon ion laser was used for 
measurement of differential leukocyte count. The excitation wavelength of the laser was 488 nm. 
The FS signal was amplified with a factor 1.98, whereas SSC and fluorescence signals were not 
amplified. The voltage applied on the SSC detector was 381 V. Forward scatter and SSC were 
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measured on a linear scale. Four hundred and thirty V was applied on the photomultipliers for 
both green and red fluorescence. Green fluorescence was measured using a 530-nm band-pass 
filter and registered on a log scale, whereas red fluorescence emission was measured using a 650 
nm long-pass filter and also registered on a log scale. The data were analysed using the 
CellQuest (Becton Dickinson) software. Flow cytometric differential leukocyte count of milk 
after SYTO13 staining was quantified using the SSC - green fluorescence (FL-1) dot plot. Flow 
cytometric cell sorting of SYTO13-labeled milk cells was performed using a FACSVantage 
cell sorter (Becton Dickinson).  
 
Confocal Laser Scanning Microscopy 
A lambda (wavelength) scan was performed on cytospin smears of SYTO13-labeled 
milk cells using an inverted confocal laser scanning microscope (DMIRBE HCB fluoro 
microscope with a TCS SP2 confocal system; Leica Microsystems, Wetzlar, Germany). Four 
different regions of interest (ROI) were defined around 4 different cell types based on size and 
shape. The fluorescence emission intensity at wavelengths between 498 and 644 nm was 
registered for these 4 ROI’s. 
 
Milk Sample Preparation for Differential Leukocyte Count 
All milk samples were gently mixed before dilution and further processing. For the flow 
cytometric cell sorting procedure, cells were isolated from milk according to Hoeben et al. 
(1997) and finally resuspended to a concentration of 5 x 106/ml after counting with an electronic 
particle counter (Coulter Counter Z2). For the differential leukocyte count procedure developed 
in this study, 1.5 ml milk samples were layered on 3.5 ml PBS into 12 x 75 mm polystyrene flow 
cytometry tubes (Vel, Leuven, Belgium) and centrifuged during 10 min at 180 x g. Fat was 
removed, the supernatant was discarded and the tubes were kept upside down until they were 
carefully cleaned with a cotton swab to remove all fat adhering to the test tube wall. The pellet 
was then resuspended with 490 µl RPMI for flow cytometric differential leukocyte count or with 
1 ml tryptic soy broth (TSB; Sigma Chemicals) for preparation of microscope slides.  
Different dilution buffers were tested with low SCC milk samples from 6 cows: PBS;  
RPMI 1640 supplemented with 1% bovine serum albumin (Sigma) and 0.2% sodium azide 
(Sigma); and PBS supplemented with 0.1% paraformaldehyde (Sigma).  
The following dilutions of milk samples were evaluated: 0.5, 1.0, 1.5 and 2.0 ml milk + 
4.5, 4.0, 3.5 and 3 ml PBS, respectively, using low SCC milk samples from 6 cows. In order to 
evaluate the effect of temperature on the differential leukocyte count of milk, low SCC milk 
samples from 6 cows were maintained at 4, 20 and 37°C from immediately after collection, over 
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transportation and processing until flow cytometric analysis. The optimal dilution (1.5 ml milk 
with 3.5 ml PBS) and transportation and processing temperature (20°C) were further used for 
validation of the standard differential leukocyte count procedure.  
 
Variability of Differential Leukocyte Count Method 
The variability of the flow cytometric measurement of differential leukocyte count was 
tested by performing 6 repeated measurements on one sample. Variability of the complete 
differential cell count method was evaluated by performing 5 repetitions of the identification 
procedure for low SCC milk samples from 6 different cows. Significant differences in 
identification between the milk samples were evaluated for 2, 3, 4 and 5 repeated differential cell 
counts. The variability of the method was also evaluated at 500; 1,000; 2,000 and 3,000 analysed 
cells, with 6 repeated measurements for each number of cells analysed in a single sample. In the 
standard procedure, 3,000 cells per sample were analysed (Table 5). 
 
Preparation of Microscope Slides and Comparison Between Flow Cytometric and 
Microscopic Differential Leukocyte Count 
A described procedure for preparing microscope slides was used (Dulin et al., 1982). 
Slides were prepared in a cytocentrifuge (Shandon, Astmoor, UK) using 200 µl cell suspension 
with a concentration between 1 and 5 x 105 cells/ml. The suspensions were centrifuged during 10 
min at 113 x g. The smears were stained with May-Grünwald’s eosin-methylene blue (Merck 
Diagnostica, Darmstadt, Germany). At least 200 cells were identified per sample, at a 
magnification of 1,000. Polymorphonuclear leukocytes were identified based on their multi-
lobed dark purple stained nucleus and lightly blue stained cytoplasm. Polymorphonuclear 
leukocytes were characterised for apoptosis based on the morphologic features of pycnotic 
nuclei. Mature MΦ were large, with a light purple stained round nucleus and a vacuolated 
cytoplasm. Milk LM had the same appearance as their counterparts in the blood. Epithelial cells 
were large, mostly without nucleus, irregularly shaped and homogeneously light blue stained. 
For comparison of the flow cytometric differential leukocyte count method with microscopy, 
low SCC milk samples from 7 cows in early lactation were prepared in duplicate using the 
sample preparation method described above. One sample was used for flow cytometry and from 
the other one, slides were prepared in duplicate. Correlation between the % LM, PMN and 
mature MΦ obtained with the 2 methods was calculated. 
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Statistical Analysis 
In part 1, differences between sampling techniques for SCC, milk composition, bacterial 
contamination, viability, phagocytosis, intracellular killing, PMA-stimulated and non-stimulated 
CL were evaluated by least squares ANOVA with Bonferroni's correction (Statistix, Analytical 
Software, Tallahassee, FL, USA). Significant differences were determined at P < 0.05*, P < 
0.01**, and P < 0.001***. 
In part 2, the effects of sample dilution, temperature and storage time at 4°C were 
evaluated using ANOVA. For evaluation of the method variability, the results were subjected to 
a Wilk Shapiro rankit plot to examine the normality of the distribution of repeated differential 
cell count analyses.  
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RESULTS 
 
Somatic Cell Count and Milk Composition  
No significant difference in SCC, fat, protein, lactose and glucose content was found 
between STER-SPL and MAN-SPL, nor between STER-SPL and CONT-SPL milk sampling 
(Table 1). 
 
Table 1. SCC and milk composition of STER-SPL vs. MAN-SPL and STER-SPL vs. CONT-
SPL milk samples during early lactation. Data are means (± SEM).  
 
 Milk Sampling Technique 
 STER-SPL MAN-SPL CONT-SPL 
SCC (log10/ml) 4.4 ± 4.1 4.5 ± 3.9  
 4.4 ± 4.0  4.9 ± 4.7 
FAT (mg/ml) 24.2 ± 5.2 22.3 ± 4.6  
 25.5 ± 5.8  42.8 ± 7.0 
PROTEIN (mg/ml) 39.5 ± 2.6 40.1 ± 2.8  
 39.0 ± 3.7  37.3 ± 3.6 
LACTOSE (mg/ml) 49.3 ± 1.5 50.1 ± 1.6  
 49.3 ± 2.1  46.2 ± 2.7 
GLUCOSE (mg/l) 93.6 ± 11.2 102.0 ± 0.8  
 106.9 ± 12.9  94.0 ± 9.7 
 
Bacterial Contamination  
 Bacterial contamination was not significantly different between STER-SPL and MAN-
SPL milk sampling, whereas it was significantly (P < 0.001) higher in CONT-SPL compared to 
STER-SPL milk sampling (Table 2). 
 
Table 2. Bacterial contamination (CFU/ml) from STER-SPL vs. MAN-SPL and STER-SPL vs. 
CONT-SPL milk samples during early lactation. Data are means (± SEM). Significant 
difference: a STER-SPL vs. CONT-SPL (P < 0.001). 
 
 Milk Sampling Technique 
 STER-SPL MAN-SPL CONT-SPL 
bacterial count (CFU/ml) 0 660 ± 413  
 0 a  6,620 ± 2,339 a 
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Resident Milk Cell Viability  
 No significant difference in viability was found between STER-SPL and MAN-SPL, nor 
between STER-SPL and CONT-SPL milk sampling (Fig. 4). During early lactation, milk PMN 
viability was on average 38.6 ± 6.83 %. 
 
 
 
 
 
 
 
 
Figure 4. Viability of resident PMN: (a) trial 1: STER-SPL  vs. MAN-SPL  milk samples, 
and (b) trial 2: STER-SPL  vs. CONT-SPL  milk samples during early lactation. Data 
(expressed as %) are means (± SEM). 
 
Phagocytosis and Intracellular Killing of Staphylococcus aureus 
 Neither of both PMN functionality tests were significantly influenced by the different 
milk sampling techniques (Fig. 5). Phagocytosis and intracellular killing during early lactation 
were on average 83.4 ± 2.63 % and 14.8 ± 7.33 %, respectively. 
 
 
 
 
 
 
 
 
Figure 5. Phagocytosis (A) and intracellular killing (B) of S. aureus: (a) trial 1: STER-SPL  
vs. MAN-SPL  milk samples, and (b) trial 2: STER-SPL  vs. CONT-SPL  milk samples 
during early lactation. Data (expressed as %) are means (± SEM). 
 
Non-Stimulated and PMA-Stimulated Chemiluminescence  
Non-stimulated and PMA-stimulated CL were not significantly different between STER-
SPL and MAN-SPL, nor between STER-SPL and CONT-SPL milk sampling (Fig. 6). During 
early lactation, non-stimulated and PMA-stimulated CL were 1,150 ± 220 AUC and 2,087 ± 351 
AUC, respectively. 
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Figure 6. Non-stimulated chemiluminescence (A) and PMA-stimulated chemiluminescence (B): 
(a) trial 1: STER-SPL  vs. MAN-SPL  milk samples, and (b) trial 2: STER-SPL  vs. 
CONT-SPL  milk samples during early lactation. Data (expressed as AUC) are means (± 
SEM). 
 
Flow Cytometry and Cell Sorting was Performed Based on Green Fluorescence (FL-1) and 
Side Scatter (SSC) 
Both red (FL-3) and green (FL-1) fluorescence emission of bovine milk cells was 
observed following SYTO13 labelling. Because the best resolution between the populations 
was obtained with FL-1 and SSC, these parameters were used for the differential leukocyte count 
procedure. Red fluorescence was reduced at lower SYTO13 concentrations, but this also 
resulted in decreased resolution in the green fluorescence (Table 3). In the FL-1 – SSC dot plot 
of isolated cells, 5 different leukocyte populations were identified (Fig. 7A). Following flow 
cytometric cell sorting of SYTO13-labeled milk cells using the FL-1 − SSC dot plot (Fig. 7A), 
the different cell populations were identified as: 1) SSClow – FL-1
high: high FL-1 LM (R1); 2) 
SSClow – FL-1intermediate: intermediate FL-1 LM (R1); 3) SSClow – FL-1low: cells with apoptotic 
features (R2); 4) SSChigh – FL-1high: mature MΦ (R4) and 5) SSChigh – FL-1intermediate: PMN (R5) 
(Fig. 7B). Uptake of SYTO13 did not occur immediately and differed between the cell types 
(Table 4). Saturation of the fluorescence intensity was obtained in most cell types after a 10-min 
incubation and remained nearly constant during 20 min. The highest green fluorescence intensity 
was observed in mature MΦ and viable PMN. Lower fluorescence intensity values were found in 
cells with apoptotic features, FL-1low LM and debris. For the standard procedure, a 10-min 
incubation time of cells with SYTO13 was used. 
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Table 3. Green (FL-1) and red (FL-3) fluorescence emission intensity (mean fluorescence 
intensity) of different cell types at different SYTO13 concentrations, measured by flow 
cytometry. Values are means (± SEM) of 5 cows. 
 
 SYTO

13 concentration (nM) 
 20 40 200 
 FL-1 FL-3 FL-1 FL-3 FL-1 FL-3 
Lymphocytes 20 ± 4 2 ± 0  53 ± 21  4 ± 1 176 ± 41 16 ± 3 
Macrophages 286 ± 34 46 ± 24 1,816 ± 125 148 ± 34 2,825 ± 156 243 ± 28 
PMN 37 ± 4  11 ± 8    378 ± 21 30 ± 3 479 ± 31 57 ± 5 
 
Table 4. Effect of incubation time of bovine milk cells with SYTO13 on green fluorescence 
emission intensity (mean fluorescence intensity). Values are the average of 3 repeated 
identification assays. 
 
 Incubation time (min) 
 0 5 10 20 30 
Lymphocytes-monocytes 10 556 1,199 1,829 2,140 
Macrophages 177 3,279 3,365 3,626 3,802 
PMN 162 3,116 3,302 3,628 3,668 
Cells with apoptotic features 4 158 410 831 1,056 
Debris 24 132 140 147 155 
 
Confocal Laser Scanning Microscopy Could Confirm and Identify the Different Cell Types 
Sorted by Flow Cytometry 
 Using a lambda scan of SYTO13-labeled milk cells with confocal laser scanning 
microscopy, a different morphology could be associated with different fluorescence emission 
characteristics (Fig. 8A-B). The cells in ROI1 had an intermediate size, were round-shaped with 
a round nucleus and had a maximal fluorescence emission at 514 nm. This is consistent with the 
characteristics of LM. The cells in ROI2 were large, irregularly shaped and also had a maximal 
fluorescence emission at 514 nm but their fluorescence intensity was much higher than any of 
the other cell types. These cells conform to the characteristics of mature MΦ. The cells in ROI3 
had a multi-lobed nucleus and a maximal but low fluorescence intensity at 498 nm, which are 
typical features of PMN. Finally, the cells in ROI4 had similar fluorescence characteristics as the 
cells in ROI3 but the fluorescence intensity was higher, especially in the higher emission 
wavelength region. These cells contain all characteristics of high FL-1 LM. 
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Figure 7. Flow cytometric analysis (A) of SYTO13-labeled bovine milk cells: green 
fluorescence (FL-1) – side scatter (SSC) dot plot of isolated milk cells used for flow cytometric 
cell sorting and subsequent microscopic identification (B). R1: LM; R2: apoptotic cells; R3: 
cellular debris; R4: MΦ; and R5: PMN. 
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Figure 8. Confocal laser scanning microscopic analysis of fluorescence emission of different 
SYTO13-labeled bovine milk cells using a wavelength scan. A) identification of different 
regions of interest (ROI); B) fluorescence emission characteristics of the different ROI’s 
identified in A). ROI1: LM (high FL-1); ROI2: MΦ; ROI3: PMN; and ROI4: LM (low FL-1). 
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Milk Sample Preparation and Effect of Storage 
Optimal conditions for milk sample preparation were the following: 1) milk sample 
dilution with PBS or RPMI-BSA; 2) 30% (v/v) dilution (i.e. 1.5 ml milk + 3.5 ml PBS) (Fig. 9); 
3) a sample collection, transportation and processing temperature of 20°C (Fig. 10). Both the 
SCC and the differential leukocyte count remained constant throughout a 48-h storage period at 
7°C (Fig. 11).  
 
 
 
 
 
 
 
 
 
Figure 9. Effect of sample dilution on the differential leukocyte count of SYTO13-labeled 
bovine milk cells in low SCC (SCC < 200,000 cells/ml) milk samples. The following dilutions 
were performed: 0.5, 1.0, 1.5, and 2.0 ml milk with 4.5, 4.0, 3.5 and 3.0 ml PBS, respectively. 
Average values for 6 cows are presented. Different cell types analysed from bottom to top are: 
debris, cells with apoptotic features, PMN, mature MΦ and LM. 
 
 
 
 
 
 
 
 
 
 
Figure 10. Effect of sample collection, transportation, processing and labelling temperature on 
the differential leukocyte count and on % debris. Average values of 6 cows are presented. 
Different cell types analysed from bottom to top are: debris, cells with apoptotic features, PMN, 
mature MΦ and LM. 
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Figure 11. Effect of sample storage at 4°C during 24 and 48 h on the differential leukocyte 
count of bovine low SCC (SCC < 200,000 cells/ml) milk samples. Average values for 6 cows are 
presented. Different cell types analysed from bottom to top are: debris, PMN, mature MΦ and 
LM. 
 
Variability of the Differential Leukocyte Count Method 
The coefficient of variation for repeated measurements in identical cell suspensions was 
1.5% for LM, 1.4% for mature MΦ, 0.7% for PMN and 0.8% for cells with apoptotic features. 
Average coefficients of variation for the complete differential leukocyte count method including 
sample dilution, resuspension and SYTO13 labelling of milk samples from 6 cows were 2.5% 
for LM, 15.8% for mature MΦ, 11.8% for PMN and 10.7 % for cells with apoptotic features 
(Fig. 12). According to the Wilk-Shapiro rankit plot against the ordered data, which resulted in a 
straight line, the samples conformed to a normal distribution. Significant differences between the 
samples were obtained at P < 0.05 for duplicate differential leukocyte count assays and at P < 
0.01 for 3 or more repeated assays. The highest variability between repeated measurements was 
observed with 500 analysed cells. The variability further decreased from 1,000 over 2,000 to 
3,000 cells (Table 5). The average % cells in the different regions was not dependent on the 
number of analysed cells. 
 
Table 5. Variability of the differential leukocyte count method at different numbers of analysed 
cells. Values are the average percentage of each cell type (± SEM) for 6 repeated measurements. 
 
 Number of analysed cells 
 500 1,000 2,000 3,000 
Lymphocytes 69 ± 14 68 ± 4 67 ± 3 67 ± 1 
Macrophages 11 ± 3 11 ± 1 12 ± 1 12 ± 1 
PMN 9 ± 3 9 ± 1 9 ± 1 9 ± 1 
Cells with apoptotic features  11 ± 1 12 ± 1 12 ± 1 12 ± 1 
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Figure 12. Triplicate differential leukocyte count of milk samples from 6 mid-lactating cows. 
The average coefficients of variation for the complete differential leukocyte count method 
including sample dilution, resuspension and SYTO13 labelling of milk samples from these 
cows were 2.5 % for LM, 15.8 % for mature MΦ, 11.8 % for PMN and 10.7 % for cells with 
apoptotic features. Data (expressed as %) are means (± SEM). 
 
Correlation between Flow Cytometric and Microscopic Differential Leukocyte Count 
Methods 
For the LM population, a coefficient of correlation of 0.81 (P < 0.05) and for the PMN 
population, a coefficient of correlation of 0.90 (P < 0.01) was obtained between flow cytometric 
and microscopic differential leukocyte count. The coefficient of correlation for the mature MΦ 
count was 0.71 (not significant) between the 2 methods. For LM, flow cytometric results were 
systematically higher and for PMN and mature MΦ, flow cytometric results were systematically 
lower than microscopic results. During early lactation, milk SCC was composed of 76.7 ± 2.45% 
LM, 5.2 ± 1.31% MΦ, 13.1 ± 1.62% PMN and 4.9 ± 1.09% apoptotic cells.  
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DISCUSSION 
 
 In the present study, milk sample collection was validated and the effect of external 
bacterial contamination on viability and functions of milk cells was studied in healthy mammary 
glands with low SCC. Therefore, normal milk was obtained without stimulation of the mammary 
gland and all milk samples had low SCC (< 2 x 105 cells/ml). In previous studies, PMN 
recruitment into the mammary gland was stimulated by either the insertion of an intramammary 
device (Paape et al., 1976; Saad and Hageltorn, 1985), or by intramammary infusion of E. coli 
endotoxin (Dulin et al., 1988).  
A new sterile milk sampling technique (STER-SPL) was introduced as reference 
technique, which allowed milk sample collection under aseptical conditions without external 
bacterial contamination. Although manual milk sampling (MAN-SPL) could increase the risk of 
external contamination, bacterial counts observed with this sampling technique were 
unexpectedly low. In this milk, no change in viability and different cell functions of isolated 
milk cells was observed. In contrast, machine milking (CONT-SPL) had a significantly higher 
contamination level as compared to STER-SPL. Despite this bacterial contamination, no 
significant differences in viability and different cell functions of isolated milk cells were found. 
It seems that the bacterial contamination present in CONT-SPL milk samples could not 
significantly activate the isolated resident milk cells. However, it is important to mention that the 
whole study was performed on milk, which was slowly cooled down to 1°C. Under these 
conditions, cell functions are inhibited and cells do not react when challenged by these 
contaminating bacteria. Nevertheless, milk cells did not loose their reaction potential, since they 
performed CL, intracellular killing and phagocytosis when collected and maintained under the 
specified conditions. It can be concluded that all three milk sampling techniques are equally 
appropriate for the study of cellular and non-cellular qualities of bovine milk and resident cells. 
The reference technique (sterile cannula) is the best for eliminating bacterial contamination, 
although for practical routine milk sample collection manual milk sampling (MAN-SPL) can be 
used.  
In the present study, a simple, accurate and reproducible flow cytometric differential 
leukocyte count method for low SCC milk from healthy cows was developed. The method is 
complementary to flow cytometric differential leukocyte count methods for high SCC milk 
(Redelman et al., 1988; Pillai et al., 2001). The low amount of cells in milk from healthy cows (< 
105 cells/ml; Laevens et al., 1997), makes the identification of leukocytes more difficult than in 
high SCC milk (109 cells/ml during coliform mastitis; Dosogne et al., 1997). A maximal amount 
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of identifiable cells in low SCC milk was obtained with 1) a 30 % (v/v) dilution of milk samples 
(which corresponds with large-scale isolations; Hoeben et al., 1997); 2) centrifugation and 
removal of the fat layer; 3) resuspension of the pellet with RPMI 1640; 4) a sample collection, 
storage and processing temperature of 20 °C. Although the initial SCC of the milk samples was 
low, a sufficient amount of cells was obtained from 1.5 ml samples. Thus, our method is 
applicable for small volumes of low SCC milk samples. Another advantage of the method 
described here is that milk samples can be stored for 2 days at 7°C without any effect on the 
differential leukocyte count. The method was also shown to be reproducible, even at a very low 
number of cells analysed: variability was not significantly different between 1,000; 2,000 or 
3,000 analysed cells and the average values for differential milk leukocyte count were not 
dependent on the number of analysed cells. 
Four populations with different fluorescence emission characteristics were obtained 
upon SYTO13 staining of milk leukocytes. The high fluorescence of mature MΦ is consistent 
with previous results obtained with acridine orange labelling (Hageltorn and Saad, 1986) and 
could be explained by a higher degree of mitochondrial RNA staining. Indeed, green 
fluorescence obtained with the SYTO dyes is not only governed by stoichiometric DNA 
binding, but also by cytoplasmic mitochondrial labelling (Poot et al., 1997). The emission 
wavelength maximum of SYTO13-labeled RNA (514 nm) is similar to DNA (509 nm) 
(Molecular probes, SYTO green fluorescent nucleic acid stains product information sheet). 
Mitochondrial labelling could also explain the high green fluorescence of some LM and is 
indicative of a high metabolic rate. Polymorphonuclear leukocytes and LM had similar 
fluorescence characteristics but could be distinguished on the basis of cytoplasmic granularity, 
which was typically higher for PMN than for LM. 
 
CONCLUSION 
 
Following validation of milk sample collection under aseptical conditions, no effect of 
limited bacterial contamination on PMN viability and functions could be observed. Manual milk 
sample collection will be preferred for further use during experimental challenge, because the 
technique results in a small bacterial contamination and is easy to perform during repeated 
sample collection. During early lactation, pre-infection milk SCC is mainly composed of 
lymphocytes, whereas only small percentages of monocytes, PMN and apoptotic cells are 
present.  
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EXPERIMENTAL ANIMALS AND STUDY FACILITIES 
 
The Ethical Committee of the Faculty of Veterinary Medicine (Ghent University, 
Merelbeke, Belgium) approved all experimental infections. All primiparous cows (n = 74) were 
between 24 and 30 months of age at calving. Depending on the study design, cows arrived at the 
commercial dairy farm (Oudenaarde, Belgium) in their 7th month of pregnancy (n = 33) or 
within 7 days after calving (n = 41). The animals were on a system of zero-grazing from arrival 
until the end of the inoculation trial and were fed twice daily at 0700 a.m. and 1700 p.m. The 
ration consisted of corn silage, good quality hay and water ad libitum. Concentrates (Sandilac; 
Dumoulin Voeders Sanders, Moorslede, Belgium) were distributed according to milk 
production. 
 For inclusion into the intramammary inoculation trial, treatment of clinical diseases 
(retentio secundinarum, mastitis, metritis, …) was not allowed within 10 d before the 
intramammary inoculation. Therefore, only healthy animals, free of major mastitis pathogens 
through 3 consecutive bacteriologically negative examinations were included for the 
intramammary E. coli challenge (IDF, 1971; Hillerton, 1999). Primiparous cows accepted for the 
intramammary challenge were inoculated between 12 and 28 d post-parturition and had a quarter 
milk SCC of 57,145 ± 16,478 cells/ml before infection.  
Milking was performed daily at 0800 a.m. and 1800 p.m. using a quarter milking device 
(Packo & Fullwood, Zedelgem, Belgium). Daily quarter milk production, the yield of the 
evening and subsequent morning milking, expressed as l/d, was measured at d-7, d-4, d-1, d0 
(post-infusion hour (PIH) 0-24), d+1 (PIH 24-48), d+2 (PIH 48-72), d+3 (PIH 72-96), d+6 (PIH 
144-168), d+9 (PIH 216-240) and d+13 (PIH 312-336) (Fig. 1). Before infection, cows (n = 74) 
had an average milk production of 15.9 ± 0.38 l/d.  
 
 
 
 
 
Figure 1. Time schedule of registration points for daily quarter milk production before, during 
and after experimentally induced E. coli mastitis in primiparous cows. 
-7 
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INOCULATION DOSE 
 
The generation time of E. coli in mammary secretions can be as short as 20 min (Petsch 
and Anspach, 2000; Burvenich et al., 2003). Because we were interested in bacterial elimination 
rather than bacterial growth in the affected mammary glands, a high inoculum dose was used in 
all the experiments. Practically, two different high inoculum doses were applied, depending on 
the experiment: 1 x 104 and 1 x 106 CFU. 
During in vitro bacterial growth in a batch culture system, in which nothing is added to 
or removed from the environment once the medium is inoculated with the living cells, several 
distinct phases can be identified (Fig. 2). Due to the closed nature of a batch culture system, cell 
multiplication can only be supported for a limited time and during bacterial growth, progressive 
changes in the original growth medium occur.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Idealised normal growth cycle for a bacterial population (expressed as log10 of the 
number of viable bacteria) in a batch culture system. Time is expressed in relative units. 
 
Growth proceeds through a lag phase, during which cell numbers do not increase. This is 
followed by a growth phase, which is usually characterised by an exponential increase in 
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bacterial numbers. Ultimately, changes in the chemical and/or physical environment of the 
medium result in a phase of no net increase in bacterial numbers, the maximum stationary phase. 
Cells in stationary phase still require an energy source for viability maintenance. By definition, 
the availability of an energy source is limited in a batch culture, and hence a death phase follows, 
often characterised by an exponential decrease in the number of living cells. 
Following overnight culture, bacteria harvested for intramammary challenge were in 
maximum stationary phase at the time of inoculation. Although a change in growth medium (i.e. 
healthy mammary gland) should enhance their growth, it is clear from several previous 
experiments that intramammary bacterial kinetics are variable depending on the initial inoculum 
dose. When a low number of bacteria is infused, an exponential growth may occur (Shuster et 
al., 1996), which is followed by subsequent clearance of the bacteria after peak numbers are 
reached (Fig. 3a). In contrast, stationary phase is immediately reached when a high number of 
bacteria is inoculated (Hoeben et al., 2000a), which is followed by clearance of bacteria (Fig. 
3b). 
  
 
   
 
 
 
 
 
Figure 3. Intramammary growth of inoculated E. coli bacteria starting from a) a low inoculum 
dose (~ 30 CFU; Shuster et al., 1996) or b) a high inoculum dose (~ 10,000 CFU; Hoeben et al., 
2000a).  
 
INTRAMAMMARY INOCULATION PROCEDURE 
 
Inoculation was performed as described before (Hoeben et al., 2000a; 2000b). Briefly, E. 
coli  P4:O32 (H37, β-glucuronidase +, haemolysin -), maintained as a stock in lyophilisation 
medium at –20°C, was subcultured in brain-heart infusion broth (CM225; Oxoid, Nepean, USA) 
at 37°C during 3 consecutive days and subsequently washed 3 times with pyrogen-free PBS, and 
resuspended in PBS. Just before inoculation, the suspension was diluted in pyrogen-free PBS to 
a final concentration of 1 x 104 CFU/ml or 1 x 106 CFU/ml, depending on the inoculum dose 
required in each specific study. On d0, 30 min after morning milking (1.5 h after feeding), the 
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cows were inoculated in the left front and rear quarters with a total volume of 10 ml, containing 
1 ml of inoculum and 9 ml of pyrogen-free saline solution (NaCl 0.9%; Baxter N.V., Lessines, 
Belgium) per quarter. All bacterial suspensions were infused into the teat cistern using a sterile, 
pyrogen-free teat cannula (L 7 cm, Ø 2 mm; Me.Ve.Mat, Deinze, Belgium). Before challenge, 
the teat ends were disinfected with 70% ethanol containing 0.5% chlorhexidin. After infusion, 
the bacterial suspension was thoroughly distributed into the udder cistern through a 30 s massage 
(Fig. 4).  
Following inoculation, a control sample of the inoculum was diluted, plated out on 
Columbia agar with 5% sheep blood (Biokar Diagnostics, Beauvois, France) and incubated for 
24 h at 37°C to check for correct inoculum preparation and adequate inoculum dose 
administration at intramammary E. coli challenge. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Intramammary inoculation in the left rear quarter (picture of MMRC, Merelbeke, 
Belgium). 
 
EXPERIMENTAL DESIGN 
 
 To study the influence of lactation number on severity of inflammation and kinetic 
response of the innate immunity, two different high inoculum doses were used, namely 1 x 104 
and 1 x 106 CFU per quarter.  
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For modulation of moderate inflammatory reaction through variation of the inoculum 
dose, both previously used doses were randomly assigned to animals during the experimental 
trial. Modulation of moderate inflammatory reaction through inhibition of prostaglandin 
synthesis was performed following inoculation of 1 x 104 CFU in the two left quarters of all 
animals. In the study on effect of vaccination against the endotoxin, 6 animals were inoculated 
with 1 x 104 CFU, the others (n = 17) received 1 x 106 CFU in both left quarters.  
 
TREATMENT PROTOCOLS 
  
 The modulation of moderate inflammatory reaction in primiparous cows has been 
performed through variation of the inoculum dose, inhibition of prostaglandin synthesis and 
vaccination against the endotoxin. 
 In the first study, no specific treatments were performed following the random 
assignment of the two inoculum doses to the experimental animals. In this study, clinical 
response in animals receiving the usual inoculum dose of 1 x 104 CFU was compared to animals 
inoculated with a higher dose of 1 x 106 CFU (study p. 145). 
 In the second study, the inducible COX-2 enzyme was inhibited using a NSAID, 
carprofen, administered at PIH 9, when acute clinical symptoms were already present. Carprofen 
(1.4 mg/kg, Rimadyl; Pfizer Animal Health, Sandwich, UK) was administered according to 
body weight (2.9 ml/100 kg). Control animals received saline solution (0.9% NaCl; Baxter N.V., 
Lessines, Belgium) according to body weight (2.9 ml/100 kg) (study p. 167) 
 In the third study, vaccination against the endotoxin was performed following a tight 
vaccination schedule. Animals received three 2 ml doses and each animal received the same 
treatment (vaccine or saline) for all three injections. The first dose was administered at 56 (±7) d 
prior to expected calving, followed by a second dose at 28 d after the first vaccination. The third 
dose was administered at 7 (±7) d post-parturition. The active ingredients of the J5 vaccine 
(Enviracor; Pfizer Animal Health, Sandwich, UK) were the E. coli J5 mutant, mixed with a 
proprietary adjuvant. Controls received saline solution (0.9% NaCl; Tomlinson Ltd., Corby, 
UK). The vaccine and saline were injected subcutaneously behind the shoulder and one hand’s 
width away from it. The first injection for all animals was made on the left side, the second 
injection on the right side and the third again on the left side (study p. 189). 
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SAMPLING PROCEDURE 
   
Blood and milk samples were collected at d-7, d-4, d-1, d0, d+1, d+2, d+3, d+6, d+9, and d+13 
relative to the day of challenge. On the day of challenge, blood and milk samples were collected 
at PIH 3, 6, 9, 12, 15, 18 and 21 (Fig. 5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Schedule for blood and milk sampling before, during and after experimentally induced 
E. coli mastitis in primiparous cows.  
 
Blood samples were drawn aseptically from the external jugular vein of each cow by 
venipuncture in evacuated tubes (Table 1).  
Foremilk (5 ml) was aseptically collected for diagnostic bacteriology on major 
pathogens before inoculation and for quantification of the population of E. coli (CFU) from PIH 
3 onward. Furthermore, milk samples (100 ml) were collected manually, using a procedure 
which was validated previously, for determination of SCC, milk composition and the preparation 
of milk whey through centrifugation. All samples were kept on melting ice (1°C) during 
transport and at the laboratory until analysis was performed or aliquots were prepared for 
freezing (−20°C).  
-7 -4 -1 0 1 2 3 6 9 13 
0 3 6 9 12 15 18 21 24 
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days relative to infection 
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Table 1. Evacuated tubes for venous blood collection and subsequent analytical possibilities. 
 
Type Evacuated tube Analysis 
Unclotted blood - plasma BD vacutainer LH 143 I.U Blood leukocyte count 
  Differentiation blood smears 
  Packed cell volume 
  PGE2 
  TXB2 
   
Clotted blood - serum BD vacutainer SST LBP 
  BHBA 
   
Unclotted blood - NaF BD vacutainer FX 12.5 mg 10 mg Glucose 
 
 
CLINICAL EXAMINATION 
 
Classical clinical parameters were examined. Rectal temperature (RT), heart rate (HR), 
respiration rate (RR), reticulorumen motility, skin turgor, fecal appearance, appetite, general 
attitude, body condition score (Edmondson et al., 1989) and aspects of the mammary gland 
(abnormal milk, swelling, temperature, pain, teat relaxation and milk leakage (Massart-Leën et 
al., 1988)) were recorded at each blood and milk sampling. Normal values of different clinical 
parameters before infection were calculated (Table 2). 
 
Table 2. Normal values of different clinical parameters obtained during clinical examination 
before intramammary E. coli inoculation (n = 74).  
 
Clinical parameter Mean ± SEM 
Rectal temperature (°C) 38.5 ± 0.04 
Heart rate (beats/min) 71 ± 0.9 
Respiration rate (/min) 22 ± 0.6 
Body condition score (0-5) 2.8 ± 0.03 
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 SEVERITY DETERMINATION AND CLINICAL SEVERITY SCORE 
  
Throughout the years, severity prediction following experimentally induced E. coli 
mastitis has been performed using different clinical and laboratory parameters, such as number 
of E. coli in the infected quarters (Kremer et al., 1993; van Werven et al., 1997), capacity of 
reactive oxygen species production (Heyneman et al., 1990) and quarter milk production 
(Burvenich, 1983; Burvenich and Peeters, 1983; Heyneman et al., 1990; Vandeputte-Van 
Messom et al., 1993; Dosogne et al., 1997).  
Burvenich (1983) first quantified severity of an intramammary E. coli inflammation 
through the reduction in quarter milk production of the uninfected quarters. This severity 
classification was subsequently used in many experimental E. coli mastitis studies (Heyneman et 
al., 1990; Vandeputte-Van Messom and Burvenich, 1993; Vandeputte-Van Messom et al., 1993; 
Dosogne et al., 1997). Two mechanisms might be involved in production losses during mastitis. 
The first is a direct effect on milk synthesis by local alteration of the mammary epithelial 
activity, which is most pronounced in the infected glands. The second mechanism causing a 
decrease in milk production is rather indirect. During mastitis, milk secretion may be suppressed 
as a result of general illness in the animals, thereby reducing the availability of milk precursors. 
This mechanism is responsible for losses in production in the uninfected quarters, since no 
indication of severe alteration of the blood-milk barrier could be demonstrated in these quarters 
(Vandeputte-Van Messom et al., 1993).  A striking difference in degree and onset of different 
phenomena of inflammatory parameters could be observed between moderate and severe 
responders. Besides the pronounced reduction in quarter milk production in the uninfected 
quarters, blood PMN count was severely reduced and a drastic shift in circulating cell types was 
established in the days following experimental E. coli challenge (Heyneman et al., 1990; 
Vandeputte-Van Messom et al., 1993). Moreover, a significant correlation existed between 
reactive oxygen species production on d-1 and the reduction in quarter milk production 
(Heyneman et al., 1990; Vandeputte-Van Messom et al., 1993). Significant differences in several 
blood and milk constituents already existed before intramammary challenge (Vandeputte-Van 
Messom et al., 1993).  
The severity of E. coli mastitis was determined based on quarter milk production in the 
uninfected quarters at d+2 post-infusion. Animals with a quarter milk production in the 
uninfected quarters at d+2 higher than 50% of the quarter milk production at d-1 in the same 
quarters were scored as moderate responders, whereas animals with a quarter milk production at 
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d+2 lower than 50% were scored as severe responders (Vandeputte-Van Messom et al., 1993; 
Dosogne et al., 1997; 1999) (Fig. 6).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Classification of newly calved cows into moderate and severe responders following 
intramammary E. coli challenge, based on quarter milk production in the uninfected quarters at 
d+2 post-infection. The dashed line indicates the border between severe (under line, < 50 %) and 
moderate (above line, > 50 %) responders (Dosogne et al., 1997; 1999).  
 
The assessment of disease severity using systemic disease signs in dairy cows with acute 
coliform mastitis was introduced by Wenz et al. (2001). We developed a classification scheme 
based on readily observable systemic disease signs, which used rectal temperature, hydration 
status, rumen contraction rate and attitude as major parameters. In contrast to Wenz et al. (2001), 
hydration status (assessed through degree of enophtalmus) and attitude (assessment of signs of 
depression) were scored using another scale (Vangroenweghe et al., 2004). Therefore, severity in 
our studies was scored based on Wenz et al. (2001) with some slight modifications. Clinical data 
(RT, skin turgor, reticulorumen motility and general attitude) obtained from PIH 9 to 48 were 
scored as described in Table 3 and based on their total score, primiparous cows were classified 
into mild, moderate and severe responders.  
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Table 3. Severity scoring system, based on systemic disease signs, for the classification of 
primiparous cows, following an experimental intramammary inoculation with E. coli P4:O32 
(according to Wenz et al., 2001; with slight modifications). Briefly, the 4 parameters are scored, 
total score is calculated and compared to respective ranges for classification into mild, moderate 
or severe disease.  
 
Variable Criteria Score 
Rectal temperature (°C) 37.80 - 39.25 0 
 39.30 – 39.80 1 
 > 39.80 or < 37.80 2 
   
Skin turgor regains normal shape in < 5 sec 0 
  > 5 sec to regain normal shape 1 
   
Rumen motility rate 3 x / 2 min 0 
 (contractions/min) 1 – 2 x / 2 min 1 
 0 x / 2 min 2 
   
General attitude Alert 0 
 (signs of depression) Lethargic 1 
 depressed – unable to stand 2 
 extremely sick – recumbent 3 
   
Total score Mild disease 0 - 2 
 Moderate disease 3 - 5 
 Severe disease 6 - 8 
 
SOMATIC CELL COUNT AND MILK COMPOSITION 
  
The terminology ‘somatic cell count’ was first introduced by Paape et al. (1963), 
because of the presence of epithelial cells in milk, and has become the internationally accepted 
IDF terminology. Somatic cell count was determined using a fluoro-opto electronic method 
(Fossomatic 5000 cell counter; Foss Electrics, Hillerφd, Denmark) by the Milk Control Centre 
(MCC, Lier, Belgium) under accreditation circumstances (ISO 13366-2; Ubben et al., 1997). 
Briefly, whole milk samples are heated to 42 ± 2°C, thoroughly homogenised by gentle mixing 
and analysed within 25 min. Nuclear DNA of the somatic cells present in the milk is stained with 
a fluorescent probe (ethidiumbromide) and followed by flow cytometric analysis and 
quantification (cells/ml). Somatic cell count values range from 10,000 to 9,999,000 cells/ml. 
Control of SCC analysis is performed at three subsequent levels. The first level control includes 
blank sample analysis every 400 determinations and standard control sample analysis every 35 
determinations. Second level control is performed by governmental officials, whereas third level 
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control includes participation in organised national (Belgian) and international (IDF 
collaborative test) ring test analyses.  
Fat, protein and lactose concentration (mg/ml) were determined using mid-infrared-
photospectrometry (MilkoScan 4000; Foss Electrics) (Fig. 7) by the Milk Control Centre (MCC) 
under accreditation circumstances (IDF standard 141; Trossat and Leray, 1996).  
 
 
 
 
 
Figure 7. MilkoScan 4000 mid-infrared-
photospectrometer (Foss Electrics) for the 
quantitative analysis of fat, protein and 
lactose in whole milk samples under 
accreditation circumstances (picture of 
MCC, Lier, Belgium).  
 
Briefly, whole milk samples are prepared as previously described for SCC 
determination. Fat, protein and lactose each contain specific chemical structures with different 
wavelength absorption spectra in the mid-infrared spectrum. The electromagnetic absorption 
measured at these wavelengths enables quantitative determination (mg/ml) of the different 
components. Whole milk determination for fat, protein and lactose ranges from 20-70 mg/ml, 
25-50 mg/l and 20-70 mg/ml, respectively. Control of milk composition analysis is also 
performed at three subsequent levels as described for SCC analysis.  
 Milk samples for the determination of serum albumin (mg/dl), sodium (Na+), chlorine 
(Cl-) and potassium (K+) concentration (mmol/l) were centrifuged at 1,000 x g (30 min, 4°C). Fat 
was removed and samples of skim milk were taken and immediately frozen at –80°C until 
analysis. After thawing, serum albumin was quantified using a radial immunodiffusion kit 
(bovine low level albumin, Bethyl VET-RID; Bethyl Laboratories, Montgomery, TX, USA). 
Briefly, 10 µl of milk whey was added to each well and incubated at 20°C for 24 h before the 
diameter of the radial immunodiffusion reaction was assessed. Squared diameters (d2) were 
compared with a constructed standard curve of known amounts of serum albumin. Ion 
concentration was analysed using an ion-selective electrode analyser (Ilyte; Instrumentation 
Laboratories, Milan, Italy). Briefly, milk samples are brought into contact with specific 
electrodes consisting of a particular glass composition, which are sensitive to one of the analysed 
ions, namely Na+, Cl- or K+. This leads to potential differences, which can be measured and 
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transformed, into ion concentration values. Average concentrations of different milk components 
before intramammary challenge are given in Table 4. 
 
Table 4. Normal values of different parameters for milk composition obtained before 
intramammary E. coli inoculation.  
  
Milk component Mean ± SEM N 
Fat (mg/ml) 18.7 ± 1.27 130 
Protein (mg/ml) 30.7 ± 0.27 114 
Lactose (mg/ml) 49.8 ± 0.22 130 
Serum albumin (mg/dl) 17.0 ± 1.37 104 
Na+ (mmol/l) 28.5 ± 1.11 111 
K+ (mmol/l) 43.5 ± 0.91 111 
Cl- (mmol/l) 33.2 ± 1.14 111 
 
PACKED CELL VOLUME, BLOOD LEUKOCYTE COUNT AND 
DIFFERENTIATION OF BLOOD SMEARS 
 
Blood packed cell volume (PCV) (%) was determined in hematocrit-capillaries (60 µl/75 
mm; Hirschmann Laborgeräte, Eberstadt, Germany) using a micro-hematocrit centrifuge 
(Hawksley, London, UK). Normal values before inoculation were 29 ± 0.4% (n = 66). Blood 
leukocyte count (log10/ml) was determined using an electronic particle counter (Coulter Counter 
Z2; Coulter Electronics Ltd., Luton, UK). Briefly, 25 µl of whole heparinised blood was added 
to 20 ml of isotonic solution (Coulter ISOTONII Dilution; Beckman Coulter Diagnostics 
GmbH; Krefeld, Germany). Following addition of 3 drops of zapoglobin (ZAP-OGLOBINII 
Lytic Reagent; Beckman Coulter Diagnostics GmbH), the sample was gently mixed and 
duplicate measurements were performed. Settings for the electronic particle counter were at gain 
256, current 0.707 and lower threshold 30 fl. Following assessment, concentration per ml was 
automatically calculated (x 40) and displayed as such. For statistical analysis, results were log10-
transformed. Blood leukocyte count was 8.5 ± 0.24 x 106/ml (6.8 ± 0.04 log10/ml) before 
infection (n = 74).  
Differential counts were performed on blood smears. Briefly, 10 µl of homogenised 
whole blood was added onto a microscope slide and very thin smears were prepared, following 
drying and staining as described previously (Mehrzad et al., 2001). Differential counts of the 
blood smears were carried out according to Wilde (1964). Two hundred cells were counted on 
each smear and percentages of PMN (myelocytes-metamyelocytes, band cells and mature PMN), 
monocytes, lymphocytes and eosinophils were determined (Fig. 8). Myelocytes-metamyelocytes 
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were characterised by their round-oval to elongated-arciform nuclei with yellowish cytoplasm. 
Band cells had longer, circular formed nuclei with more condensed chromatin, situated near the 
periphery of the cell. Mature PMN had clearly defined nuclei with 3 to 6 lobes and typical 
neutral granules. Monocytes were round to irregular in shape containing greyish-blue cytoplasm, 
with foamy appearance in which fine red granules could be found. The nuclear substance had a 
fine reticulate structure with evenly distributed chromatin. Lymphocytes had compact nuclei, 
surrounded by cytoplasm varying from a narrow band to a wider, more irregular mass. 
Eosinophils had their specific eosinophilic granules in the cytoplasm and nuclei with 2 to 3 
lobes. Normal values of different cell types before infection were calculated (Table 5). 
 
Table 5. Normal values (expressed as %) of different cell types before intramammary E. coli 
inoculation (n = 33). 
 
Cell type Mean ± SEM 
Myelocytes-metamyelocytes 9.6 ± 0.78 
Band cells 2.1 ± 0.26 
Mature PMN  26.5 ± 2.17 
Macrophages  8.8 ± 0.88 
Lymphocytes  51.2 ± 2.36 
Eosinophils  1.9 ± 0.28 
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Figure 8. Differential leukocyte count of blood smears: a) myelocyte, b) metamyelocyte, c) band 
cell, d) mature PMN, e) lymphocyte, f) monocyte, and g) eosinophil (pictures of MMRC, 
Merelbeke, Belgium).              indicates the specified cell type. 
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BACTERIOLOGY ON MAJOR PATHOGENS 
 
 Diagnostic bacteriology on major pathogens (i.e. Escherichia coli, Streptococcus uberis, 
Staphylococcus aureus, Corynebacterium bovis, Streptococcus dysgalactiae, Streptococcus 
agalactiae) was carried out at the laboratory of Dierengezondheidszorg-Vlaanderen (Drongen, 
Belgium) under accreditation circumstances. Briefly, quarter foremilk samples were plated out 
onto Columbia agar with 5% sheep blood (Biokar Diagnostics) and incubated at 37°C for 24 h. 
Suspect colonies were tentatively identified based on colony morphology and growth 
characteristics, and subsequently typed using specific laboratory identification standards. Results 
of diagnostic laboratory analysis were reported as negative or positive for major pathogens with 
specifications of the isolated bacterial species.  
 
COLONY-FORMING UNITS IN THE INOCULATED QUARTERS 
  
The number of E. coli (CFU/ml) after experimental inoculation was determined by 
appropriate 10-fold dilutions of each milk sample in PBS. Ten µl of these dilutions was plated 
out on Columbia agar with 5% sheep blood (Biokar Diagnostics). All dilutions were performed 
in duplicate. Colonies were counted after a 24 h incubation at 37°C. The colony count was 
converted to CFU/ml based on the factor of dilution and finally expressed as log10/ml for 
statistical analysis. 
Typical colony morphology of inoculated E. coli was rough with a predominantly grey 
colour (Fig. 9a). Occasionally, mutation to smooth colonies could be observed during 
intramammary passage (Fig. 9b). 
 
 
 
 
 
 
 
 
 
Figure 9. Colony morphology of inoculated E. coli following a 24 h incubation at 37°C on 
Columbia agar with 5% sheep blood. A. Rough mutant, B. Smooth mutant (pictures of MMRC). 
A B 
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β-HYDROXYBUTYRATE  
  
On arrival at the laboratory, clotted blood was incubated for 2 h at 37°C to neutralise the 
cryoglobulins present in bovine serum. After centrifugation (1,000 x g, 20 min, 20°C), serum 
was aliquoted and stored at –80°C until analysis of BHBA.  
 β-hydroxybutyrate (mmol/l) was determined twice in the week before challenge to check 
the status of the cow’s energy balance. For analysis, the method with acetone oxidation, 
described by Williamson and Mellanby (1970), was used. Briefly, 1 ml of HClO4 (0.9 M) was 
mixed with 1 ml of plasma and subsequently centrifuged (1,000 x g, 10 min). Four ml KOH was 
added to 1 ml supernatant fluid (pH 7.0) and mixed. Subsequently, 2 ml of the mixture was 
transferred into photospectrometry cups and 1 ml of Tris-hydrazin-EDTA buffer (pH 8.5 in 
NaOH) and 50 µl NAD-solution were added. After gently mixing, OD was determined at 340 
nm. After the first measurement (OD1), 5 µl of β-hydroxybutyrate dehydrogenase was added, 
followed by incubation at 4°C for 90 min before the second measurement (OD2). β-
hydroxybutyrate concentration in the sample was calculated as following:  
 
  β-hydroxybutyrate = (OD2 – OD1) x 2.89 
 
GLUCOSE 
 
NaF-collected blood was centrifuged (1,000 x g, 20 min, 20°C) and plasma was 
collected and stored at –20°C until analysis of glucose. Glucose concentration (mmol D-
glucose/l) was determined using an UV-method (D-Glucose; Roche Diagnostics, Brussels, 
Belgium). Briefly, 1 ml HClO3 was added to 100 µl plasma and centrifuged at 1,000 x g for 10 
min to purify the samples. Subsequently, D-glucose was enzymatically transformed to D-
glucose-6-phosphate by addition of hexokinase and ATP. Then, D-glucose-6-phosphate was 
oxidised by glucose-6-phosphate-dehydrogenase into D-gluconate-6-phosphate, with a 
simultaneous reduction of NADP+ into NADPH. The produced amount of NADPH is a measure 
for the quantity of D-glucose in the initial plasma sample and is determined by 
spectrophotometry (Beckman DU 640D; Beckman Coulter Diagnostics GmbH) at 340 nm 
wavelength. D-glucose concentration is calculated according to manufacturer’s instructions, 
taking into account dilution effects, molecular weight, and extinction coefficient of the analysed 
solution. Normal glucose concentration before challenge was 3.3 ± 0.20 mmol/l (n = 23). 
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DETERMINATION OF IL-8 
  
Milk IL-8 concentration was determined from undiluted whey samples assayed with a 
commercially available human IL-8 enzyme-linked immunosorbent assay (ELISA) kit (R&D 
Systems, Inc., Minneapolis, USA) (Fig. 10). The range of the IL-8 kit was 31.2 to 2,000 pg/ml. 
The antibody pairs used in this kit have previously been shown to cross-react with bovine IL-8 
(Shuster et al., 1996; 1997).  
 
 
 
 
 
 
 
 
 
Figure 10. Schematic principle of direct sandwich ELISA for the 
determination of IL-8 in bovine milk whey samples. (a) mouse 
monoclonal IL-8 antibody, (b) milk whey sample or standard, (c) 
polyclonal HRP-conjugated anti-IL-8 antibody, (d) TMB substrate 
solution resulting in a blue product colour, and (e) H2SO4 stop 
solution.  
 
Briefly, 100 µl of milk whey sample was added to flat-bottomed microtiter plates, pre-
coated with mouse monoclonal anti-IL-8 antibodies, and incubated for 1 h at 20°C. Following 
washing, polyclonal anti-IL-8 antibodies conjugated to horse-radish peroxidase (HRP) were 
added and incubated (1 h, 20°C). The substrate solution (3,3’,5,5’-tetramethylbenzidine (TMB)) 
was freshly prepared and added to each well following washing of the wells. After a 30 min 
incubation at room temperature, the reaction was stopped with 2 N H2SO4. The optical density at 
450 nm and a correction wavelength of 550 nm were measured on an automated microplate 
reader (Bio-Kinetics Reader; Bio-Tek Instruments, Winooski, USA). Values expressed in 
picograms per millilitre were extrapolated using linear regression from a standard curve of 
known amounts of human IL-8. Normal concentration of IL-8 before challenge was 1.9 ± 0.21 
pg/ml (n = 82). 
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DETERMINATION OF C5a 
 
Milk C5a was quantified by ELISA as previously described (Rainard et al., 1998) (Fig. 
11). The range of the C5a ELISA test was 20 to 5,000 pg/ml. 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. Schematic principle of indirect sandwich ELISA for 
the determination of C5a in bovine milk whey samples. (a) goat 
anti-mouse IgG, (b) monoclonal anti-C5a antibody, (c) milk whey 
sample or standard, (d) rabbit anti-bovine C5a/C5 antibody, (e) 
goat anti-rabbit HRP-conjugated antibody, and (f) ABTS substrate 
solution resulting in a green product colour. 
 
Briefly, flat-bottomed microtiter plates (Immulon 1; Dynatech, Chantilly, USA) were 
coated with 100 µl of goat anti-mouse IgG (Jackson Immunoresearch Laboratories, West Grove, 
USA) diluted to 2 µg/ml in 0.1 M carbonate bicarbonate buffer pH 9.6 for 1.5 h at 39°C. After 
each incubation, the plates were washed five times with PBS supplemented with 0.1% (v/v) 
Tween 20 (PBST). Unsaturated binding sites were blocked with a solution of 0.5% (w/v) gelatin. 
The sequence of incubation steps with 100 µl reagents diluted with PBST plus 0.1% gelatin 
(PBSTG) was as follows: (i) a 1/10,000 dilution of the anti-C5a monoclonal antibody (mAb) 
6G4 for 1 h; (ii) twofold dilutions of purified C5adesArg for the calibration curve, or appropriate 
dilutions of the milk whey sample under test, diluted in PBSTG containing 1 mM EDTA for 1.5 
h; (iii) a 1/5,000 dilution of rabbit anti-bovine C5a/C5 for 30 min; (iv) a 1/10,000 dilution of 
HRP-conjugated goat anti-rabbit IgG (Jackson Immunoresearch Laboratories) for 30 min; (v) 52 
mM 2,2’-azido-di-(3-ethylbenzthiazoline-6-sulphonic acid) (ABTS; Sigma) in 0.1 M citrate 
buffer pH 4.2 with 7.5 mM hydrogen peroxide (Sigma). The absorbance at 415 nm was read 
after about 30 min with an automated microplate reader (Bio-Kinetics Reader; Bio-Tek 
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Instruments). Values expressed in picograms per millilitre were extrapolated using linear 
regression from a standard curve of known amounts of C5adesArg (Rainard et al., 1998). 
Concentration of C5adesArg before intramammary E. coli inoculation was 210.1 ± 22.08 pg/ml (n 
= 82). 
 
DETERMINATION OF sCD14 
 
 A sandwich ELISA was used to quantify sCD14 levels in milk whey as described by 
Bannerman et al. (2003) (Fig. 12). The range of the sCD14 ELISA test was 780 to 50,000 ng/ml.  
 
 
 
 
 
 
 
 
 
Figure 12. Schematic principle of direct sandwich ELISA for the 
determination of sCD14 in bovine milk whey samples. (a) 
monoclonal mouse anti-bovine CD14 antibody, (b) milk whey 
sample or standard, (c) polyclonal HRP-conjugated mouse anti-
bovine CD14 antibody, (d) TMB substrate solution resulting in a 
blue product colour, and (e) H2SO4 stop solution. 
 
Briefly, flat-bottom 96-well plates were coated overnight with 5 µg/ml of mouse anti-
bovine CD14 monoclonal antibody (CAM36A; VMRD, Inc., Pullman, USA) diluted in 0.05 M 
sodium carbonate-bicarbonate (Sigma), pH 9.6 at 4°C. The plates were washed x4 with 0.05% 
Tween 20 diluted in 50 mM Trizma-buffered saline (TBS; Sigma), pH 8.0, and subsequently 
blocked with 2% fish skin gelatin (Sigma) for 1 h at room temperature. Plates were washed and 
100 µl of diluted whey samples (1:10) were added to each well in duplicate. Plates were 
incubated for 1 h at room temperature and subsequently washed as above. Mouse anti-bovine 
CD14 antibody (MM61A clone, VMRD, Inc.) was conjugated to HRP using a commercially 
available kit (EZ-Link Plus Activated Peroxidase Kit; Pierce Chemical Co., Rockford, USA) 
and used as the detection antibody. This HRP-conjugated anti-bovine CD14 antibody was 
diluted 1:1,000 in TBS wash buffer containing 2% gelatin, and 100 µl of the resulting solution 
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was added to each well. Plates were incubated for 1 h at room temperature, washed as above, 
and 100 µl of 3,3’,5,5’-tetramethylbenzidine substrate solution (TMB; Pierce Chemical Co.) was 
added to each well. The reaction was stopped by the addition of 100 µl of 2 M H2SO4 and the 
absorbance read at 450 nm on a microplate reader (Multiskan PLUS; Labsystems, Helsinki, 
Finland). A background correction reading of 550 nm was subtracted from the 450-nm 
absorbance readings. Values expressed in micrograms per millilitre were extrapolated using 
linear regression from a standard curve of known amounts of rbosCD14 (Wang et al., 2002). 
Soluble CD14 concentration in healthy mammary glands before E. coli challenge was 7.0 ± 0.84 
µg/ml (n = 82).  
 
DETERMINATION OF LBP 
 
Milk whey and plasma LBP levels were determined with a commercially available LBP 
ELISA kit that cross-reacts with bovine LBP (Cell Sciences, Inc., Norwood, USA) (Fig. 13). The 
range of the LBP kit was 1.6 to 100 ng/ml. Milk and plasma samples were diluted 1:400 and 
1:1,500, respectively, and assayed according to the manufacturer’s instructions.  
 
 
 
 
 
 
 
 
 
 
 
Figure 13. Schematic principle of indirect sandwich ELISA 
for the determination of LBP in bovine plasma and milk whey 
samples. (a) anti-human LBP antibody, (b) plasma/milk whey 
sample or standard, (c) biotinylated LPS tracer, (d) 
streptavidin HRP-conjugated mouse LBP, (e) TMB substrate 
solution resulting in a blue product colour, and (f) citric acid 
stop solution.   
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Briefly, diluted milk whey or plasma samples were added to flat-bottomed microtiter 
plates, pre-coated with solid bound antibodies recognising LBP of a wide variety of species, and 
incubated at room temperature for 1 h. The plates were washed 3 times and biotinylated LPS-
tracer molecules were added. Following incubation (1 h, 20°C) and three washings, streptavidin-
peroxidase conjugated LBP was added (1 h, 20°C). After washing the non-bound conjugated 
LBP, freshly prepared substrate solution (TMB) was added and the plates were incubated for 30 
min (20°C). The enzymatic reaction was stopped by addition of citric acid. The optical density at 
450 nm and a correction wavelength of 550 nm were measured on a microplate reader 
(Multiskan PLUS; Labsystems). The concentration of LBP (expressed in micrograms per 
millilitre) was calculated by extrapolation using linear regression from a standard curve of 
known amounts of human LBP. LPS-binding protein concentration in milk whey and plasma 
before intramammary E. coli mastitis were 17.2 ± 2.04 µg/ml (n = 82) and 65.4 ± 7.24 µg/ml (n 
= 41), respectively. 
 
DETERMINATION OF PGE2 
 
Milk whey and plasma PGE2 concentrations were determined with a commercially 
available PGE2 competitive ELISA kit (Neogen, Lexington, USA) according to manufacturer’s 
instructions (Fig. 14). The range of the PGE2 kit was 100 to 4,000 pg/ml.  
 
 
 
 
 
Figure 14. Schematic principle of competitive ELISA for the 
determination of PGE2 in bovine plasma and milk whey 
samples. (a) monoclonal mouse anti-PGE2 antibody, (b) 
plasma/milk whey sample or standard, (c) HRP-conjugated 
PGE2, and (d) TMB substrate solution resulting in a blue 
product colour. 
 
Briefly, quarter milk samples from acute E. coli mastitis were filtered with a 70 µm cell 
strainer (Becton Dickinson; Erembodegem, Belgium) in order to discard cell clusters. One ml of 
milk or plasma sample was diluted with 1 ml of distilled water, and 1 ml of the mixture was 
loaded on a 100 mg C18 column (Varian, St.-Katelijne-Waver, Belgium) after conditioning with 
2 ml of distilled water followed by 2 ml of methanol. The column was subsequently washed with 
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1 ml of each of the following substances: distilled water, methanol:distilled water (30:70), and 
hexane. The column was centrifuged at 3,200 x g for 3 min to withdraw any trace of hexane. 
Finally, eicosanoids were eluted from the C18 column with 1 ml of methanol. The collected 
eluate was evaporated to dryness under a stream of nitrogen. Dried samples were reconstituted in 
an appropriate volume of assay buffer.  
Fifty µl of the sample was added to the flat-bottomed microtiter plates, pre-coated with 
mouse monoclonal anti-PGE2 antibodies. Subsequently, 50 µl of diluted enzyme conjugate was 
added and the mixture was incubated at 20°C for 1 h. After washing the plates, 150 µl of 
substrate solution (TMB) was added and incubated (30 min, 20°C). The optical density at 630 
nm and a correction wavelength at 490 nm were measured on a microplate reader (Multiskan 
PLUS; Labsystems). The concentration of PGE2 (expressed in picograms per millilitre) was 
calculated by extrapolation using linear regression from a standard curve of known amounts of 
PGE2. Concentrations of PGE2 in milk and plasma before intramammary E. coli mastitis were 
334.8 ± 21.05 pg/ml (n = 50) and 429.2 ± 25.19 pg/ml (n = 25), respectively. 
 
DETERMINATION OF TXB2 
 
Milk and plasma TXB2 concentrations were determined with a commercially available 
TXB2 competitive ELISA kit (Neogen, Lexington, USA) according to manufacturer’s 
instructions (Fig. 15). The range of the TXB2 kit was 4 to 400 pg/ml. Samples were prepared for 
analysis as described above for PGE2.  
 
 
 
 
 
Figure 15. Schematic principle of competitive ELISA for the 
determination of TXB2 in bovine plasma and milk whey 
samples. (a) monoclonal mouse anti-TXB2 antibody, (b) 
plasma/milk whey sample or standard, (c) HRP-conjugated 
TXB2, and (d) TMB substrate solution resulting in a blue 
product colour.  
 
 
Briefly, 50 µl of the sample was added to the flat-bottomed microtiter plates, pre-coated 
with rabbit monoclonal anti-TXB2 antibodies. After addition of 50 µl of diluted enzyme 
a 
b 
c 
d 
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conjugate, the mixture was incubated at 20°C for 1 h. Following washing, 150 µl of substrate 
(TMB) was added and incubated (30 min, 20°C). The optical density at 630 nm and a correction 
wavelength at 490 nm were measured on a microplate reader (Multiskan PLUS; Labsystems). 
The concentration of TXB2 (expressed in picograms per millilitre) was calculated by 
extrapolation using linear regression from a standard curve of known amounts of TXB2. 
Concentrations of TXB2  in milk and plasma before intramammary E. coli mastitis were 84.3 ± 
5.07 pg/ml (n = 50) and 180.4 ± 26.50 pg/ml (n = 25), respectively. 
 
STATISTICAL ANALYSIS 
  
The general linear model is a commonly used statistical tool in agricultural research to 
study the relationship between a normally distributed dependent variable and one or more 
independent variables. The independent variables can be either continuous or discrete. If an 
independent variable is discrete, it only takes a restricted number of values and the effect of each 
level of the discrete variable generates a separate parameter in the model. If an independent 
variable is, on the other hand, continuous, an underlying functional relationship has to be 
assumed between the independent variable and the response variable. The number of model 
parameters corresponds to the number of parameters in the function describing the underlying 
relationship (Duchateau et al., 1998). The model parameters arising from either a continuous or a 
discrete independent variable can be fixed or random effects. The mixed model methodology 
was specifically developed to describe and analyse experiments, which contain both random and 
fixed effects factors (Duchateau et al., 1998). A major advantage of a mixed model framework is 
that complex data structures can be described and analysed in a natural way (Duchateau, 1997).  
The mixed model was used to analyse the data of the experimental infection randomised 
trials because animals were measured repeatedly over time during the infection and these 
repeated measures are not independent. By introducing cow as a random effect in the model, a 
compound symmetry structure was imposed on the repeated measures, thus accounting for the 
correlation between the repeated measures.  
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INTRODUCTION 
 
Several factors have been shown to play a role in the clinical outcome of E. coli mastitis, 
namely farm management (Jackson and Bramley, 1983; Oz et al., 1985; Smith et al., 1985; 
Jones, 1986; Pankey et al., 1987; Schukken et al., 1989a; 1989b; Oliver et al., 1990; Lam et al., 
1995; Barkema et al., 1999), bacterial factors (Frost et al., 1980; Hill, 1981; Linton and 
Robinson, 1984; Sanchez-Carlo et al., 1984a; 1984b; Todhunter et al., 1991; Hogan et al., 1992; 
1995; 1999; Cross et al., 1993; Nemeth et al., 1994; Nagy and Fekete, 1999) and physiological 
factors (Heyneman et al., 1990; Gilbert et al., 1993; Kremer et al., 1993a; 1993b; Vandeputte-
Van Messom et al., 1993; Dosogne et al., 1997; 2001; van Werven et al., 1997; Mehrzad et al., 
2001; 2002; Vangroenweghe et al., 2001; Burton and Erskine, 2003).  
Preventive measures, that are known to be efficient against contagious mastitis, such as 
post-milking teat disinfection (Schukken et al., 1989a; 1989b; Barkema et al., 1999) have been 
shown to be inefficient in the control of E. coli mastitis (Smith et al., 1985; Oliver et al., 1990; 
Lam et al., 1995). In contrast, a few studies (Pankey et al., 1987; Oliver et al., 1993) showed that 
pre-milking teat disinfection may prevent infections with environmental pathogens. Several 
epidemiological studies have demonstrated a negative correlation between SCC and the 
incidence of E. coli mastitis. Therefore, SCC is thought to be a farm related risk factor for the 
susceptibility to E. coli mastitis (Schukken et al., 1989a; 1989b; Barkema et al., 1999). 
Significant management factors that are related to a higher incidence of clinical coliform mastitis 
are: infection pressure from the environment (Jackson and Bramley, 1983), the use of saw dust 
as bedding material (Oz et al., 1985) and permanent indoor housing during winter (Jackson and 
Bramley, 1983). Prevention of cows from laying down after milking is often advised to omit 
contact with bedding  material (Jones, 1986). 
Various bacterial virulence factors have been studied during E. coli mastitis (Sanchez-
Carlo et al., 1984a; 1984b), however, only a few have been found to substantially influence the 
eventual outcome of the disease. Escherichia coli is of environmental origin (Nemeth et al., 
1994). Although over 100 serotypes have yet been recognised, no specific O-serotypes have 
been related to bovine E. coli mastitis (Linton and Robinson, 1984). Nevertheless, 
intramammary challenge with E. coli 487 caused more severe clinical signs of mastitis than did 
E. coli 727 (Todhunter et al., 1991; Hogan et al., 1992; 1995; 1999). Moreover, a capsulated E. 
coli B117 strain appeared to cause more severe clinical symptoms of mastitis, because it was 
more difficult to opsonise than a non-capsulated E. coli P4 strain (Hill, 1981). Clinical 
expression after challenge with low doses of E. coli is comparable with those after inoculation of 
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high doses (Frost et al., 1980). In vivo adhesion of E. coli to the epithelial surface of the 
mammary gland is thought to be unimportant during the initial phase of infection (Bramley et al., 
1979), because in healthy udders collagen or fibronectin are not exposed. Recently, Döpfer et al. 
(2000) found some indications for in vitro adhesion to mammary epithelial cells (MAC-T cells). 
However, these strains were isolated from recurrent cases of coliform mastitis, a rare disease 
(Döpfer et al., 2000). The  adhesion factors present in enterotoxigenic E. coli, which are essential 
during the initial steps of adhesion in the pathogenesis, do not play a role in the pathogenesis of 
E. coli mastitis (Nagy and Fekete, 1999). A bacterial factor, that plays an important role in the 
pathogenesis of E. coli mastitis, is endotoxin or LPS. Lipopolysaccharide is a potent inducer of 
inflammatory cytokines (Shuster et al., 1993) during growth and killing (Burvenich, 1983; 
Petsch and Anspach, 2000). Clinical signs following experimentally induced E. coli mastitis are 
rather due to mediator shock than to endotoxin shock, because endotoxin mainly plays a local 
role (Hoeben et al., 2000; Dosogne et al., 2002). The capability of some E. coli strains to resist 
the bactericidal activity of serum has also been demonstrated as a virulence factor (Barrow and 
Hill, 1989).  
Physiological factors have a big impact on the clinical outcome of E. coli mastitis 
(Burvenich et al., 2003), far more than farm management and bacterial characteristics that were 
cited above. Several markers to predict the clinical outcome of E. coli mastitis have been 
studied, such as: the number of circulating leukocytes, production of reactive oxygen species  by 
neutrophils (Heyneman et al., 1990; Vandeputte-Van Messom et al., 1993) and chemotactic 
activity of PMN (Kremer et al., 1993a; 1993b; Dosogne et al., 1997; van Werven et al., 1997). 
However, predictability of clinical outcome is only significant during 1 to 2 days pre-challenge 
and does not explain any causal relationship. These markers were mainly studied in multiparous 
cows, varying between 2nd lactation (Heyneman et al., 1990; Vandeputte-Van Messom et al., 
1993; Dosogne et al., 1997) to 2nd – 6th lactation (Kremer et al., 1993a; 1993b; van Werven et al., 
1997). Because BHBA alters both PMN chemotactic activity and reactive oxygen species 
production (Heyneman et al., 1990; Kremer et al., 1993a; 1993b; Vandeputte-Van Messom et al., 
1993), many E. coli challenges that were done at Ghent University and the University of Utrecht 
were performed on cows with a serum BHBA concentration < 1.4 mmol/l (Kremer et al., 1993b).  
Early lactating cows, infected with E. coli, are much more severely affected than cows 
after peak lactation (Hill, 1981). This is mainly due to the impairment of early lactation 
leukocyte function, as observed by many research groups (Burton and Erskine, 2003). During 
this period a decrease in cell function of the PMN, resident in the healthy mammary gland 
(Dosogne et al., 2001; Mehrzad et al., 2001; Vangroenweghe et al., 2001) has been observed. 
The decrease in cell function was mainly related to the decrease in viability, oxidative burst and 
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intracellular killing by PMN (Dosogne et al., 2001; Mehrzad et al., 2001; Vangroenweghe et al., 
2001).  
Besides energy balance and stage of lactation, cow parity was also found to be an 
important physiological factor that influences severity of clinical mastitis (Gilbert et al., 1993; 
van Werven et al., 1997; Mehrzad et al., 2002). Blood PMN function was higher in younger 
animals than in cows after their 4th parturition (Gilbert et al., 1993; van Werven et al., 1997). 
Moreover, viability and oxidative burst have been found to be significantly different between 
primiparous cows and multiparous cows during the periparturient period (Mehrzad et al., 2002).  
 In conclusion, many studies indicate that physiological factors determine the clinical 
outcome of E. coli mastitis. In this study, the clinical outcome of E. coli mastitis was studied in 
primiparous cows using the same criteria for severity as in other studies using multiparous cows 
(Heyneman et al., 1990; Vandeputte-Van Messom et al., 1993; Dosogne et al., 1997; van 
Werven et al., 1997; Hoeben et al., 2000).   
The purpose of the present study was to evaluate the outcome of intramammary E. coli 
inoculation in primiparous cows under identical conditions as described before with multiparous 
cows (Heyneman et al., 1990; Vandeputte-Van Messom et al., 1993; Dosogne et al., 1997; 
Hoeben et al., 2000; Dosogne et al., 2002). Moreover, the relation between pre-infection 
parameters and the outcome of infection in term of severity was assessed. Finally, two high 
inoculum doses, with a 100-fold difference (1 x 104 and 1 x 106 colony-forming units (CFU)), 
were used because the amount of LPS produced is related to the number of E. coli bacteria 
(Burvenich, 1983; Cross et al., 1993; Monfardini et al., 1999). The primiparous cows in this 
study were inoculated with the same strain as described before (Vandeputte-Van Messom et al., 
1993; Hoeben et al., 2000; Dosogne et al.,  2002).  
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MATERIALS AND METHODS 
 
Experimental Animals and Study Facilities 
All primiparous cows (n = 19) were in their 7th month of pregnancy on arrival at the 
commercial dairy farm. At calving, cows were between 24 and 30 months of age.  
 
Experimental Design 
Animals were challenged with E. coli P4:O32 on 4 different trial days. The 1 x 104 CFU 
inoculum group (group A) was challenged in a group of 4 and 5 animals, the 1 x 106 CFU 
inoculum group (group B) in two groups of 5 animals. 
 
Sampling Procedure 
  Blood and milk samples were collected at d-4, d-1, d0, d+1, d+2 and d+3 relative to the 
day of challenge. On the day of challenge, blood and milk samples were collected at PIH 3, 6, 9, 
12, 15, 18 and 21. 
  
SCC and Milk Composition 
 In this study, SCC and milk composition were determined. The daily production of fat, 
protein and lactose (g/24 h per quarter) was calculated based on daily quarter milk production 
and concentrations of these parameters. 
 
Statistical Analysis 
 The two inoculum groups were not formally compared because inoculum dose was not 
randomly assigned to animals. Pre-infection values of blood and milk constituents of the 
inoculum groups were compared just before intramammary E. coli inoculation using a paired 
two-sided t-test, assuming unequal variances (Statistix; Analytical Software, Tallahassee, USA) 
(Table 1). The  relationship between pre-infection concentrations of blood and milk constituents 
and the milk production reduction in the uninfected quarters at d+2 (PIH 48-72) was assessed by 
linear regression with an adjustment for inoculum size. 
 
For Further Details see chapter 'Materials and Methods Experimental Infections', p. 97.
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RESULTS 
 
Relation Between Pre-infection Blood and Milk Constituents and Percentage Reduction in 
Milk Production at d+2 Post-Infection 
 No significant differences were observed in pre-infection levels of blood and milk 
constituents (Table 1).  
 
Table 1. Pre-infection levels of blood and milk constituents (expressed as means ± SEM) in 
primiparous cows infused with 1 x 104 (group A; n = 9) and 1 x 106 (group B; n = 10) CFU E. 
coli P4:O32.  
 
 (Values are means ± SEM) 
 Group A Group B 
 (n = 9) (n = 10) 
Blood constituents   
 β-hydroxybutyric acid (mmol/l) 0.89 ± 0.20 0.66 ± 0.05 
 Glucose (mmol/l) 3.8 ± 0.3 3.2 ± 0.2 
 Blood leukocyte count (log10/ml) 6.942 ± 0.024 6.903 ± 0.027 
   
Milk constituents   
 SCC (log10/ml) 4.46 ± 0.10 4.18 ± 0.07 
 Albumin (mg/dl) 23.4 ± 3.3 27.8 ± 3.1 
 Milk production (l/24 h per quarter)  3.4 ± 0.4 3.8 ± 0.2 
 Fat (g/24 h per quarter) 155 ± 22 164 ± 29 
 Protein (g/24 h per quarter) 101 ± 5 110 ± 8 
 Lactose (g/24 h per quarter) 169 ± 18 186 ± 12 
 
No significant relationships between pre-infection blood and milk constituents and the 
reduction in milk production at d+2 post-infection could be demonstrated (Table 2). 
 
Clinical and Laboratory Results of Primiparous Cows in Group A Inoculated with 1 x 10
4
 
CFU 
All primiparous cows in group A had a moderate clinical outcome of E. coli mastitis, 
based on their quarter milk production of the uninfected quarters on d+2 post-infection. Milk 
production in the uninfected quarters returned to pre-infection level on d+2 post-infection (Fig. 
1).  
Rectal temperature increased from PIH 9 onward, with peak fever reached at PIH 12 
(Fig. 2a). Heart rate and RR peaked at PIH 12 (Fig. 2b-c). Rumen motility was depressed from 
PIH 9 onward, resulting in a decrease in appetite. Primiparous cows returned to normal appetite 
and reticulorumen motility around PIH 21. Udder parameters, such as swelling and elevated 
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quarter temperature, appeared at PIH 9 in the infected quarters. Teat relaxation, milk leakage and 
diarrhoea, considered as indicators for severe clinical illness, only appeared in a small number of 
animals. Changes to abnormal milk with clots, flakes and a watery appearance were maximally 
present in all infected animals at PIH 18 (results not shown). Body condition score slightly 
decreased from 3.5 to 2.5 between calving and the end of the experimental challenge period. 
 
Table 2. Relationship between pre-infection blood and milk constituents and the reduction in 
quarter milk production at d+2 (PIH 48-72) in the uninfected quarters of primiparous cows from 
both groups, assessed by linear regression with correction for inoculum dose. The slope value 
indicates the change in milk production reduction for one unit change in the blood and milk 
constituents.  
 
 Slope Standard error P-value 
Blood constituents    
 β-hydroxybutyric acid (mmol/l) -24 14 0.110 
 Glucose (mmol/l) -11 6 0.089 
 Blood leukocyte count (log10/ml) -44 64 0.497 
    
Milk constituents    
 SCC (log10/ml) +12 20 0.529 
 Albumin (mg/ml) -0.8 0.5 0.126 
 Milk production (l/24 h per quarter) +0.013 0.014 0.120 
 Fat (g/24 h per quarter) +0.14 0.07 0.060 
 Protein (g/24h per quarter) +0.37 0.20 0.089 
 Lactose (g/24 h per quarter) +0.23 0.12 0.067 
 
Based on the severity scoring adapted from Wenz et al. (2001), primiparous cows in 
group A  predominantly reacted with a mild response (n = 7) at PIH 9. At PIH 12, the clinical 
symptoms progressed mostly to a moderate response (n = 7). Thereafter, only one primiparous 
cow with a moderate response was observed at PIH 15. No severe responses were observed at 
any time point between PIH 9 and 48 in group A, which received the 1 x 104 CFU E. coli 
inoculum dose. 
 Milk production in the infected quarters maximally decreased (± 55%) on the day of 
challenge. At d+1 post-infection, milk production gradually increased and almost totally 
recovered by d+3 post-infusion (Fig. 2d). The number of E. coli in the infected quarters peaked 
at PIH 6, followed by a rapid elimination until PIH 15. At PIH 72, only 5 animals still had low 
numbers of E. coli in the infected quarters (Fig. 2e). Somatic cell count rapidly increased from 
PIH 6, reached a maximum at PIH 12, and remained high until the end of the experiment at PIH 
72 (Fig. 2f).  
Blood leukocyte number decreased to nadir at PIH 12 and recovered to pre-infection 
level at PIH 48 (Fig. 2j). The presence of early immature PMN (myelocytes-metamyelocytes) in 
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circulation increased at PIH 6, reaching peak levels at PIH 21 (Fig. 2g). Similarly, maximal 
percentages of late immature PMN (band cells) were reached at PIH 21 (Fig. 2h). 
Concomitantly, circulating mature PMN decreased at PIH 6 with nadir at PIH 12 (Fig. 2i).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Milk production (l/d) of the uninfected right quarters from d-4 until d+3 relative to 
infusion from primiparous cows infused with 1 x 104 (; group A; n = 9) and 1 x 106 (------; 
group B; n = 10) CFU E. coli P4:O32. Data are means (± SEM). 
 
The concentration of lactose in the infected quarters decreased from PIH 9 with a 
minimum at PIH 21-24 (Fig. 2k). Serum albumin in the infected quarters increased from PIH 9, 
and peaked at PIH 15 (Fig. 2l). Sodium and chlorine concentrations peaked at PIH 12 (Fig. 2m-
n), whereas potassium concentration decreased from PIH 9, and reached its greatest reduction at 
PIH 12 (Fig. 2o). All indicators for the presence of mastitis gradually recovered to pre-infection 
levels at PIH 72, after reaching their peak values (Fig. 2k-o). 
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Figure 2. Rectal temperature (a), heart rate (b), respiration rate (c), left quarter milk production 
(d), number of CFU E. coli P4:O32 (e), SCC (f), % myelocytes-metamyelocytes (g), % band 
cells (h), % mature neutrophils (i), blood leukocyte count (j), lactose (k), serum albumin (l), milk 
sodium (m), milk chlorine (n) and milk potassium (o) from PIH –96 until PIH 72 in infected 
quarters or blood, respectively, from primiparous cows infused with 1 x 104 (; group A; n = 
9) and 1 x 106 (------; group B; n = 10) CFU E. coli P4:O32. Data are means. 
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Clinical and Laboratory Results of Primiparous Cows in Group B Inoculated with 1 x 10
6
 
CFU 
 Clinical reaction and changes in laboratory parameters were similar to the above 
described results for group A. However, the changes during inflammation generally appeared 
more rapidly (approximately 3 h) in primiparous cows from group B, infused with the 1 x 106 
CFU E. coli inoculum dose, compared to group A, infused with the 1 x 104 CFU E. coli 
inoculum dose. 
 All primiparous cows in this group reacted with a moderate clinical response to 
intramammary E. coli infusion. Milk production in the uninfected quarters was only decreased 
until d+1 post-infection (Fig. 1). Rectal temperature increased from PIH 6, peaked at PIH 9 and 
gradually decreased to pre-infection values at PIH 18 (Fig. 2a). Peak tachycardia was reached at 
PIH 9 (Fig. 2b), whereas maximal RR was reached at PIH 12 (Fig. 2c). Reticulorumen motility 
and all other clinical parameters seemed to change some 3 h earlier in group B. The same trend 
in BCS could be observed as in group A. 
Clinical scores, adapted from Wenz et al. (2001), showed an earlier reaction (approx. 3 
h) in group B compared with group A. At PIH 9, most of the primiparous cows reacted 
moderately (n = 8), gradually decreasing at PIH 12 (n = 5). Only one animal in group B had a 
prolonged moderate response until PIH 24. No severe responses were present in this group at 
any time point between PIH 9 and 48. 
Milk production reduction in the infected quarters was maximal (± 65%) on the day of 
infusion and recovered rapidly to pre-infection production at d+3 post-infection (Fig. 2d). The 
number of E. coli in the infected quarters peaked at PIH 3 (Fig. 2e). A rapid influx of cells into 
the infected quarters was observed from PIH 3, with a peak at PIH 9 (Fig. 5f).  
The number of circulating blood leukocytes decreased from PIH 6, peaking at PIH 9. A 
pronounced rebound effect was observed between PIH 15 and 48 (Fig. 2j). The increase in 
circulating early immature cells was pronounced and peaked at PIH 15 (Fig. 2g). Band cells 
increased at PIH 9, and peaked at PIH 18, thereafter gradually decreasing to reach  pre-challenge  
levels at PIH 72 (Fig. 2h). The greatest reduction in circulating mature PMN was reached at PIH 
3, gradually increasing to pre-infection values at PIH 21 (Fig. 2i).  
The concentrations of lactose, serum albumin, sodium, chlorine and potassium followed 
similar kinetics as in group A, although the initial changes appeared approximately 3 h earlier 
(Fig. 5k-o). 
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DISCUSSION 
  
 In this study, the same strain and range of high inoculum doses of E. coli was used to 
induce E. coli mastitis as previously described (Heyneman et al., 1990; Vandeputte-Van Messom 
et al., 1993; Hoeben et al., 2000; Dosogne et al., 2002). In contrast to previous studies, 
primiparous cows were used. Similar clinical symptoms, such as quarter inflammation, fever, 
depression of reticulorumen motility, loss of appetite and general discomfort were observed as 
expected. In previous studies, however, the clinical responses showed large variations from 
mild-moderate to severe; whereas in the present study, the variation in clinical response was 
quite narrow. Quarter inflammation was associated with a temporary loss of milk production, 
combined with the secretion of abnormal milk from the infected glands. Maximal decrease in 
milk production in the infected and uninfected quarters occurred on the day of challenge, in 
contrast to previous observations where maximal decrease in milk production was observed later 
(Heyneman et al., 1990; Hoeben et al., 2000). In the present study, none of the animals reacted 
severely following intramammary E. coli challenge (Fig. 3). In both infected and uninfected 
quarters, milk production seemed to recover more rapidly on d+1 post-infection in primiparous 
cows from group B, which received the 1 x 106 CFU E. coli inoculum dose. Animals were 
scored as previously described (Vandeputte-Van Messom et al., 1993) and compared with the 
clinical score used by Wenz et al. (2001). This  resulted in a similar classification of mild and 
moderate responses. The only difference that could be observed between group A and B was the 
time of latency that was shorter when higher inoculum doses were used.  
 Body condition score and the concentration of BHBA and glucose indicated that the 
primiparous cows in this study were not ketotic at the time of challenge (Kremer et al., 1993b), 
although their quarter milk production was comparable to the multiparous cows previously 
challenged (Heyneman et al., 1990; Vandeputte-Van Messom et al., 1993). 
The number of circulating PMN, a marker to predict the clinical outcome of the disease, 
was similar to the levels previously observed in moderate responders (Vandeputte-Van Messom 
et al., 1993). Primiparous cows in this study could therefore be expected to react with a moderate 
clinical response. Although no PMN functionality was determined in this study, it is expected 
that PMN reactive oxygen species production was high in these primiparous cows. Mehrzad et 
al. (2002) recently found that in the period from 5 weeks before until 5 weeks post-parturition 
the CL activity of PMN was higher in primiparous cows than in multiparous cows. 
Polymorphonuclear leukocyte reactive oxygen species production and chemotactic activity were 
inversely correlated to the clinical outcome of E. coli mastitis (Heyneman et al., 1990; Kremer et 
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al., 1993a; 1993b). No significant relationship with the reduction in quarter milk production on 
d+2 post-infection was observed, possibly due to the limited number of animals in this study.  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. Percentage of the initial quarter milk production in the uninfected quarters on d+2 (PIH 
48-72) relative to infection. A. Primiparous cows infused with 1 x 104 (group A; n = 9) or 1 x 106 
(group B; n = 10)  CFU E. coli P4:O32 in both left quarters (present study). B. Multiparous cows 
infused with 1 x 103 CFU E. coli O157 in both left quarters and scored into moderate (n = 7) and 
severe (n = 5) clinical response (Dosogne et al., 1997; historical control). Means (•) and standard 
deviation (I) of percentages of the initial milk production in the uninfected quarters were given 
for each group. Line (……) at 50% of the initial milk production arbitrarily indicates the 
difference between moderate and severe responders (Vandeputte-Van Messom et al., 1993). 
 
 The onset of local clinical signs of mastitis, characterised by quarter swelling, coincided 
with the influx of PMN to the infected quarters. Somatic cell count increased rapidly in both 
groups, which is in accordance with earlier observations, where moderate responders had a 
rapidly occurring leukocytosis in the infected glands (Vandeputte-Van Messom et al., 1993). The 
extraction of mature PMN from the blood to the infected glands is known to result in early and 
late immature PMN recruitment from the bone marrow to restore the number of circulating 
PMN. In this study the recruitment of immature PMN was of short duration, compared to 
Heyneman et al. (1990), who observed immature forms in circulation for at least 3 d in moderate 
responders and for almost 10 d in severe responders.  
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The rapid influx of PMN into the infected glands was associated with fast elimination of 
bacteria from the quarters. In this study, high inoculum doses were used for experimental 
induction of E. coli mastitis, because we were mainly interested in bacterial elimination rather 
than bacterial growth in the mammary gland. In contrast to an earlier study with the same 
inoculum dose in multiparous animals (Vandeputte-Van Messom et al., 1993), peak bacterial 
numbers were  already reached around PIH 3 to 6. This peak number of bacteria was followed 
by a rapid elimination from the affected glands. Contrary to the induction of E. coli mastitis with 
low inoculum doses, where elimination is preceded by excessive bacterial growth, in this study, 
peak numbers were reached within 6 h post-infection and followed by a subsequent bacterial 
elimination. Therefore, PMN influx is thought to be fast and strong enough to rapidly clear the 
bacteria from the affected glands. It can be presumed that the bactericidal capacity of the PMN 
migrated to the infected quarters is high, because more efficient PMN functionality was reported 
in primiparous cows recently (Mehrzad et al., 2002). 
 Several indicators (lactose, serum albumin, sodium, chlorine and potassium) for the 
presence of mastitis were determined in this study. Generally, the changes could be observed 
approximately 3 h earlier in group B, although peak levels were almost identical for both groups, 
which coincides with all other data, indicating that the animals reacted with a mild to moderate 
response and little variation in the clinical response was present in this study.  
From this study, it appears that the inflammatory response in primiparous cows from 
group B has an earlier onset compared to group A. One possible explanation for this observation 
could be the 100-fold difference in the number of E. coli infused into the mammary glands, 
because the amount of LPS produced is related to the number of E. coli bacteria (Burvenich, 
1983; Cross et al., 1993; Monfardini et al., 1999). A direct effect of LPS present in the inoculum 
can be excluded, because the bacterial cultures were washed three times in pyrogen-free PBS 
before further dilutions were made. Lipopolysaccharide, known as a potent inducer of 
inflammatory cytokines (Shuster et al., 1993), can be produced quite rapidly during bacterial 
growth following intramammary E. coli infusion. Therefore, a sufficient amount of 
inflammatory cytokines should be produced early during inflammation in both groups, resulting 
in the rapid attraction of PMN from the blood into the mammary gland, with a subsequent 
pronounced increase of SCC in the infected glands.  
Following E. coli mastitis, treatment with a bactericidal antibiotic at PIH 10 has been 
shown inefficient to alter local and systemic symptoms already present, although the number of 
bacteria in the infected quarters decreased 100-fold (Monfardini et al., 1999). Therefore, it can 
be suggested that early inflammatory events (first 3 h) could play an important role in the further 
regulation of the inflammatory response to combat the invading organisms. Experimental design 
Influence of parity on severity of inflammation 
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in this study, particularly in relation to the number and time of samplings, was however not 
suitable to unravel these elements of early acute phase response. 
Nevertheless, the moderate inflammation model with primiparous cows in the present 
study clearly indicates that a mild to moderate response following intramammary challenge with 
E. coli is sufficient to combat the induced mastitis with a maximal resolution of mammary gland 
functionality.  
 
CONCLUSION 
 
 In conclusion, despite the use of relative high inoculum doses, primiparous cows react 
with a moderate inflammatory response following intramammary infusion. This moderate 
response was evident from the pre-infection number of circulating leukocytes, the concentration 
of BHBA and glucose, the prompt clinical response, the rapid influx of PMN into the infected 
quarters, the efficient bacterial elimination of the affected glands and the fast recovery of milk 
production in both infected and uninfected glands. To follow-up the bacterial elimination from 
the affected glands, the use of a high inoculum dose was of particular interest. In contrast to 
previous studies, pre-infection parameters were not significantly related to the clinical outcome 
of the disease in terms of severity. The absence of a significant relation between these 
parameters could be due to the narrow variation in clinical response in the present study, 
especially compared to the large variation, ranging from mild-moderate to severe, observed in 
previous studies. The difference in time of latency between both inoculum doses could also be 
considered as an interesting observation. However, to further elucidate the effect of inoculum 
dose, a completely randomised study should be designed for this purpose. The moderate 
inflammation model with primiparous cows presented here, clearly indicates that a mild to 
moderate response following intramammary challenge with E. coli is sufficient to combat the 
induced mastitis with a maximal resolution of mammary gland functionality. 
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INTRODUCTION 
  
The importance of innate immunity in recognising microbial pathogens and mounting a 
response against them is now widely recognised. The immediate, innate immune response is 
mediated largely by white blood cells such as PMN and macrophages, cells that phagocytose and 
kill the pathogens, and that concurrently co-ordinate additional host responses by synthesising a 
wide range of inflammatory mediators and cytokines (Aderem and Ulevitch, 2000). Several 
species of Gram-negative bacteria, including E. coli, Klebsiella pneumoniae, and various species 
of Enterobacter, are common mastitis pathogens and are all characterised by the presence of 
endotoxin or LPS in their outer membrane. Lipopolysaccharide is a pro-inflammatory molecule 
that is shed from the bacterial surface during bacterial replication or death (Burvenich, 1983; 
Petsch and Anspach, 2000; Burvenich et al., 2003). Clinical signs following experimentally 
induced E. coli mastitis contributed to mediator shock rather than to endotoxin shock, because 
endotoxin mainly plays a local role (Hoeben et al., 2000; Dosogne et al., 2002). 
 Several of the pro-inflammatory cytokines that mediate the localised and systemic 
response to Gram-negative mastitis, including IL-1β, IL-6, IL-8, and TNF-α are upregulated by 
LPS (Shuster et al., 1993; Guha and Mackman, 2001). The upregulation of these cytokines is 
mediated by the interaction of LPS with the accessory proteins, LBP and CD14 (Guha and 
Mackman, 2001). LPS-binding protein, an acute phase protein binding with circulating LPS, 
facilitates the transfer of LPS to mCD14,  found on PMN and cells of the monocytic lineage 
(Wright et al., 1990). Membrane-associated CD14 is a glycosyl phosphatidylinositol-anchored 
protein that lacks an intracellular cytoplasmic domain, rendering it incapable of signal 
transduction across the cell membrane. In cells lacking mCD14, such as epithelial and 
endothelial cells, activation is dependent on cellular recognition of LPS-LBP complexes bound 
to circulating sCD14, which is derived from the shedding of mCD14 (Tapping and Tobias, 1997) 
from CD14-bearing cells. Toll-like receptor-4 has been identified in both cells of the monocytic 
lineage and non-mCD14-bearing cells as a LPS transmembrane receptor capable of activating 
cells (Chow et al., 1999; Faure et al., 2000). Recently, it was shown that LBP in addition to 
transferring LPS to CD14 also forms an integral part of a trimolecular LPS-LBP-sCD14 
complex. Monocytes can therefore detect the presence of LPS at concentrations as low as 10 
pg/ml (Thomas et al., 2002). Transmembrane signalling and cell activation in cells lacking 
mCD14 is thought to be associated with TLR-4, through a cell surface assembly of a multi-
protein recognition complex consisting of CD14, MD-2, and TLR-4 (Akashi et al., 2000). 
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Activation and transmembrane signal transduction through the TLR-4 complex activates several 
NF-κB controlled genes such as IL-8 in endothelial cells (Aderem and Ulevitch, 2000).  
 A role for sCD14 and LBP in mediating bovine host responses to intramammary LPS or 
E. coli challenge have recently been demonstrated (Wang et al., 2002; Bannerman et al., 2003; 
Lee et al., 2003a; 2003b). Following intramammary LPS infusion, sCD14 increases in milk 
(Bannerman et al., 2003; Lee et al., 2003a) paralleled by an increase in LBP (Bannerman et al., 
2003). Moreover, sCD14 has been shown to sensitise the mammary gland to LPS (Wang et al., 
2002) and to reduce the severity of experimental E. coli mastitis in mice (Lee et al., 2003c) and 
cows (Lee et al., 2003b). Interestingly, maximal levels of the chemoattractant IL-8 were 
observed before increases in either milk LBP or sCD14. This suggests that initial host cell 
activation can occur in the presence of basal levels of sCD14 and LBP (Bannerman et al., 2003). 
Furthermore, PMN influx as determined by SCC, was similarly elevated before increases in 
sCD14 and LBP, indicating that heightened levels of these molecules were not required for 
immediate host innate immune responses (Bannerman et al., 2003). 
 Several physiological factors impact on the clinical outcome of E. coli mastitis 
(Burvenich et al., 2003). Early lactating cows, infected with E. coli, are more severely affected 
than cows after peak lactation (Hill, 1981). This is mainly due to the impairment of early 
lactation leukocyte function which begins a few weeks before parturition and only recovers 
several weeks post-partum (Kehrli et al., 1989; Sordillo and Babiuk, 1991a; 1991b; Sordillo and 
Peel, 1992; Detilleux et al., 1995; Dosogne et al., 1999; Mehrzad et al., 2002). This pronounced 
immunosuppresion is not only related to parturition itself (Kimura et al., 1999), but is influenced 
by several periparturient diseases (Kehrli and Goff, 1989) and has a consequence on many other 
diseases, such as retained placenta (Kimura et al., 2002). In addition to stage of lactation, parity 
was also reported to be an important physiological factor that influences severity of clinical 
mastitis (Gilbert et al., 1993; van Werven et al., 1997; Mehrzad et al., 2002; Vangroenweghe et 
al., 2004). Blood PMN function was higher in younger animals than in cows after their 4th 
parturition (Gilbert et al., 1993; van Werven et al., 1997). Moreover, PMN viability and 
oxidative burst activity have been found to be significantly different between primiparous cows 
and multiparous cows during the periparturient period (Mehrzad et al., 2002). In a non-
randomised intramammary challenge study using large numbers of E. coli, primiparous cows 
reacted as moderate responders based on their quarter milk production in the uninfected quarters 
on d+2 post-infection. Based on clinical severity, all of the primiparous animals were scored as 
mild to moderate in their clinical response throughout the entire experimental challenge period 
(Vangroenweghe et al., 2004).  
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 The purpose of the present study was to quantify several inflammatory mediators and 
cytokines and to evaluate the outcome of intramammary E. coli inoculation in primiparous cows 
under identical conditions as described previously (Vangroenweghe et al., 2004) with a fully 
randomised study design, using two high inoculum doses, with a 100-fold difference (1 x 104 
and 1 x 106) in CFU. This difference in inoculum dose was based on the amount of LPS 
produced related to the number of E. coli bacteria injected (Burvenich, 1983; Monfardini et al., 
1999). The hypothesis of the present study is that the application of 2 different inoculum doses 
elicits differences of the innate immune response. An effect of 2 different inoculum doses in 
highly resistant primiparous cows has never been studied before, and is important to have a 
better insight into the mechanism of innate immune response in these animals.  
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MATERIALS AND METHODS 
 
Experimental animals and study facilities 
All primiparous cows (n = 16) calved within 3 days before arrival at the commercial 
dairy farm.  
 
Experimental Design 
Animals were randomly assigned to one of both treatment groups (1 x 104 CFU (group 
A) or 1 x 106 CFU (group B)) and challenged with E. coli P4:O32 on 2 different trial days (8 
cows per challenge day, 4 cows per treatment group). 
 
Sampling Procedure 
  Blood and milk samples were collected at d-4, d-1, d0, d+1, d+2 and d+3 relative to the 
day of challenge. On the day of challenge, blood and milk samples were collected at PIH 3, 6, 9, 
12, 15, 18 and 21. 
  
Determination of cytokines in milk and plasma 
The following cytokines were determined in milk from the affected quarters: IL-8, C5a, 
sCD14 and LBP. In plasma, only LBP was quantified.  
 
Statistical Analysis 
 In order to compare the two inoculum groups with respect to the various parameters 
analysed in blood and milk, a mixed model was used with cow as random effect and time, 
inoculum and their interaction as categorical fixed effects. Furthermore, for the SCC, CFU, RT, 
IL-8, C5a, sCD14 and LBP, the two inoculum doses were compared at PIH 6, 9 and 12, using 
Bonferroni’s multiple comparisons procedure with an overall type I error equal to 5%. The effect 
of the inoculum size on the clinical score was tested by the Fisher Exact test.  
 
For Further Details see chapter 'Materials and Methods Experimental Infections', p. 97.
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RESULTS 
 
Local and Systemic Inflammatory Response 
 Rectal temperature rapidly increased after the intramammary E. coli inoculation in both 
infusion groups and was significantly higher (P < 0.002) at PIH 6 and 9 in group B compared to 
group A. The fever peak appeared 3 h earlier and was highest in group B, which received the 1 x 
106 CFU inoculum (Fig. 1a). As indicated by the significant interaction between time and 
inoculum (P < 0.0001), the kinetics of the RT curve significantly differed between the infusion 
groups. Heart rate and RR followed identical kinetics as RT (results not shown). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Rectal temperature (a), number of CFU E. coli P4:O32 (b), lactose (c), sodium (d), 
potassium (e) and chlorine (f) from PIH 0 until PIH 48 in the infected quarters, respectively, 
from primiparous cows infused with 1 x 104 (; group A; n = 8) and 1 x 106 (-----; group B; n 
= 8) CFU E. coli P4:O32. Data are means (± SEM). 
 
Rumen motility was reduced in both infusion groups from PIH 9 onwards. However, the 
depression of reticulorumen motility was less pronounced in group A with only 3 animals 
showing a slight decrease in motility (1-2 contractions/2 min) and 1 animal with a complete 
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absence of reticulorumen activity at PIH 9. In group B, the depression of rumen motility was 
also maximal at PIH 9: 3 animals with absence of motility and 4 animals showing a slight 
decrease in rumen motility. Reticulorumen returned to normal motility by PIH 24 in both 
infusion groups (results not shown). 
 Local clinical signs at the level of the infected mammary glands appeared early during 
inflammation. In group B, the first changes in milk appearance (colour, flakes, …) occurred at 
PIH 9, with a maximum around PIH 15. Swelling of the infected quarters occurred at PIH 6, 
with a maximum on PIH 9, at the time when PMN influx in the glands became apparent through 
increases in SCC. Pronounced swelling disappeared gradually, and was already at a low level (6 
quarters with moderate swelling) at PIH 72. In the group receiving the low inoculum dose, 
changes in milk appearance and quarter swelling were equal to group B, but the onset was about 
3 h later. Teat relaxation, milk leakage and diarrhoea only appeared in a small number of 
animals in both infusion groups. Body condition score decreased slightly from 3.5 to 2.5 from 
arrival at the dairy facility until the end of the intramammary E. coli challenge. 
 
Clinical Severity Scoring 
 Based on the clinical severity scoring by Vangroenweghe et al. (2004), clinical changes 
appeared earlier in group B compared to group A. At PIH 9, 6  animals in group B (n = 8) had a 
moderate clinical score, whereas in group A (n = 8), only 1 animal reacted moderately, while the 
others still exhibited a mild response (P = 0.041). By PIH 12, only 4 animals in group B (n = 8) 
reacted moderately, whereas in group A (n = 8) 6 animals showed a moderate response (P = 
0.61) (Table 1). The clinical score normalised from PIH 15 onward, with only one animal in 
each group reacting moderately at PIH 15, and none at PIH 18. No severe responses were 
observed in either of the infusion groups at any time point between PIH 9 and 48. 
 
Table 1. Classification of primiparous cows into mild-moderate-severe responders based on the 
severity scoring system at PIH 9 and 12. The numbers mentioned in the body of the table 
represent the number of animals having the specified score (sum of clinical parameters; see 
Materials and Methods Experimental Infections, p. 97) at the respective PIH. In the present 
study, the total score did not exceed 5, meaning that no severe responses were observed 
throughout the entire experimental study period. 
 
PIH Group Mild response Moderate response Severe response 
  0 1 2 3 4 5 6 7 8 
9 A 2 2 2 2 0 0 0 0 0 
 B 0 0 1 5 2 1 0 0 0 
           
12 A 0 1 1 5 1 0 0 0 0 
 B 0 2 2 3 1 0 0 0 0 
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Quarter Milk Production 
 Milk production in the infected quarters decreased (P < 0.0001) on d0, the day of 
intramammary inoculation. The maximal decrease of 60-70% appeared already on the day of 
infection (Fig. 2a). Milk production decrease (68%) was slightly more pronounced in group B, 
with a slightly more rapid recovery on d+1, but no significant differences between the two doses 
were observed. On d+3, the recovery in the infected quarters was still incomplete and averaged 
86 and 76% of the pre-infection milk production in group A and B, respectively.  
 The milk production decrease in the contralateral uninfected quarters is considered to be 
an indicator of general systemic illness due to intramammary infection in the left quarters. A 
moderate and short-termed decrease in the milk production of the contralateral quarters was 
present in both infusion groups (Fig. 2b). Based on quarter milk production at d+2, no severe 
responders were observed in the two groups. At d+3, relative to the day of infusion, milk 
production of these quarters was at 97 and 99% of the pre-infection milk production in group A 
and B, respectively. 
 
 
 
 
 
 
Figure 2. Milk production of the infected left (a) and uninfected right quarters (b) from d-1 until 
d+3 from primiparous cows infused with 1 x 104 (; group A; n = 8) and 1 x 106 (-----; group 
B; n = 8) CFU E. coli P4:O32. Data are means (± SEM). 
 
Colony-Forming Units, Somatic Cell Count and Blood Leukocyte Count  
 The number of E. coli increased to peak values (3.96 and 3.20 log10(CFU)/ml) at PIH 3 
and 6 in the high and low dose infusion group, respectively. On average, the number of E. coli 
did not significantly differ between both infusion groups. Furthermore, no significant interaction 
between time and inoculum dose was found, indicating that the number of E. coli  changed over 
time in a similar fashion for the two inoculum doses (Fig. 1b). 
Somatic cell count rapidly increased following intramammary E. coli infection and was 
significantly (P < 0.0001) higher at PIH 6 in the high dose infusion group compared to the group 
receiving the low dose. At PIH 9, both infusion groups reached a plateau level of 106.57 cells/ml 
(Fig. 3f). Peak SCC levels were reached at PIH 15 and 18 in group B and A, respectively. 
Somatic cell count kinetics significantly differed (P = 0.0005) between the inoculum groups, 
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especially due to the earlier cellular influx (PIH 6) in the infected quarters in group B. At PIH 
72, SCC did not yet attain pre-infection SCC levels.  
Blood leukocyte count decreased after intramammary E. coli infection, but kinetics of 
the blood leukocyte count decrease did not differ significantly between the inoculum groups. 
Nadir blood leukocyte count was reached at PIH 12 in both infusion groups and normal levels of 
circulating blood leukocytes appeared at PIH 48 (Fig. 3g).  
 
Differentiation of Blood Smears 
 Following intramammary challenge, marked changes in leukocyte differentiation 
appeared, resulting in an increased number of early (myelocytes-metamyelocytes) and late (band 
cells) immature PMN in the blood circulation. Band cells increased from PIH 3 to peak at PIH 
12 (group B; 29.1 ± 6.4%) and PIH 15 (group A; 27.2 ± 2.4%). A second peak was observed at 
PIH 21 (32.3 ± 2.8 and 31.6 ± 4.0% in group A and B, respectively), after which percentage of 
band cells decreased to normal levels by PIH 216 (Fig. 3i). Early immature cells (myelocytes-
metamyelocytes) appeared more frequently in the circulation from PIH 12 (group  B) and PIH 15 
(group A) onward, with peak values at PIH 18 (group A; 24.1 ± 2.5%) and PIH 21 (group B;  
18.8 ± 1.1%). Myelocytes-metamyelocytes gradually decreased in the following 96 h to reach 
normal levels at PIH 144 to 216 (Fig. 3h). 
 Mature PMN migrated from the circulation into the infected quarters, which resulted in a 
decreased percentage from PIH 9 onward in both groups, with the nadir at PIH 15 (1.0 ± 0.6 and 
3.5 ±  2.0% in group A and B, respectively). The percentage of circulating mature PMN 
gradually recovered and reached pre-infection values by PIH 144 (Fig. 3j).  
 
Milk Composition 
 Lactose, sodium, potassium and chlorine are good indicators to assess the presence of 
intramammary infection. Lactose decreases significantly in group B from PIH 6 onward, to nadir 
at PIH 12 in both groups. In group A, the disruption of the blood-milk barrier appears 3 h later 
with a decrease in lactose content at PIH 9 (Fig. 1c). Similarly, Na+ and Cl- concentrations in 
group B increased from PIH 6 to peak a first time at PIH 9. Following a slight decrease at PIH 
15, a second peak was reached at PIH 18. In group A, infused with 1 x 104 CFU per quarter, the 
onset of increased concentrations of Na+ and Cl- appeared at PIH 9, with maximal concentrations 
at PIH 18 (Fig. 1d and f). In contrast with the observed changes in Na+ and Cl- concentrations, 
K+ kinetics did not significantly differ between both infusion groups. Nadir was reached at PIH 
12, followed by a slow restoration of initial K+ levels by PIH 48 (Fig. 1e). 
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Milk IL-8 and C5a 
 Before challenge, IL-8 was very low (2.19 ± 0.93 and 1.89 ± 0.84 pg/ml in group A and 
B, respectively) in the quarters that were to be infused with E. coli. Interleukin-8 kinetics of the 
two infusion groups differed significantly from each other. In group B, a significant increase in 
IL-8 appeared as early as PIH 6 and reached a peak of 305 ± 36 pg/ml at PIH 12 (Fig. 3a). At 
PIH 6 and 9, the concentration of IL-8 in the inflamed quarters was significantly (P < 0.05) 
higher in group B, receiving the 1 x 106 CFU inoculum dose. Following infusion of 1 x 104 CFU 
(group A), significant increases in IL-8 occurred at PIH 9 and reached peak levels of 240 ± 40 
pg/ml at PIH 12. Elevated levels of IL-8 persisted until PIH 24 in both groups, after which the 
levels returned to baseline. 
 The complement component C5a had similar kinetics in both groups. The initial increase 
in C5a following intramammary challenge appeared at PIH 6 (± 1.5 ng/ml), and rapidly reached 
maximal values of 37.1 ± 16.0 ng/ml and 30.6 ± 12.4 ng/ml at PIH 12 for group A and B, 
respectively. Elevated levels of C5a persisted until PIH 24 in both groups, after which the levels 
returned to baseline (Fig. 3b). 
 
Milk sCD14 
 To determine whether E. coli could alter mammary gland levels of sCD14, a sandwich 
ELISA was used to quantitate milk sCD14 (Fig. 3c). Before challenge, sCD14 in mammary 
quarters (7.7 ± 2.7 µg/ml and 10.4 ± 3.1 µg/ml for group A and B, respectively) was in the range 
previously described (Lee et al., 2003a) for early lactating uninfected glands (5.46 to 6.90 
µg/ml). At PIH 6, a significant increase in milk sCD14 was observed in group B, whereas in 
group A, the increase in milk sCD14 only appeared at PIH 9. Concentrations of sCD14 were 
significantly (P < 0.0001) different between the two groups at PIH 12. Milk sCD14 peaked at 
PIH 15 in both groups, although the level of sCD14 was significantly (P = 0.0323) higher (205 ± 
44 µg/ml) in group B compared to group A (151 ± 54 µg/ml) (Fig. 3c). 
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Figure 3. Interleukin-8 (a), C5a (b), sCD14 (c), plasma LBP (d), milk LBP (e), SCC (f), blood 
leukocyte count (g), % myelocytes-metamyelocytes (h), % band cells (i) and % mature PMN (j) 
from  PIH 0 until PIH 48 in the infected quarters or blood, respectively, from primiparous cows 
infused with 1 x 104 (; group A; n = 8) and 1 x 106 (-----; group B; n = 8) CFU E. coli 
P4:O32. Data are means (± SEM). 
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 Plasma and Milk LBP 
 It has been shown previously (Bannerman et al., 2003) that elevated levels of sCD14 are 
associated with similar increases in milk LBP, thereby providing an environment for optimal 
host recognition of LPS, originating from infused E. coli bacteria. Plasma LBP was also assayed 
as it is known that hepatic synthesis of this protein increases during the acute phase response, 
mainly due to hepatic cell stimulation by IL-1β and IL-6 (Tobias et al., 1999). Under basal 
conditions, LBP was detected in bovine blood at concentrations of 29.8 ± 7.5 µg/ml and 41.9 ± 
5.4 µg/ml for group A and B, respectively; whereas the concentration of LBP in milk was lower 
with a 8.5 ± 5.1 µg/ml and 14.5 ± 11.5 µg/ml for group A and B, respectively. At PIH 9, plasma 
LBP in group B increased and this increase persisted throughout the entire study period (Fig. 
3d). Plasma LBP levels reached maximal levels of 70.1 ± 1.5 and 68.8 ± 1.1 µg/ml at PIH 18, 
after which they slightly declined to plateau until the end of the study. In quarters inoculated 
with E. coli, significant elevation of milk LBP was observed as early as PIH 9, resulting in a first 
peak at PIH 15 (44.4 ± 10.6 and 40.4 ± 8.7 µg/ml in group A and B, respectively). Milk LPB 
was significantly (P = 0.0431) higher in group B at PIH 12. A second peak (61.6 ± 12.3 and 61.2 
± 12.0 µg/ml in group A and B, respectively) was reached at PIH 24, after which milk LBP 
levels remained high until the end of the study (Fig. 3e). Peak levels of milk LBP were observed 
6 h later than the maximal elevation of plasma LBP levels. 
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 DISCUSSION 
  
In this study, the same strain and range of high inoculum doses of E. coli was used to 
induce E. coli mastitis as previously described (Heyneman et al., 1990; Vandeputte-Van Messom 
et al., 1993; Hoeben et al., 2000; Dosogne et al., 2002; Vangroenweghe et al., 2004). The 
outcome of experimental E. coli inoculation was expected based on the results obtained in a 
previous study with primiparous cows under identical conditions (Vangroenweghe et al., 2004). 
In the present study, none of the animals reacted severely following intramammary E. coli 
challenge. Animals were scored as described by Vangroenweghe et al. (2004), which resulted in 
a similar classification of mild and moderate responses. Interestingly, the time of latency to 
become moderately ill was approximately 3 h shorter in group B compared to group A.  
The number of circulating PMN, a marker to predict the clinical outcome of the disease, 
was similar to the levels previously observed in moderate responders (Heyneman et al., 1990; 
Vandeputte-Van Messom et al., 1993; Dosogne et al., 1997; van Werven et al., 1997; 
Vangroenweghe et al., 2004). Primiparous cows in this study could therefore be expected to 
react with a moderate clinical response. Following intramammary E. coli challenge, a rapid 
decrease of circulating PMN was observed, which coincided with the influx of PMN into the 
infected quarters and started around PIH 6-9. No significant difference in blood leukocyte count 
could be observed between both infusion groups, whereas for SCC a significantly earlier influx 
was observed in the high dose inoculum group.  
The onset of local clinical signs of mastitis, characterised by quarter swelling, coincided 
with the influx of PMN to the infected quarters. Somatic cell count increased rapidly in both 
groups, which is in accordance with earlier observations, where moderate responders had a 
rapidly occurring leukocytosis in the infected glands (Vandeputte-Van Messom et al., 1993). 
However, in the present study, distinct differences in the onset of PMN influx into the infected 
glands could be observed. The extraction of mature PMN from the blood to the infected glands is 
known to result in early and late immature PMN recruitment from the bone marrow to restore 
the number of circulating PMN. Recently, IL-8 has been shown to be responsible for rapid 
granulocytosis with the release of PMN from the bone marrow (Terashima et al., 1998). In the 
present study, IL-8 was released through activation of the mammary epithelial cells from PIH 6-
9, which coincided with the appearance of significantly increased numbers of band cells in the 
blood circulation. However, the recruitment of PMN was of short duration, compared to 
Heyneman et al. (1990), who observed immature forms in circulation for at least 3 d in moderate 
responders and for almost 10 d in severe responders.  
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 The rapid influx of PMN into the infected glands was associated with rapid elimination 
of bacteria from the quarters. In the present study, high inoculum doses were used for 
experimental induction of E. coli mastitis, because we were mainly interested in bacterial 
elimination rather than bacterial growth in the mammary gland. In contrast to an earlier study 
with the same inoculum dose in multiparous animals (Vandeputte-Van Messom et al., 1993), 
peak bacterial numbers were already reached around PIH 3 to 6, which was in accordance with a 
previous study in primiparous cows (Vangroenweghe et al., 2004). This peak number of bacteria 
was followed by a rapid elimination from the infected glands. Contrary to the induction of E. 
coli mastitis with low inoculum doses, where elimination is preceded by excessive bacterial 
growth (Shuster et al., 1996; 1997; Riollet et al., 2000; Scaletti et al., 2003), in this study, peak 
numbers were reached within 6 h post-infection and followed by a subsequent bacterial 
elimination. Therefore, PMN influx rapidly cleared the bacteria from the affected glands. It can 
be presumed that the bactericidal capacity of the PMN that migrated to the infected quarters was 
high, because more efficient PMN functionality has recently been reported in primiparous cows 
(Mehrzad et al., 2002). 
 Several indicators (lactose, sodium, chlorine and potassium) for the presence of mastitis 
were determined in this study. The changes appeared significantly earlier (approximately 3 h) in 
group B, receiving the 1 x 106 CFU inoculum dose, although peak levels were almost identical 
for both groups, which coincides with all other data, indicating that the animals reacted with a 
mild to moderate response and little variation in clinical response was present in this study.  
Complement component C5a and its derivative C5adesArg play a potential role in the 
inflammatory response accompanying mastitis (Rainard et al., 1998). The level of C5a/C5adesArg 
on the day of challenge was within the range previously described by Rainard et al. (1998), 
taking into account that the average SCC immediately before intramammary infusion was a little 
higher (approximately 90,000 cells/ml vs. 25,000 cells/ml). In the present study, increased levels 
of C5a/C5adesArg could be observed from PIH 3 onwards, which is in accordance with an earlier 
study (Rainard et al., 1998), although in this study the induction of inflammatory symptoms was 
performed with E. coli endotoxin and not with live bacteria. The assessment of C5adesArg 
concentrations in milk following infusion of E. coli endotoxin or live bacteria showed that 
biologically significant amounts of C5a/C5adesArg are present in mastitis milk. The bulk of 
complement-derived components in mastitis milk are likely to have their origin in blood plasma, 
exudating through the damaged blood-milk barrier following inflammation of the mammary 
gland (Rainard et al., 1998). However, milk concentrations of C5a/C5adesArg are probably not a 
reliable indicator of exudation, as C5a/C5adesArg is rapidly taken up by several cell types present 
in inflamed milk, in particular PMN (Rainard et al., 1998). Major elimination mechanism of this 
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inflammatory mediator is believed to rely on the binding of C5a/C5adesArg to cell surface 
receptors. As milk from inflamed quarters contained high concentrations of cells, mainly PMN, 
it can be put forward that the concentrations of C5a/C5adesArg measured in milk were 
underestimates of the total amounts of C5a/C5adesArg which had originally been generated. 
Complement component C5a generated in milk could well contribute to the activation of the 
recruited phagocytic cells, with the consequence of improving their bactericidal activity 
(Rainard, 2003). 
Interleukin-8 is considered to play an important role in PMN recruitment to the inflamed 
quarters (Baggniolini and Clark-Lewis, 1992; Barber and Yang, 1998). In contrast to Shuster et 
al. (1997), who suggested the importance of C5a to be greater than IL-8 during the early 
inflammatory response mainly due to earlier peak maxima, in the present study, peak levels of 
IL-8 appeared 6 h earlier than C5a. The increase of IL-8 chemotactic activity appears coincident 
with the increment in SCC at the level of the infected quarters. The increase in C5a also 
appeared as early as PIH 3-6, but its peak maximum was only reached at PIH 18. The induction 
of IL-8 production and release is known to be independent of the presence of IL-1β and TNF-α 
(Persson-Waller et al., 2003). Induction of IL-8 is rather associated with the formation of the 
tripartite LPS-LBP-sCD14 complex, that subsequently activates the mammary gland epithelial 
cells through a cell surface assembly of a multi-protein recognition complex consisting of CD14, 
TLR-4 and MD-2 (Akashi et al., 2000), resulting in the activation of the NF-κB controlled IL-8 
gene (Aderem and Ulevitch, 2000).  
Detectable increases in milk LBP were observed after initial increases in blood LBP, and 
maximal levels of LBP in milk were observed at PIH 24, some 6 h after the peak levels of 
plasma LBP. In accordance to Bannerman et al. (2003), the increases in milk LBP paralleled 
increments in sCD14 levels. From a host perspective, the simultaneous increase in both LBP and 
sCD14 levels would be expected to be advantageous as both molecules act in concert to facilitate 
activation of host defence mechanisms by presenting LPS, released during bacterial growth and 
death, to the transmembrane LPS receptor, TLR-4 (Bannerman and Goldblum, 2003). 
Interestingly, the increase in IL-8 already started at PIH 6 in group B, receiving the 1 x 106 CFU 
inoculum dose, whereas significant increases of sCD14 and LBP only appeared from PIH 9, 
suggesting that initial host cell activation can take place in the presence of basal levels of sCD14 
and LBP. Although the increase in sCD14 was earlier and significantly higher in group B, PMN 
influx as determined by SCC in the infected quarters was similarly elevated before pronounced 
increment of SCD14. It was proposed that heightened levels of these molecules are not required 
for immediate host innate immune responses (Bannerman et al., 2003). However, peak levels of 
SCC were not observed until PIH 15-18, at a time when levels of both sCD14 and LBP in milk 
Variation of the inoculum dose 
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were elevated. Whether increments in sCD14 and LBP are necessary for maximal recruitment of 
PMN to the inflamed mammary glands remains unknown.  
 From this study, it appears that the inflammatory response in primiparous cows from 
group B has an earlier onset compared to group A. One possible explanation for this observation 
could be the 100-fold difference in the number of E. coli infused into the mammary glands, 
because the amount of LPS produced is related to the number of E. coli bacteria (Burvenich, 
1983; Monfardini et al., 1999). Because the bacterial cultures were washed three times in 
pyrogen-free PBS before further dilutions were made, a direct effect of LPS present in the 
inoculum can be excluded. Lipopolysaccharide, known as a potent inducer of inflammatory 
cytokines (Shuster et al., 1993), can be produced quite rapidly during bacterial growth following 
intramammary infusion. In the present study, the increase in sCD14 and LBP, which are known 
to bind to LPS, facilitated the release of IL-8 from mammary endothelial cells in the infected 
quarters. Moreover, the infused bacteria rapidly activated the complement system through the 
alternative pathway, resulting in an early abundant production of C5a. The combined effects of 
these events resulted in a rapid attraction of PMN from the blood into the mammary gland, with 
a subsequent pronounced increase of SCC in the infected glands.  
The novelty of the present study is the fact that primiparous cows, recently shown to 
react as mild to moderate responders (Vangroenweghe et al., 2004), are responding faster 
following an 100-fold increase in the inoculum dose. This quicker response is related to an 
earlier activation of innate host immunity. 
Following E. coli mastitis, treatment with antibiotics at PIH 10 did not alter local and 
systemic symptoms despite a 100-fold decrease in CFU (Monfardini et al., 1999). From the 
present study, it is evident that at the set time point, antibiotic treatment is unable to alter the 
production or release of various inflammatory mediators. Therefore, it can be suggested that 
early inflammatory events (first 3 h) could play an major role in the further regulation of the 
inflammatory response to combat the invading pathogens. 
 
CONCLUSIONS 
  
Despite the use of  relatively high inoculum doses, primiparous cows react with a 
moderate inflammatory response following intramammary E. coli infusion. This moderate 
response was evident from the pre-infection number of circulating leukocytes, the prompt 
clinical response, the rapid influx of PMN into the infected quarters, the efficient bacterial 
clearance of the affected glands and the fast recovery of milk production in both infected and 
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uninfected glands. In the present study, the difference in time of latency between both inoculum 
doses could be confirmed and documented with kinetics of various inflammatory mediators such 
as sCD14, LBP, IL-8 and C5a. The early increase in IL-8 following activation of the mammary 
gland epithelium appeared before increases in sCD14 or LBP, indicating that innate host cell 
activation can occur in the presence of basal levels of sCD14 and LBP. Although C5a increased 
during early innate host immune response, maximal levels were reached after IL-8 had peaked. 
In conclusion, primiparous cows were able to efficiently clear an intramammary E. coli infection 
and the increase in inoculum dose induced a more rapid clinical response, mainly due to the 
earlier activation of the innate host immune response. To further elucidate the regulation of early 
events, mammary gland biopsies and milk sample collection during the early phase of 
inflammation should be performed. 
Variation of the inoculum dose 
 - 163 -  
REFERENCES 
 
Aderem, A., and R.J. Ulevitch. 2000. Toll-like receptors in the induction of the innate immune response. 
Nature 460:782-787. 
Akashi, S., H. Ogata, F. Kirikae, T. Kirikae, K. Kawasaki, M. Nishijima, R. Shimazu, Y. Nagai, K.  
Fukudome, M. Kimoto, and K. Miyake. 2000. Regulatory roles for CD14 and phosphatidylinositol in the 
signalling via Toll-like receptor 4 – MD-2. Biochem. Biophys. Res. Comm. 268:172-177. 
Baggniolini, M., and I. Clark-Lewis. 1992. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS 
Lett. 307:97-101. 
Bannerman, D.D., and S.E. Goldblum. 2003. Mechanisms of bacterial lipopolysaccharide-induced 
endothelial apoptosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 284:L899-L914. 
Bannerman, D.D., M.J. Paape, W.R. Hare, and E.J. Sohn. 2003. Increased levels of LPS-binding protein in 
bovine blood and milk following bacterial lipopolysaccharide challenge. J. Dairy Sci. 86:3128-3137. 
Barber, M.R., and T.J. Yang. 1998. Chemotactic activities in nonmastitic and mastitic mammary 
secretions: presence of interleukin-8 in mastitis but not in non-mastitic secretions. Clin. Diagn. Lab. 
Immunol. 5:82-86. 
Burvenich, C. 1983. Mammary blood flow in conscious lactating goats in various physiological and 
pathological (mastitis) conditions. Ph.D. Thesis, Ghent University, Belgium. 
Burvenich, C., V. Van Merris, J. Mehrzad, A. Diez-Fraile, and L. Duchateau. 2003. Severity of E. coli 
mastitis is mainly determined by cow factors. Vet. Res. 34:521-564. 
Chow, J.C., D.W. Young, D.T. Golenbock, W.J. Christ, and F. Gusovsky. 1999. Toll-like receptor-4 
mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem. 274:10689-10692. 
Detilleux, J.C., M.E. Kehrli, Jr., J.R. Stabel, A.E. Freeman, and D.H. Kelley. 1995. Study of 
immunological dysfunction in periparturient Holstein cattle selected for high and average milk 
production. Vet. Immunol. Immunopathol. 44:251-267.  
Dosogne, H., C. Burvenich, T. van Werven, E. Roets, E.N. Noordhuizen-Stassen, and B. Goddeeris. 1997. 
Increased surface expression of CD11b receptors on polymorphonuclear leukocytes is not sufficient to 
sustain phagocytosis during Escherichia coli mastitis in early postpartum dairy cows. Vet. Immunol. 
Immunopathol. 60:47-59. 
Dosogne, H., C. Burvenich, A.E. Freeman, M. E. Kehrli, Jr., J.C. Detilleux, J. Sulon, J.-F. Beckers, and D. 
Hoeben. 1999. Association between pregnancy-associated glycoprotein and decreased 
polymorphonuclear leukocyte function in early postpartum dairy cows. Vet. Immunol. Immunopathol. 
67:47-54. 
Dosogne, H., E. Meyer, A. Sturk, J. van Loon, A.-M. Massart-Leën, and C. Burvenich. 2002. Effect of 
enrofloxacin treatment on plasma endotoxin during bovine Escherichia coli mastitis. Inflamm. Res. 
51:201-205. 
  - 164 -  
Faure, E., J.W. Equils, P.A. Sieling, L. Thomas, F.X. Zhang, C.J. Krischning, N. Polentarutti, M. Muzio, 
and M. Arditi. 2000. Bacterial lipopolysaccharide activates NF-kappaB through Toll-like receptor 4 
(TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in 
endothelial cells. J. Biol. Chem. 275:11058-11063. 
Gilbert, R.O., Y.T. Gröhn, P.M. Miller, and D.J. Hoffman. 1993. Effect of parity on periparturient 
neutrophil function in dairy cows. Vet. Immunol. Immunopathol. 36:75-82. 
Guha, M., and N. Mackman. 2001. LPS induction of gene expression in human monocytes. Cell. Signal. 
13:85-94. 
Heyneman, R., C. Burvenich, and R. Vercauteren. 1990. Interaction between the respiratory burst activity 
of neutrophil leukocytes and experimentally induced Escherichia coli mastitis in cows. J. Dairy Sci. 
73:985-994. 
Hill, A.W. 1981. Factors influencing the outcome of Escherichia coli mastitis in the dairy cow. Res. Vet. 
Sci. 73:985-994. 
Hoeben, D., C. Burvenich, E. Trevisi, G. Bertoni, J. Hamann, R. M. Bruckmaier, and J. W. Blum. 2000. 
Role of endotoxin and TNF-α in the pathogenesis of experimentally induced coliform mastitis in 
periparturient cows. J. Dairy Res. 67:503-514. 
Kehrli, M. E., Jr. and J. P. Goff. 1989. Periparturient hypocalcemia in cows: effects on peripheral blood 
neutrophil and lymphocyte function. J. Dairy Sci. 72:1188-1196.  
Kehrli, M. E., Jr., B. J. Nonnecke, and J. A. Roth. 1989. Alterations in bovine neutrophil function during 
the periparturient period. Am. J. Vet. Res. 50:207-214.  
Kimura, K., J.P. Goff, and M.E. Kehrli, Jr. 1999. Effects of the presence of the mammary gland on 
expression of neutrophil adhesion molecules and myeloperoxidase activity in periparturient dairy cows. 
J. Dairy Sci. 82:2385-2392. 
Kimura, K., J.P. Goff, M.E. Kehrli, Jr., and T.A. Reinhardt. 2002. Decreased neutrophil function as a 
cause of retained placenta in dairy cattle. J. Dairy Sci. 85:544-550. 
Lee, J.-W., M.J. Paape, T.H. Elsasser, and X. Zhao. 2003a. Elevated milk soluble CD14 in bovine 
mammary glands challenged with Escherichia coli lipopolysaccharide. J. Dairy Sci. 86:2382-2389. 
Lee, J.-W., M.J. Paape, T.H. Elsasser, and X. Zhao. 2003b. Recombinant soluble CD14 reduces severity 
of intramammary infection by Escherichia coli. Infect. Immun. 71:4034-4039. 
Lee, J.-W., M.J. Paape, and X. Zhao. 2003c. Recombinant bovine soluble CD14 reduces severity of 
experimental Escherichia coli mastitis in mice. Vet. Res. 34:307-316. 
Mehrzad, J., L. Duchateau, S. Pyörälä, and C. Burvenich. 2002. Blood and milk neutrophil 
chemiluminescence and viability in primiparous and pluriparous dairy cows during late pregnancy 
around parturition and early lactation. J. Dairy Sci. 85:3268-3276. 
Monfardini, E., C. Burvenich, A.-M. Massart-Leën, E. Smits, and M.J. Paape. 1999. Effect of antibiotic 
induced bacterial clearance in the udder on L-selectin shedding of blood neutrophils in cows with 
Escherichia coli mastitis. Vet. Immunol. Immunopathol. 67:373-384. 
Persson-Waller, K., I.G. Colditz, S. Lun, and K. Östensson. 2003. Cytokines in mammary lymph and milk 
during endotoxin-induced bovine mastitis. Res. Vet. Sci. 74:31-36. 
Variation of the inoculum dose 
 - 165 -  
Petsch, D., and F.B. Anspach. 2000. Endotoxin removal from protein solutions. J. Biotechnol. 76:97-119. 
Rainard, P., P. Sarradin, M.J. Paape, and B. Poutrel. 1998. Quantification of C5a/C5adesArg in bovine 
plasma, serum and milk. Vet. Res. 29:73-88. 
Rainard, P. 2003. The complement in milk and defence of the bovine mammary gland against infection. 
Vet. Res. 34:647-670. 
Riollet, C., P. Rainard, and B. Poutrel. 2000. Differential induction of complement fragment C5a and 
inflammatory cytokines during intramammary infections with Escherichia coli and Staphylococcus 
aureus. Clin. Diagn. Lab. Immunol. 7:161-167. 
Scaletti, R.W., D.S. Trammell, B.A. Smith, and R.J. Harmon. 2003. Role of dietary copper in enhancing 
resistance to Escherichia coli mastitis. J. Dairy Sci. 86:1240-1249. 
Shuster, D.E., M.E. Kehrli, Jr., and M.G. Stevens. 1993. Cytokine production during endotoxin-induced 
mastitis in lactating dairy cows. Am. J. Vet. Res. 54:80-85. 
Shuster, D.E., E.K. Lee, and M.E. Kehrli, Jr. 1996. Bacterial growth, inflammatory cytokine production, 
and neutrophil recruitment during coliform mastitis in cows within ten days after calving, compared with 
cows at midlactation. Am. J. Vet. Res. 57:1569-1575. 
Shuster, D.E., M.E. Kehrli, Jr., P. Rainard, and M.J. Paape. 1997. Complement fragment C5a and 
inflammatory cytokines in neutrophil recruitment during intramammary infection with Escherichia coli. 
Infect. Immun. 65:3286-3292. 
Sordillo, L.M., and L.A. Babiuk. 1991a. Controlling acute Escherichia coli mastitis during the 
periparturient period with recombinant bovine interferon gamma. Vet. Microbiol. 28:189-198. 
Sordillo, L.M., and L.A. Babiuk. 1991b. Modulation of bovine mammary neutrophil function during the 
periparturient period following in vitro exposure to recombinant bovine interferon gamma. Vet. 
Immunol. Immunopathol. 27:393-402. 
Sordillo, L.M. and J.E. Peel. 1992. Effect of interferon-g on the production of tumor necrosis factor during 
acute Escherichia coli mastitis. J. Dairy Sci. 75:2119-2125. 
Tapping, R.L., and P.S. Tobias. 1997. Cellular binding of soluble CD14 requires lipopolysaccharide (LPS) 
and LPS-binding protein. J. Biol. Chem. 272:23157-23164. 
Terashima, T., D. English, J.C. Hogg, and S.F. van Eeden. 1998. Release of polymorphonuclear 
leukocytes from the bone marrow by interleukin-8. Blood 92:1062-1069. 
Thomas, C.J., M. Kapoor, S. Sharma, H. Bausinger, U. Zyilan, D. Lipsker, D. Hanau, and A. Surolia. 
2002. Evidence of a trimolecular complex involving LPS, LPS binding protein and soluble CD14 as an 
effector of LPS response. FEBS Lett. 531:184-188. 
Tobias, P.S., R.L. Tapping, and J.A. Gegner. 1999. Endotoxin interactions with lipopolysaccharide-
responsive cells. Clin. Infect. Dis. 28:476-481. 
Vandeputte-Van Messom, G., C. Burvenich, E. Roets, A.-M. Massart-Leën, R. Heyneman, W.D.J. 
Kremer, and A. Brand. 1993. Classification of newly calved cows into moderate and severe responders 
to experimentally induced Escherichia coli mastitis. J. Dairy Res. 60:19-29. 
Vangroenweghe, F., L. Duchateau, and C. Burvenich. 2004. Moderate inflammatory response during 
experimental E. coli mastitis in primiparous cows. J. Dairy Sci. 87:886-895. 
  - 166 -  
van Werven, T., E.N. Noordhuizen-Stassen, A.J.J.M. Daemen, Y.H. Schukken, A. Brand, and C. 
Burvenich. 1997. Pre-infection in vitro chemotaxis, phagocytosis, oxidative burst, and expression of 
CD11/CD18 receptors and their predictive capacity on the outcome of mastitis induced in dairy cows 
with Escherichia coli. J. Dairy Sci. 80:67-74. 
Wang, Y., D.S. Zarlenga, M.J. Paape, and G.E. Dahl. 2002. Recombinant bovine soluble CD14 sensitizes 
the mammary gland to lipopolysaccharide. Vet. Immunol. Immunopathol. 86:115-124. 
Wright, S.D., R.A. Ramos, P.S. Tobias, R.J. Ulevitch, and J.C. Mathison. 1990. CD14, a receptor for 
complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-1433. 
  - 167 -   
 
2. 
 
INHIBITION OF PROSTAGLANDIN SYNTHESIS   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     
Inhibition of prostaglandin synthesis 
 
- 169 - 
INTRODUCTION 
  
Production costs attributed to mastitis are the largest economic loss to the dairy industry. 
Mastitis caused by coliform bacteria is responsible for a major portion of these losses, 
predominantly as a result of acute disease. Coliform mastitis in cattle may be associated with 
systemic clinical disease, which occurs predominantly in the period immediately after calving 
(Hill, 1981; Wilesmith et al., 1986; Burvenich et al., 2003). Systemic signs include general 
depression, fever, tachycardia, inhibition of reticulorumen motility, and many non-specific 
responses, such as neutropenia, followed by leukocytosis (Verheijden et al., 1983). Considerable 
losses in milk production may occur in cows suffering from E. coli mastitis (Hill, 1981; Lohuis 
et al., 1989; Dosogne et al., 1997; Hoeben et al., 2000). Inhibition of reticulorumen motility is a 
frequent complication of E. coli mastitis (Verheijden et al., 1983) and as a result the microbial 
degradation of ingested feed is disturbed and the milk yield is reduced. Moreover, marked 
decreases in plasma tyrosine levels occur (Vandeputte-Van Messom et al., 1987), which are not 
directly related to peak fever.  
The pathophysiology of E. coli mastitis is characterised by the presence of endotoxin or 
LPS in the outer membrane of the etiological bacteria. Lipopolysaccharide is a pro-inflammatory 
molecule that is shed from the bacterial surface during bacterial replication or death (Burvenich 
et al., 2003). Clinical signs following experimentally induced E. coli mastitis are attributed to 
mediator shock rather than to endotoxin shock, because endotoxin mainly plays a local role 
(Hoeben et al., 2000; Dosogne et al., 2002). Several of the pro-inflammatory cytokines that 
mediate the localised and systemic response to Gram-negative mastitis, including IL-1β, IL-6, 
IL-8, and TNF-α, are upregulated by LPS (Shuster et al., 1993; Guha and Mackman, 2001). 
Binding of LPS to cell membranes also activates the membrane-bound enzyme, phospholipase 
A2, liberating arachidonic acid which can be metabolised by two major enzyme systems, COX 
and lipoxygenase. The prostaglandins, prostacyclin and thromboxanes are the products of the 
cyclo-oxygenase pathway, whereas the leukotrienes are synthesised following lipoxygenase 
enzyme activity. The eicosanoids are important mediators and modulators of inflammation, and 
play a role in the mediation of acute inflammation (Anderson, 1989; Rose et al., 1989). 
Intracerebroventricular injection of 50 to 200 µg PGE2 in lactating goats elicited fever in normal 
lactating goats, the increment and decrement stage being accompanied respectively by a decrease 
and an increase of mammary blood flow (Burvenich et al., 1982). Pre-treatment with 
flurbiprofen, administered through intracerebroventricular cannulation, inhibited fever and 
changes in HR following experimentally induced LPS mastitis, but had little effect on the Cl- 
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concentration in the affected mammary gland. Nevertheless, the first peak in the mammary blood 
flow curve occurred with some delay, whereas the second peak was clearly decreased 
(Burvenich, 1985). Intravenous pre-treatment with flurbiprofen totally abolished fever and 
delayed the changes in milk ion concentration (Burvenich et al., 1989). It is also known that the 
release of plasma cortisol after intravenous LPS administration is partially controlled by 
prostaglandins (Massart-Leën et al., 1992).   
Cyclo-oxygenase has two isoforms, the COX-1, which is constitutively expressed in 
most tissues and is responsible for maintenance of various physiological processes, such as 
normal body temperature, and the inducible COX-2, a pro-inflammatory enzyme. Induction of 
COX-2 synthesis is stimulated by several cytokines (IL-1, TNF-α), growth factors and LPS 
(Lees et al., 2000). Nearly all currently used veterinary NSAID’s are non-selective COX-1 and 
COX-2 inhibitors. It was recently demonstrated in a rat model of inflammation that the acute 
early peak expression of COX-2 which was pro-inflammatory, was followed by a second, larger 
increase of COX-2 expression, being anti-inflammatory. Cyclo-oxygenase-2 inhibitors, 
therefore, inhibited inflammation at the early stage, but significantly exacerbated inflammation 
later on at 48 h (Gilroy et al., 1999). However, there is considerable interest in the development 
of specific COX-2 inhibitors for therapeutic use. The COX antagonists currently used in 
veterinary medicine are all regarded as non-specific inhibitors of COX-1 and 2, with similar 
potencies against both enzymes, or even some selectivity for COX-1 inhibition (Lees et al., 
2000). Exceptions are nimesulide, carprofen and meloxicam, which have a partial selectivity for 
COX-2 inhibition and may be described as preferential COX-2 inhibitors (Lees et al., 2000). 
A role for sCD14 and LBP in mediating bovine host responses to intramammary LPS or 
E. coli challenge has recently been demonstrated (Wang et al., 2002; Bannerman et al., 2003; 
Lee et al., 2003a; 2003b). Following intramammary LPS infusion, sCD14 increases in milk 
(Bannerman et al., 2003; Lee et al., 2003a) are paralleled by an increase in LBP (Bannerman et 
al., 2003). Moreover, sCD14 has been shown to sensitise the mammary gland to LPS (Wang et 
al., 2002) and to reduce the severity of experimental E. coli mastitis in mice (Lee et al., 2003c) 
and cows (Lee et al., 2003b). Interestingly, maximal levels of the chemoattractant IL-8 and C5a 
were observed before increases in either milk LBP or sCD14. This  suggests that initial host cell 
activation can occur in the presence of basal levels of sCD14 and LBP (Bannerman et al., 2003; 
Vangroenweghe et al., 2004b). Furthermore, PMN influx as determined by SCC, was similarly 
elevated before increases in sCD14 and LBP, indicating that heightened levels of these 
molecules were not required for immediate host innate immune responses (Bannerman et al., 
2003; Vangroenweghe et al., 2004b). 
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Non-steroidal anti-inflammatory drugs have been reported to alter the clinical course of 
E. coli or endotoxin-induced mastitis in the bovine. A distinct difference has to be made between 
their potential antipyretic and antiphlogistic activity. Various NSAID’s have different physico-
chemical characteristics, which result in unequal tissue distribution throughout the body and 
cause variations in pharmacokinetics, efficacy and toxicity among species (Brune, 1990). In 
addition, the mechanism of action of NSAID's may vary by selective inhibition of the synthesis 
of a particular class of prostaglandins and endoperoxides and by inhibition of biochemical 
reactions, in addition to COX inhibition (Kopcha and Ahl, 1989; Kopcha et al., 1992). The use 
of NSAID’s has been suggested as an adjunctive or alternative therapy to systemic or 
intramammary antibiotics (Shpigel et al., 1994). 
The effect of NSAID’s has been studied in experimental coliform and endotoxin-induced 
mastitis models. These NSAID’s have included flunixin meglumine (Anderson et al., 1986; 
Anderson, 1989; Lohuis et al., 1989), carprofen (Lohuis et al., 1991), flurbiprofen (Burvenich 
and Peeters, 1982; Vandeputte-Van Messom et al., 1987; Burvenich et al., 1989; Lohuis et al., 
1989), ketoprofen (Ziv and Longo, 1991), ibuprofen (DeGraves and Anderson, 1993), 
indomethacine (Burvenich and Peeters, 1982), suprofen (Burvenich and Peeters, 1982) and 
meloxicam (Banting et al., 2000). In these studies, NSAID’s positively affected various clinical, 
hematological, biochemical and pathophysiological parameters. Recently, ketoprofen, 
phenylbutazone and dipyrone have been shown beneficial in the treatment of field cases of 
clinical mastitis (Shpigel et al., 1994; 1996). All NSAID’s in this study were used as an 
adjunctive therapy in combination with the administration of a systemic antibiotic, trimethoprim-
sulphonamide.  
Carprofen ((±)-6-chloro-α-methylcarbazole-2-acetic acid) is an NSAID that is well 
tolerated in the bovine (Ludwig et al., 1989). In healthy cows, carprofen is pharmacokinetically 
characterised by a small distribution volume (0.09 l/kg), a relatively low systemic clearance (2.4 
ml/h/kg) and a long elimination half-life (30.7 h) (Lohuis et al., 1991). During an endotoxin-
induced mastitic episode, systemic clearance decreased, whereas elimination half-life 
significantly increased (43.0 h). Following carprofen treatment at 2 h post-challenge, a 
significant reduction in severity of clinical parameters was observed.  
Until now, few reports have been published on the treatment of experimentally induced 
E. coli mastitis with NSAID’s and the effects of these drugs have been mainly assessed for 
clinical symptoms and much less for laboratory parameters and eicosanoids. The objective of the 
present study was to examine the modulatory effect of carprofen treatment on different clinical, 
blood and milk parameters following moderate inflammation in primiparous cows.  
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MATERIALS AND METHODS 
 
Experimental Animals and Study Facilities 
All primiparous cows (n = 25) calved within 7 days before arrival at the commercial 
dairy farm. 
 
Inoculation Dose 
 Primiparous cows were inoculated with 1 x 104 CFU E. coli P4:O32 in both left quarters.  
 
Sampling Procedure 
  Blood and milk samples were collected at d-4, d-1, d0, d+1, d+2, d+3 and d+6 relative to 
the day of challenge. On the day of challenge, blood and milk samples were collected at PIH 3, 
6, 9, 12, 15, 18 and 21. 
 
Determination of Inflammatory Cytokines and Eicosanoids 
 Two specific eicosanoids, PGE2 and TXB4, were quantified besides IL-8, C5a, sCD14 
and LBP in order to assess for the effect of NSAID treatment following intramammary E. coli 
challenge. 
 
Statistical Analysis 
 In order to compare the two treatment groups with respect to the various parameters 
analysed in blood and milk, a mixed model was used with cow as random effect and treatment, 
time and their interaction as categorical fixed effects. Furthermore, the two treatment groups 
were compared at PIH 12 for all analysed parameters and some determined parameters were 
tested at post-treatment intervals PIH 12-18 (RT, HR, blood leukocyte number and PCV), PIH 
12-48 (IL-8, C5a, sCD14, LBP, PGE2 and TXB2) and PIH 12-72 (SCC, CFU, lactose, Na
+, K+, 
Cl- and serum albumin), respectively, for significant differences between both treatment groups. 
Bonferroni’s multiple comparisons procedure with an overall type I error equal to 5% was used 
to adjust for multiple comparison. Quarter milk production in both infected and uninfected 
quarters were tested for significant differences between treatments at d+1 and the interval d+1 - 
d+3. The effect of treatment on the local aspects of the mammary gland was tested by the 
Wilcoxon rank sum test. 
 
For Further Details see chapter 'Materials and Methods Experimental Infections', p. 97.
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RESULTS 
 
Local and Systemic Inflammatory Response 
Following intramammary E. coli inoculation, RT rapidly increased from PIH 9 onward, 
to reach its maximum at PIH 12 in the saline treated group. Carprofen administration 
immediately reduced RT significantly (P < 0.0001) at 3 and 6 h post-treatment, and RT 
normalised at PIH 15 (6 h post-treatment). No relapses of RT increase were observed in the 
carprofen treated group, whereas in the saline treated group, RT increased above 39°C again at 
PIH 24 (Fig. 1a). 
Heart rate followed almost identical kinetics as described for RT. In the carprofen 
treated group, HR was significantly (P < 0.05) lower at PIH 12, 15 and 18. From 9 h post-
treatment onward, HR in the carprofen treated animals remained lower, although not significant, 
until the end of the observation period (Fig. 1b).  
Carprofen treatment following intramammary E. coli inoculation had a beneficial effect 
on the duration of reticulorumen motility depression. Although reticulorumen motility was 
equally depressed in both treatment groups at PIH 9 (time of treatment), the motility increased 
following carprofen treatment (P < 0.01), whereas in the saline treated group, depression of 
reticulorumen motility reached its maximum at PIH 12 (Fig 1c).  
Local clinical symptoms at the level of the mammary gland were also assessed during 
clinical examination. Local swelling appeared at PIH 6 and reached its maximum at PIH 12 in 
both treatment groups. In the carprofen treated animals, quarter swelling decreased from PIH 18 
and normal quarter consistency was present at PIH 144. Quarter swelling disappeared more 
slowly in control animals, although normal quarter consistency at palpation was also reached by 
PIH 144. Maximal quarter swelling score was significantly lower (P < 0.05) in the carprofen 
treated animals. Milk appearance, quarter milk leakage scores and maximum milk leakage scores 
were significantly (P < 0.05) higher in the carprofen treated group at PIH 12. Quarter pain and 
temperature did not differ between both treatment groups (results not shown).  
 
Clinical Severity Scoring 
 Based on the clinical severity scoring by Vangroenweghe et al. (2004a), clinical scores 
increased to a maximum at PIH 9 and 12 in the carprofen and saline treated animals, 
respectively. The clinical severity score in the carprofen treated group decreased more rapidly 
from 3 h post-treatment onwards. At PIH 12 (P < 0.0001) and 15 (P < 0.01), clinical severity 
score was significantly lower in the carprofen treated group compared to the saline treated group. 
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 At PIH 9, the time of treatment, approximately equal numbers of animals in both 
treatment groups displayed a mild and moderate response. Following carprofen administration, 
all animals (n = 12) responded mildly (score 0-2), whereas in the saline treated group, 6 animals 
reacted with a moderate response (score 3-5) and only 7 animals had a mild response. By 6 h 
post-treatment, 10 animals in the carprofen treated group had a score 0, whereas in the other 
group, only 3 animals had score 0 and the others respectively scored 1 (n = 4), 2 (n = 5) or 3 (n = 
1). During the following observations, the clinical severity score in both groups seemed to 
normalise with only a slight flare-up of 3 animals (score 2) in the saline treated group at PIH 24. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Rectal temperature (a), heart rate (b), reticulorumen motility (c), packed cell volume 
(d), blood leukocyte count (e), plasma LPB (f), plasma PGE2 (g) and plasma TXB2 (h) from PIH 
0 until PIH 144 from primiparous cows infused with 1 x 104 CFU E. coli P4:O32 and treated at 
PIH 9 (dashed vertical line) with carprofen (; n = 12) or saline (-----; n = 13). Data are 
means (± SEM). 
 
Quarter Milk Production 
 Milk production in the infected quarters decreased equally on d0, the day of 
intramammary E. coli challenge, in both treatment groups. No significant effect of carprofen 
treatment on the recovery of milk production in the infected quarters could be observed (Fig. 2a). 
 In the uninfected control quarters, no significant differences in milk production could be 
observed throughout the entire study period (Fig. 2b). As expected, none of the animals in both 
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treatment groups reacted as severe responder, based on the quarter milk production of the 
uninfected quarters at d+2 compared to the quarter milk production in these quarters at d-1 
(Vandeputte-Van Messom et al., 1993). This is in agreement with recent findings that 
primiparous cows react moderately following intramammary E. coli challenge (Vangroenweghe 
et al., 2004a; 2004b).  
 
 
 
 
 
 
 
 
 
Figure 2. Quarter milk production in the infected (a) and uninfected (b) quarters from PIH –168 
until PIH 144 from primiparous cows infused with 1 x 104 CFU E. coli P4:O32 and treated at 
PIH 9 with carprofen (; n = 12) or saline (-----; n = 13). Data are means (± SEM). 
 
Intramammary Growth of the Inoculated E. coli, Somatic Cell Count, Packed Cell Volume 
and Blood Leukocyte Count 
The number of E. coli increased to plateau (4.07 and 3.89 log10(CFU)/ml) at PIH 6. This 
plateau was followed by a slow, but steady decrease in both treatment groups. No significant 
differences in number of E. coli (PIH 12-48) could be observed throughout the entire 
experimental period (Fig. 3a). Somatic cell count increased during the early phase of 
inflammation, although SCC only exceeded 1 x 106 cells/ml at PIH 9 in both treatment groups. 
Following treatment at PIH 9, no significant differences in SCC (PIH 12-48) could be observed 
throughout the entire experimental period (Fig. 3b)  
 A decrease in blood leukocyte number occurred from PIH 9 onward, and nadir blood 
leukocyte number was reached at PIH 12. This was followed by a steady increase to pre-
infection levels at PIH 24 (Fig. 1e). Blood leukocyte count did not differ significantly between 
the two treatment groups during the period immediately following intravenous carprofen 
treatment (PIH 12-18).  
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Figure 3. Colony-forming units of E. coli (a), SCC (b), lactose (c), serum albumin (d), sodium 
(e), potassium (f) and chlorine (g) in the infected quarters from PIH 0 until PIH 144 from 
primiparous cows infused with 1 x 104 CFU E. coli P4:O32 and treated at PIH 9 (dashed vertical 
line) with carprofen (; n = 12) or saline (-----; n = 13). Data are means (± SEM). 
 
Milk Composition 
 Lactose, serum albumin, sodium, potassium and chlorine are indicators of changes in 
milk composition following mastitis (Burvenich, 1983). Following E. coli challenge, the lactose 
concentration started to decrease at PIH 9, reaching the nadir at PIH 12 (3 h post-treatment) in 
both treatment groups. No significant differences (PIH 12-48) in lactose concentration were 
observed following carprofen treatment (Fig. 3c). Maximal concentrations of serum albumin in 
milk were reached at PIH 15. In the interval PIH 12-48, serum albumin concentration showed a 
significant interaction between time and treatment (P = 0.013), meaning that serum albumin 
kinetics were different between both groups. At PIH 21, carprofen treated animals had 
significant (P = 0.0099) lower concentrations of serum albumin in the milk of the affected 
quarters (Fig. 3d). 
 The Na+ concentration was significantly lower in the carprofen treated animals at PIH 21 
(P = 0.005) and PIH 24 (P = 0.007), whereas the K+ concentration was significantly higher in the 
carprofen treated animals at PIH 21 (P = 0.002) and PIH 24 (P = 0.005) (Fig. 3e and f). The Cl- 
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concentration just failed to be significantly different at PIH 21 (P = 0.013 compared to 
Bonferroni adjusted comparisonwise significance level of 0.05/6 = 0.0083) (Fig. 3g).   
 
Milk IL-8, C5a and sCD14  
 Before challenge, IL-8 was very low (1.66 ± 0.23 and 2.11 ± 0.35 pg/ml in the saline and 
carprofen treated groups, respectively) in the quarters that were to be infused with E. coli. Until 
PIH 9, the time of treatment, IL-8 kinetics did not differ between both treatment groups. Peak 
concentrations (471 ± 50 pg/ml and 389 ± 61 pg/ml for the saline and carprofen treated group, 
respectively) were reached in the period PIH 12-15. No significant differences between both 
treatments could be observed throughout the study period (Fig. 4a).  
  The complement component C5a had similar kinetics in both treatment groups until PIH 
18, 9 h post-treatment. From PIH 21, C5a concentration decreased in the carprofen treated 
animals, whereas animals in the saline treated groups reached peak C5a levels at PIH 24, 
followed by a decrease at PIH 48, but no significant differences between the two groups were 
observed. At PIH 72, C5a levels in both groups reached similar values (Fig. 4b). 
To determine whether carprofen treatment following intramammary E. coli challenge 
could alter mammary gland levels of sCD14, an ELISA was used to quantitate milk sCD14. 
Before challenge, sCD14 in mammary quarters (7.33 ± 1.72 µg/ml and 3.77 ± 0.70 µg/ml in 
saline and carprofen treated animals, respectively) was in the range previously described (Lee et 
al., 2003a) for early lactating uninfected glands (5.46 to 6.90 µg/ml). In both treatment groups, a 
first peak was observed at PIH 12 (11 ± 2 µg/ml and 13 ± 2 µg/ml, respectively) followed by a 
second higher peak at PIH 24 (27 ± 4 µg/ml and 31 ± 6 µg/ml, respectively). Following peak 
concentrations, sCD14 decreased from PIH 48 onwards to reach normal pre-infection values by 
PIH 144. No significant differences in sCD14 concentrations were observed throughout the 
entire experimental period (Fig. 4c). 
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Figure 4. IL-8 (a), C5a (b), sCD14 (c), LBP (d), PGE2 (e) and TXB2 (f) in the infected quarters 
from PIH 0 until PIH 144 from primiparous cows infused with 1 x 104 CFU E. coli P4:O32 and 
treated at PIH 9 (dashed vertical line) with carprofen (; n = 12) or saline (-----; n = 13). Data 
are means (± SEM). 
 
Plasma and Milk LBP 
 It has been shown previously (Bannerman et al., 2003) that elevated levels of sCD14 
were associated with similar increases in milk LBP, thereby providing an environment for 
optimal host recognition of LPS, originating from inoculated E. coli bacteria. Besides the 
quantification of milk LBP to assess possible effects of carprofen treatment on the levels of LBP 
in the infected quarters, plasma LBP was assayed, as it is known that hepatic synthesis of this 
protein increases during the acute phase response, mainly due to hepatic cell stimulation by IL-
1β and IL-6 (Tobias et al., 1999), which could be influenced by NSAID treatment through the 
intermediate eicosanoid products, PGE2 and TXB2. Under basal conditions, LBP was detected in 
bovine blood at concentrations of 71.3 ± 10.9 µg/ml and 98.3 ± 16.2 µg/ml for saline and 
carprofen treated animals, respectively; whereas the concentration of LBP in milk was lower 
with 18.1 ± 2.3 µg/ml and 23.7 ± 2.2 µg/ml for the treatment groups, respectively. Plasma LBP 
increased from PIH 15 onward to reach maximal values at PIH 24 (162 ± 10 µg/ml and 167 ± 14 
µg/ml for saline and carprofen treated animals, respectively). Thereafter, concentrations of 
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plasma LBP declined to reach pre-infection levels at PIH 144 (Fig. 1f). No significant difference 
in plasma LBP was present between the treatment groups throughout the experimental period. In 
quarters inoculated with E. coli, significant elevation of milk LBP appeared from PIH 9 onward, 
with maxima (58 ± 1 µg/ml and 61 ± 1 µg/ml in saline and carprofen treated animals, 
respectively) at PIH 21. From PIH 48 on, milk LBP concentrations declined (Fig. 4d). A 
significant difference (P = 0.0001) in milk LBP was observed between the carprofen and saline 
treated animals at PIH 12. 
 
Plasma and Milk Prostaglandin E2 and Thromboxane B2 
Plasma PGE2 concentration was 429.2 ± 25.2 pg/ml at the time of inoculation in both 
treatment groups. Prostaglandin E2 started to decrease in plasma as early as PIH 9 and reached 
nadir at PIH 15 in both treatment groups. Plasma PGE2 concentrations did not differ between 
carprofen and saline treated animals (Fig. 1g). Thromboxane B2 concentration in plasma was as 
high as 180.4 ± 26.5 pg/ml at the time of infection. Throughout the inflammatory episode, no 
changes over time and no differences between treatment groups were observed (Fig. 1h).  
In milk, PGE2 concentration was lower than in plasma and was 334.8 ± 21.1 pg/ml at the 
time of intramammary inoculation. Prostaglandin E2  subsequently increased from PIH 9 onward 
in both treatment groups. No significant difference in milk PGE2 concentration was observed 
between the carprofen and the saline treated animals (Fig. 4e). Initial milk TXB2 concentrations 
(84.3 ± 5.1 pg/ml) were also markedly lower than concentrations observed in plasma. 
Thromboxane B2 increases occurred at PIH 9, which was also the maximal concentration in the 
carprofen treated animals. In saline treated animals, TXB2 further increased and reached its 
maximum at PIH 15. The milk TXB2 concentrations continued to be higher in the saline treated 
groups as compared to the carprofen treated animals until PIH 72. 
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DISCUSSION 
  
The aim of the present study was to evaluate the potential modulatory effects of  
treatment with carprofen, a PG synthetase inhibitor through COX-2 inhibition, on a moderate 
inflammatory reaction following E. coli challenge. Therefore, the study design included 
carprofen administration following the appearance of initial clinical symptoms, which was 
mainly based on practical field data (Shpigel et al., 1994) and inflammatory dynamics of the 
moderate inflammatory model used (Vangroenweghe et al., 2004a; 2004b). It is known that pre-
treatment far more effectively inhibits the inducible COX-2 enzyme (Burvenich, 1985; 
Burvenich et al., 1989), however, from a practical point of view, the earliest occasion at which 
field cases of clinical E. coli mastitis can be diagnosed and subsequently treated, occurs at the 
milking following the infection of the mammary quarter (Shpigel et al., 1994; 1996). The first 
clinical signs in the present experimental model, using a 1 x 104 CFU inoculum dose, have been 
shown to appear around PIH 9. Therefore, the choice for a carprofen administration at PIH 9 was 
considered most suitable, as clinical signs would be present at that time, although maximal RT 
was not yet reached (Vangroenweghe et al., 2004a; 2004b). 
In the present study, the same strain and high inoculum dose of E. coli was used to 
induce a moderate inflammatory reaction in primiparous cows as described before 
(Vangroenweghe et al., 2004a; 2004b). The clinical course and changes in different laboratory 
parameters following intramammary E. coli challenge in the control animals were similar to 
animals receiving the same dose (1 x 104 CFU) in previous experiments (Vangroenweghe et al., 
2004a; 2004b). Carprofen treated animals elicited an immediate and significant decrease in RT 
at 3 h post-treatment, whereas pyrexia continued in the control animals with a peak fever at PIH 
12. Single dose carprofen administration in the present study resulted in a more pronounced and 
prolonged antipyretic effect compared to meloxicam treatment in an E. coli endotoxin model 
(Banting et al., 2000), where peak fever was reached 2 h post-treatment in both groups. 
Reticulorumen motility was equally depressed in both treatment groups at the time of carprofen 
administration. However, 3 h post-treatment, reticulorumen motility in the carprofen treated 
animals restored to normal activity, whereas a maximal depression was reached in the control 
group at PIH 12. In contrast, in an LPS model, no reticulorumen motility depression occurs, and 
therefore beneficial effects of NSAID treatment on the reticulorumen motility depression can not 
be quantified.  
Improvement of local clinical signs at the level of the affected mammary quarters by 
carprofen treatment was limited to swelling. There are fewer beneficial effects than observed by 
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Anderson et al. (1986), who reported significant improvement of quarter temperature, oedema, 
pain and size following flunixin meglumine treatment of cows suffering from endotoxin-induced 
mastitis. However, the administration of flunixin meglumine in that study was performed much 
earlier (PIH 2) as compared to our study, where carprofen was only administered at appearance 
of the first clinical symptoms.  
Clinical scores, combining several clinical parameters, have been described (Wenz et al., 
2001; Friton et al., 2002; Vangroenweghe et al., 2004a). Using the clinical severity score 
described by Vangroenweghe et al. (2004a), carprofen treated animals had a significant lower 
clinical score at PIH 12 and 15 as compared to the saline treated group. Although, as expected 
from previous trials, all animals in both groups responded mild to moderate following E. coli 
challenge, the carprofen treated animals generally showed a lower clinical severity score upon 
NSAID administration. This was mainly due to the rapid restoration of reticulorumen motility 
and the immediate antipyretic activity following the NSAID administration.  
Quarter inflammation was associated with a temporary loss of MP, combined with 
secretion of abnormal milk from the infected glands. Maximal depression in MP in the infected 
and uninfected quarters occurred on the day of challenge (d0), and was followed by a rapid 
recovery during subsequent days. Carprofen treatment did not exert any beneficial effect on milk 
yield in the infected quarters following intramammary E. coli challenge. The absence of any 
effect of carprofen on the milk production in the uninfected right quarters can mainly be 
attributed to the moderate inflammatory signs of the mastitis model (Vangroenweghe et al., 
2004a).  
In the present study, no significant effect of carprofen treatment on bacterial elimination 
occurred, which could be expected as carprofen treatment was administered alone and not as an 
adjunctive therapy to intramammary or systemic antibiotics. Enrofloxacin is known to enhance 
bacterial clearance during experimentally induced E. coli mastitis (Monfardini et al., 1999). 
Rantala et al. (2002) reported a more rapid decline in bacterial number in the infected quarters 
following combined flunixin meglumine and enrofloxacin treatment, which could probably be 
attributed to the enrofloxacin treatment and not the adjunctive NSAID therapy.  
 The leukocyte influx into the infected glands following E. coli challenge was not 
significantly affected by carprofen treatment. This observation is in accordance with previous 
results obtained using flurbiprofen in experimentally induced LPS mastitis in goats (Burvenich, 
1985; Burvenich et al., 1989). Comparable results were obtained following ibuprofen treatment 
at 2 h post-endotoxin infusion (DeGraves and Anderson, 1993). Although the dose of carprofen 
(1.4 mg/kg BW) administered intravenously in the present study was twice as high as the dose 
(0.7 mg/kg BW) used by Lohuis et al. (1991), oedema and leukocyte infiltration in the affected 
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glands could not be prevented. Nevertheless, the applied treatment was potent enough to reduce 
eicosanoid generation in the affected mammary glands in the carprofen treated animals. In the 
blood, similar kinetics could be observed in blood leukocyte number between both treatment 
group. Nadir blood leukocyte number was reached at PIH 12, 3 h post-treatment in both 
treatment groups, and was followed by progressive recovery of blood leukocyte number to pre-
infection levels by PIH 24.  
 Dehydration is often assessed during acute coliform mastitis as an easy tool to judge 
clinical severity. The assessment of dehydration can be performed by skin turgor estimation.  In 
the present study, no difference in skin turgor assessment could be observed throughout the 
entire study period. This could have been expected based on the mild to moderate responses 
usually obtained using the experimental infection model. Packed cell volume did not differ 
among treatments throughout the study either. 
Lactose, serum albumin, sodium, potassium and chlorine concentrations in milk of the 
infected quarters are often determined to assess the severity and duration of the intramammary 
inflammation. Serum albumin and all ions (Na+, K+ and Cl-) showed similar kinetics, although a 
significant interaction between time and treatment was only present for serum albumin from 12 h 
post-treatment (PIH 21) onward in the carprofen treated animals. At PIH 21 and 24, both Na+ 
and K+ concentration significantly improved in the carprofen treated animals. These results 
indicate that carprofen induces a more rapid recovery of normal milk composition in animals 
intramammarily challenged with E. coli. Previous studies using ibuprofen in an endotoxin model 
were unable to demonstrate any effect on milk composition (DeGraves and Anderson, 1993). 
The elimination half-life of carprofen in healthy cows has been calculated 30.7 h, which is 
shorter than the half-life of phenylbutazone (31.2 – 82.1 h), but considerably longer than flunixin 
meglumine (8.1 h) (Lohuis et al., 1991). Therefore, it is not surprising that a single dose of 
carprofen had prolonged beneficial effects on clinical parameters compared to the control group. 
 Following intramammary E. coli challenge, significant increases in PGE2 (Peter et al., 
1990; Zia et al., 1987) and TXB2 (Anderson et al., 1985; 1986; Zia et al., 1987) have been 
observed in milk. Moreover, a significant effect of flunixin meglumine administration on TXB2 
concentrations was reported (Anderson et al., 1986). Even in the uninfected quarter a slight 
increase in PGF2α and TXB2  concentration was reported (Anderson et al., 1985), although this 
increase disappeared more rapidly than in the infected quarters. Following flunixin meglumine 
treatment, TXB2 concentrations remained at baseline levels, whereas in the saline treated 
animals, a pronounced peak value was observed at PIH 8 in the endotoxin challenged animals 
(Anderson et al., 1986).  
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Although the effect of NSAID’s on eicosanoids production following inflammation is 
well documented in literature (Anderson et al., 1986), no reports are available on the possible 
effect on other immunological inflammatory parameters, such as the chemotactic agents IL-8 
and C5a or the early innate immune molecules sCD14 and LBP. Interleukin-8 kinetics in the 
present study were similar with previous reports using the same inoculum dose (Vangroenweghe 
et al., 2004b). Local IL-8 production started at PIH 6, although major increases only occurred 
from PIH 9 onward. Because IL-8 is a well-known chemotactic agent, it is obvious from these 
results that the initial leukocyte influx into the infected quarters, which occurred around PIH 9, 
was not affected by the decline of IL-8 occurring much later during inflammation. The 
appearance and evolution of C5a concentrations in the affected quarters did not differ between 
both groups until PIH 21, 12 h post-treatment. In the control group, C5a increased until maximal 
values at PIH 24, which is 6 h later than previously observed (Vangroenweghe et al., 2004b). 
The marked difference in the onset of carprofen effects on chemotactic agents IL-8 and C5a 
could be explained by the location of mediator production. Interleukin-8 is directly produced by 
the epithelial cells in the mammary gland (Baggniolini and Clark-Lewis, 1992; Barber and Yang, 
1998), whereas C5a precursors are obtained from the blood through leakage of the disintegrated 
blood-milk barrier (Rainard et al., 1998; Rainard, 2003). 
In accordance with previous reports (Bannerman et al., 2003; Vangroenweghe et al., 
2004b), the increases in milk LBP paralleled increments in sCD14 levels. From a host 
perspective, the simultaneous increase in both LBP and sCD14 levels would be expected to be 
advantageous as both molecules act in concert to facilitate activation of host defence 
mechanisms by presenting LPS, released during bacterial growth and death, to the 
transmembrane LPS receptor, TLR-4 (Bannerman and Goldblum, 2003). Carprofen treatment 
did not affect either parameter.  
The present study showed that carprofen treatment following experimental E. coli 
challenge in a moderate inflammation model with primiparous cows has only slight modulatory 
effects, which are mainly limited to RT and reticulorumen motility. Administration of carprofen 
at PIH 9, when first clinical signs occurred, showed beneficial effects on general clinical 
condition, recovery of milk composition, and reduced production of eicosanoids. Mediators of 
early innate immune response, IL-8, C5a, sC14 and LBP, were not affected by NSAID 
treatment.  
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CONCLUSIONS 
 
Although carprofen treatment was administered late during the acute phase reaction, 
when first clinical signs appeared, the NSAID had some modulatory effects on clinical, 
production and immunological parameters in a moderate inflammation model with primiparous 
cows. The main modulatory potential occurred at the level of improved clinical condition, 
mainly due to the antipyretic effects and the ability of carprofen to improve reticulorumen 
motility. Milk production could not efficiently be modulated through the administration of 
carprofen at PIH 9. Milk composition (serum albumin, Na+ and K+) was significantly affected by 
carprofen treatment at PIH 21 and 24, but no further effects on milk composition occurred. 
Carprofen treatment did not result in a decrease of chemotactic inflammatory mediators, IL-8 
and C5a, and no effect was observed for early innate immune molecules, such as sCD14 and 
LBP. Carprofen treatment did not affect PGE2 and TXB2 in plasma or milk, although there were 
trends for decreased concentrations of both eicosanoids in milk of the affected quarters. In 
conclusion, the inflammatory model using primiparous cows during the periparturient period is a 
minimal and moderate state of inflammation, necessary to eliminate the invading pathogens from 
the affected mammary quarters. Major modulatory effects from NSAID administration were 
therefore not observed in this model. 
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INTRODUCTION 
 
It is estimated that 20% of all cases of clinical mastitis in some dairy herds are caused by 
coliform bacteria, particularly in herds where contagious pathogens are well controlled 
(Schukken et al., 1989a; 1989b; Barkema et al., 1999). The most common of these organisms are 
E. coli, Enterobacter aerogenes, Klebsiella pneumoniae and K. oxytoca (Eberhart et al., 1977; 
Jain, 1979; Smith et al., 1985), which are all known as coliforms. Since most of these organisms 
are either normal gut inhabitants (Eberhart et al., 1977; Smith et al., 1985) or are found in 
bedding materials (Oz et al., 1985), there is an almost constant exposure of the mammary gland 
to these environmental bacteria (Jackson and Bramley, 1983). 
 The clinical manifestation of an intramammary E. coli infection is acute, sometimes 
peracute and associated with high fever and toxaemia (Hill, 1981). Chronic infections 
characterised by quiescent periods and periodic acute flare-ups may also occur (Bradley and 
Green, 2001). A factor, that plays an important role in the pathogenesis of E. coli mastitis, is 
endotoxin or LPS. Lipopolysaccharide may cause release of pre-formed inflammatory 
compounds, resulting in a mediator shock (Hoeben et al., 2000; Dosogne et al., 2002), which 
may sometimes progress to fatal disease. The effects of these mediators reflect their normal 
biological activities and include smooth muscle contraction, increased vascular permeability 
resulting in oedema, and an early increase in vascular resistance, which may be followed by 
vascular collapse if sufficiently high concentrations of these mediators are present. Uncorrected, 
the clinical signs of mediator shock are followed by metabolic acidosis, cyanosis, changed 
vascular resistance and cardiac output, coma and eventually death (Hill, 1981). 
 Treatment of acute and peracute clinical coliform mastitis can be difficult and is quite 
costly to the dairy producer. Moreover, antibiotic treatment immediately following clinical 
diagnosis has been shown to have little effect on clinical signs present, although the number of 
E. coli in the challenged quarters decreased 100-fold (Monfardini et al., 1999). Therefore, 
prevention of the disease is considered to be the best option for control. Methods of prevention 
include decreasing the exposure of the teat end to coliforms from the environment (Smith et al., 
1985; Oliver et al., 1990) and increasing the animal’s resistance to infection. Maintaining a good 
sanitation program and practising good milking procedures should reduce the amount of 
exposure to coliform organisms (Schukken et al., 1989a; 1989b). Taking these control measures 
into account, however, dairy cattle exposed to the organisms may not possess the appropriate 
immune status to resist the wide variety of coliform organisms present in the environment, 
especially as it is known that no specific O-serotypes have been related to bovine E. coli mastitis 
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(Linton and Robinson, 1984). Pre-parturient cows and cows in high production and under 
nutritional stress during early lactation are particularly susceptible to coliform mastitis, due to a 
decrease in the effectiveness of their non-specific resistance mechanisms at the mammary gland 
resident milk cell level (Dosogne et al., 2001; Mehrzad et al., 2001; Vangroenweghe et al., 
2001).  
 The severity of the inflammation, following an intramammary infection with E. coli, 
may be reduced by the use of an effective immunogen (Gonzales et al., 1989). Immunisation of 
dairy cattle with J5 E. coli bacterins has been shown to reduce the occurrence of clinical 
coliform mastitis under field conditions (Gonzales et al., 1989). The vaccine was developed with 
the concept of the exposure of the core antigen common to Gram-negative organisms in the 
mutant J5 strain. Vaccination should result in the development of cross-reactive antibodies, able 
to enhance cow’s immunity to Gram-negative pathogens that cause coliform mastitis (Tomita et 
al., 2000). 
 Recently, primiparous dairy cows have been shown to be more resistant to severe 
clinical E. coli mastitis, resulting in a moderate inflammatory reaction with complete resolution 
(Vangroenweghe et al., 2004a; 2004b). The purpose of the present study was to evaluate if a 
bacterin formulation made with a J5 mutant strain of E. coli used to immunise the animals 
against the endotoxin (Enviracor; Pfizer Animal Health, Sandwich, UK) could modulate the 
moderate inflammation in primiparous dairy cows challenged intramammarily with an E. coli.  
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MATERIALS AND METHODS 
 
Experimental Animals and Study Facilities 
All primiparous cows (n = 23) were in their 7th month of pregnancy on arrival at a 
commercial dairy farm.   
 
Inoculation Dose 
 Primiparous cows were inoculated with 1 x 104 (n = 6) or 1 x 106 CFU (n = 17) E. coli 
P4:O32 in both left quarters. Control animals were predominantly inoculated with 1 x 106 CFU 
(10 out of 11 animals), whereas inoculum doses were equally distributed in animals vaccinated 
against the endotoxin (n = 5 for 1 x 104 CFU; n = 7 for 1 x 106 CFU). 
 
Sampling Procedure 
  Blood and milk samples were collected at d-7, d-4, d-1, d0, d+1, d+2, d+3, d+6, d+9 and 
d+13 relative to the day of challenge. On the day of challenge, blood and milk samples were 
collected at PIH 3, 6, 9, 12, 15, 18 and 21. 
 
Glucose Serum 
 Glucose was determined in NaF-plasma.  
 
Statistical Analysis 
 In order to compare the two treatment groups with respect to the various parameters 
analysed in blood and milk, a mixed model was used with cow as random effect and treatment, 
time and their interaction as categorical fixed effects. Pairwise comparisons were adjusted using 
Bonferroni’s multiple comparisons procedure with an overall type I error equal to 5%. Quarter 
milk production in both infected and uninfected quarters was tested for significant differences 
between treatments at d+1 and the interval d+1 − d+3. The effect of treatment on the local 
aspects of the mammary gland was tested by the Wilcoxon rank sum test. 
 
For Further Details see chapter 'Materials and Methods Experimental Infections', p. 97.
  - 194 - 
RESULTS 
 
Local and Systemic Clinical Signs  
Following intramammary challenge, RT (Fig. 1a) and HR (Fig. 1b) increased from PIH 
6 onward and reached a peak at PIH 9 in both treatment groups. Rectal temperature and HR 
rapidly decreased following peak values and normal values were reached from PIH 18 on in both 
treatment groups. Although on average RT did not differ between the two treatment groups from 
0 to 48 hours (P = 0.43), RT evolved differently over time in the two treatment groups (P = 
0.01). Rectal temperature was significantly higher at PIH 6 (P = 0.007), but significantly lower 
at PIH 12 (P = 0.009) in the vaccinated group. No significant differences were found for HR or 
RR (Fig. 1c). Maximal RR appeared between PIH 9 and 12 in both treatment groups.  
Following intramammary E. coli inoculation, typical local clinical symptoms occurred at 
the level of the affected quarters with swelling and abnormal milk (flakes and clots). During the 
acute phase of inflammation (PIH 0-48), no significant differences in local swelling and milk 
appearance were observed.  
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Rectal temperature (a), heart rate (b), and respiration rate (c) from PIH -168 until PIH 
312 from primiparous cows vaccinated against the endotoxin (; n = 12) or the placebo (-----; 
n = 11) and intramammarily challenged with E. coli P4:O32. Data are means (± SEM). 
 
Quarter Milk Production 
Following E. coli challenge, milk production decreased in the infected and uninfected 
quarters (Fig. 2a-b). During the days following experimental challenge, milk production rapidly 
recovered and almost reached pre-infection values in the uninfected quarters (Fig. 2b). In the 
infected quarters, production at d+13 (PIH 312) was still slightly lower than pre-infection in both 
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treatment groups (Fig. 2a). No significant difference in quarter milk production at d+2 and the 
interval d+1 − d+3 could be observed between the treatment groups in infected and uninfected 
quarters. 
 
 
 
 
 
 
 
 
 
Figure 2. Quarter milk production in the infected (a) and the uninfected (b) quarters from PIH -
168 until PIH 312 from primiparous cows vaccinated against the endotoxin (; n = 12) or the 
placebo (-----; n = 11) and intramammarily challenged with E. coli P4:O32. Data are means (± 
SEM). 
 
Bacterial Growth and Milk Composition 
 Bacterial growth rapidly reached maximal levels in both treatment groups (Fig. 3a). The 
vaccinated animals eliminated bacteria from the challenged quarters slightly faster during the 
first hours post-infusion, resulting in a significantly different evolution of CFU over time in the 
two treatments group (P = 0.0034). Bacterial population (CFU/ml) was significantly lower in the 
vaccinated group at  PIH 9 (P = 0.006).  
 Intramammary E. coli challenge resulted in a rapid influx of PMN from the blood into 
the mammary gland, inducing a major increase in SCC in the infected quarters (Fig. 3b), but no 
significant differences between the two groups were observed. The highest SCC values were 
observed at PIH 6, staying at that level for an extended time. Following the acute phase of 
inflammation, SCC slowly decreased, although at d+13, it was still higher than pre-infection.  
 Changes of milk composition, as measured by the ions (Na+, K+ and Cl-), serum albumin 
and lactose are indicative for the presence of mastitis in the mammary quarters. The evolution of 
Na+ over time differed significantly between the two treatment groups (P = 0.023), with a faster 
increase in the vaccinated animals until 12 PIH, after which time the control group had higher 
Na+ concentrations than the vaccinated group (Fig. 3d). A similar but non-significant  
relationship was observed for Cl- (Fig. 3f). Changes in K+ followed the same kinetics with nadir 
around PIH 9-12 and subsequent recovery to normal pre-infection levels by d+6 to d+13 (Fig. 
3e). Serum albumin rapidly increased following intramammary challenge and reached a maximal 
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concentration at PIH 15 in both treatment groups (Fig. 3g), subsequently followed by 
normalisation from PIH 48 onward. No significant difference was observed between the two 
treatment groups.  
 Lactose concentration decreased in both groups from PIH 9 onward to reach nadir at PIH 
15 in vaccinated animals and at PIH 21 in placebo animals (Fig. 3c). The evolution of lactose 
over time differed significantly in the two groups (P = 0.0004) with the vaccinated animals 
having a more pronounced decrease of lactose during the acute phase of intramammary E. coli 
challenge. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Colony-forming units of E. coli (a), SCC (b), lactose (c), sodium (d), potassium (e), 
chlorine (f), serum albumin (g) in the affected quarters from PIH -168 until PIH 312 from 
primiparous cows vaccinated against the endotoxin (; n = 12) or the placebo (-----; n = 11) 
and intramammarily challenged with E. coli P4:O32. Data are means (± SEM). 
 
Hematology 
 Packed cell volume did not significantly differ between both treatment groups 
throughout the experimental challenge (Fig. 4a). Following E. coli challenge, blood leukocyte 
number rapidly decreased and reached nadir at PIH 9 and 12 in the vaccinated and placebo 
animals, respectively (Fig. 4b). Blood leukocyte count was on average (marginally) significantly 
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higher in the vaccinated group (P = 0.054). In the placebo group, blood leukocyte number 
remained lower than in vaccinated animals until PIH 144.  
 Leukocyte differentiation did not significantly differ between both treatment groups in 
terms of mature PMN (Fig. 4c), early (myelocytes-metamyelocytes) immature PMN (Fig. 4e), 
lymphocytes (Fig. 4f), and monocytes (Fig. 4g). Overall, a significantly lower percentage of late 
(band cells) immature cells (P = 0.052) was, however, observed in the vaccinated group (Fig. 4d) 
as compared to the placebo group.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Packed cell volume (a), blood leukocyte count (b), percentage of mature PMN (c), 
band cell (d), myelocytes-metamyelocytes (e), lymphocytes (f), monocytes  (g), and glucose (h) 
in the blood from PIH -168 until PIH 312 from primiparous cows vaccinated against the 
endotoxin (; n = 12) or the placebo (-----; n = 11) and intramammarily challenged with E. 
coli P4:O32. Data are means (± SEM). 
 
Glucose  
 The response of blood glucose to intramammary E. coli challenge was mainly 
characterised by two peak concentrations and a dip during the first 24 h post-challenge. In the 
vaccinated animals, the glucose concentration evolved differently (P = 0.045) with a significant 
lower glucose concentration during the acute phase of inflammation (Fig. 4h).  
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DISCUSSION 
 
 Peak E. coli concentrations in the infected quarters have been reported to be indicative 
for the severity of experimental E. coli mastitis (Vandeputte-Van Messom et al., 1993), and have 
been shown to be both higher and prolonged in severe cases (1 x 1010 CFU/ml) than in moderate 
(1 x 107 CFU/ml) or mild (1 x 104-5 CFU/ml) cases (Shuster et al., 1996; van Werven et al., 
1997; Hirvonen et al., 1999; Vangroenweghe et al., 2004a; 2004b). Moreover, mild cases of 
clinical coliform mastitis showed a more rapid elimination of the bacteria from the infected 
quarters compared to moderate and severe clinical cases. The AUC0-126  of CFU/ml has 
repeatedly been shown to be a significant indicator of severity of clinical E. coli mastitis (Lohuis 
et al., 1990; Kremer et al., 1993; van Werven et al., 1997). These data, obtained during 
experimentally induced coliform mastitis, are consistent with field observations by Wenz et al. 
(2001), who reported higher proportions of cases with > 1 x 105 CFU/ml E. coli concentrations 
in severe (77%) than in moderate (51%) and in mild (28%) cases.  
 Hogan et al. (1992) conducted an experimental challenge comparing cows vaccinated 
with the E. coli J5 strain, using formulations different from Enviracor, to a placebo group and 
showed favourable results for the J5 vaccinates when the infection model resulted in a rather 
high CFU/ml in milk. The mean log10 CFU/ml in the control group at the time point with the 
highest value was about 4 log10 CFU/ml. Hence, the CFU challenge obtained in the present study 
should be considered as mild. With the exception of Hogan et al. (1992), most other published 
challenge studies resulted in peak CFU/ml that were lower than those cited above. In such 
studies, few modulatory effects on the course of inflammation were observed following 
vaccination against the endotoxin (Hogan et al., 1995; Smith et al., 1999). This is also the case in 
the present study. 
In cows with E. coli mastitis, the milk production can be greatly affected in severe 
responders (Heyneman et al., 1990; Vandeputte-Van Messom et al., 1993; Shuster et al., 1996; 
Dosogne et al., 1997; van Werven et al., 1997) in which it does not normalise rapidly (Hirvonen 
et al., 1999). Although milk yield has been measured in intramammary challenge studies, 
evaluating the effect of J5 vaccination, none of these studies (Hogan et al., 1992; 1995; 1999; 
Smith et al., 1999) showed a significant improvement in milk yield loss of the J5 vaccinates over 
placebo animals. Milk yield loss in infected and uninfected quarters has been found to be highly 
correlated with other indicators of severity, in particular AUC of E. coli CFU/ml (Lohuis et al., 
1990; Kremer et al., 1993). As expected, milk yield recovered fast in the presently used 
moderate inflammation model (Vangroenweghe et al., 2004a; 2004b) and vaccination against the 
Vaccination against the endotoxin 
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endotoxin could not accelerate this phenomenon.  
Increases in RT and HR have been found to be higher in animals with a severe than with 
a moderate clinical response (Heyneman et al., 1990; Vandeputte-Van Messom et al., 1993; 
Shuster et al., 1996; Ohtsuka et al., 2001). In moderately reacting primiparous cows, RT was 
normalised around PIH 18 (Vangroenweghe et al., 2004a; 2004b). Rectal temperature and HR 
have been shown to correlate significantly positive to both E. coli CFU/ml (Kremer et al., 1993) 
and milk production in the infected and uninfected quarters (Lohuis et al., 1990). Hence, it is not 
surprising that, based on the results of quarter milk production and CFU, no significant 
differences in HR were observed between the vaccinated group and the placebo animals. 
However, significant differences in RT could be observed during the acute phase of 
inflammation. The significant difference between both groups in RT at PIH 6 and 12 could not 
be explained by the unequal distribution of the inoculum dose in both treatment groups, as 
placebo animals predominantly (10/11) received the high inoculum dose (1 x 106 CFU per 
quarter), which should induce an earlier and more rapid fever response (Vangroenweghe et al., 
2004a; 2004b).   
 Rapid and efficient increase in SCC appears to be the SCC characteristic associated with 
a moderate inflammatory reaction (Vangroenweghe et al., 2004a; 2004b). None of the previously 
reported experimental challenges comparing cows vaccinated with the E. coli J5 strain to a 
placebo group showed a significant difference in SCC between both treatment groups (Hogan et 
al., 1992; 1995; 1999; Smith et al., 1999). A significant lower SCC in the J5 vaccinates was only 
reported in one experimental challenge study, however, this difference in SCC was at a single 
time point and at 7 d post-infusion (Hogan et al., 1995). In the present study with moderately 
reacting animals, the same observations concerning the changes in SCC during the acute phase 
of inflammation were present.   
 The milk composition variables determined in the present study are all indicators of the 
presence of mastitis in the affected glands. In a moderate inflammation model, changes in the 
concentrations of lactose, potassium, sodium, chlorine and serum albumin were similar to 
previous studies (Vangroenweghe et al., 2004a; 2004b). Serum albumin has been found to be 
significantly less increased in J5 vaccinates (Hogan et al., 1995). In the present study, no 
treatment effect was observed for chlorine, potassium and serum albumin, whereas an earlier 
change was present for sodium and lactose in the vaccinated animals.  
 Only one study (Vandeputte-Van Messom et al., 1993) showed a significant lower PCV 
in severe than in moderate responders. In the present study, being a moderate inflammatory 
model, no significant difference in PCV was observed between both treatment groups. Following 
E. coli mastitis challenge, blood leukocyte number will first decrease and subsequently increase, 
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when compared to baseline values (Heyneman and Burvenich, 1992; van Werven et al., 1997; 
Ohtsuka et al., 2001). Both the initial decrease and the subsequent increase are larger in severe 
than in moderate responders (Heyneman et al., 1990; Heyneman and Burvenich, 1992; Sordillo 
and Peel, 1992; Ohtsuka et al., 2001). This typical pattern of blood leukocyte changes has been 
shown to also occur with endotoxin challenge (Tennant et al., 1975; Morris et al., 1986). From 
the present study, it is clear that although no significant difference in SCC was present between 
both treatment groups during the first 72 h post-challenge, significant differences in the blood 
leukocyte patterns were present. Blood leukocyte number was significantly higher throughout 
the experiment in the vaccinated animals as compared to the placebo animals. However, 
significant mobilisation of late immature PMN (band cells) from the bone marrow could only be 
observed in the placebo group.  
 The presently used E. coli mastitis challenge model consistently results in clinical 
mastitis and has, therefore, frequently been used to study risk factors influencing the severity of 
the response to challenge, rather than the occurrence of clinical coliform mastitis (Heyneman et 
al., 1990; Kremer et al., 1993; Vandeputte-Van Messom et al., 1993; Dosogne et al., 1997; van 
Werven et al., 1997; Hoeben et al., 2000; Dosogne et al., 2002). However, using this model in J5 
vaccination studies, it has often been difficult to produce a severe response. A first possible 
explanation for this observation is that, due to the need for vaccination from dry-off onward, 
these vaccination studies are often much longer than the classical experimental E. coli mastitis 
challenges. This means that these cattle have remained in the same familiar environment for a 
longer period prior to challenge. In a classical challenge study, the observation period to 
challenge can be much shorter, mostly 1 to 2 weeks (Dosogne et al., 1997; Blum et al., 2000 ; 
Hoeben et al., 2000), meaning that these animals had much less time to adjust to the study 
settings (experimental facilities and personnel) as well as to the extra interventions (blood and 
milk sampling, clinical examination), all of which cause extra stress. In this regard, it has been 
shown that even 1 h of isolation of a cow from her herd mates caused enough stress to result in 
an increase of leakiness of the tight-junctions between the endothelial cells in the mammary 
gland, thereby allowing an influx of serum components (serum albumin, chlorine, sodium) into 
the milk and a loss of milk components (lactose) to the serum (Stelwagen et al., 2000). Another 
major limitation to obtain a severe clinical response is the fact that in most of the cited J5 
vaccine studies the challenge did not take place within days after calving, the period when 
animals are most likely to develop severe coliform mastitis. A third aspect is that primiparous 
cows are less susceptible to severe coliform mastitis than older animals (van Werven et al., 1997; 
Vangroenweghe et al., 2004a; 2004b).  
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CONCLUSION 
 
 In the present study, pre-calving vaccination against the endotoxin through a J5 vaccine 
administration could slightly alter the clinical course of a moderate inflammatory reaction. 
Although vaccinated animals had favourable RT and blood leukocyte kinetics, no major clinical 
improvement could be observed following a moderate inflammatory reaction during E. coli 
challenge. Therefore, primiparous cows seem to have an optimal inflammatory reaction 
following intramammary E. coli inoculation, characterised by a rapid and efficient influx of 
PMN into the affected mammary quarters, resulting in a fast and short-lasting inflammation, 
finally leading to resolution of mammary gland functionality.  
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Escherichia coli, involved in bovine coliform mastitis, is part of the normal intestinal 
flora of animals. The strains isolated from bovine mastitis are essentially not different from 
strains isolated from bovine faeces. The etiological bacteria do not possess specific virulence 
factors that could be attributed to disease severity (Lehtolainen, 2004). In contrast, cow factors 
such as stage of lactation, PMN functionality and metabolic status are associated with disease 
severity (Burvenich et al., 2003; 2004). Concerning E. coli, numerous epidemiological data are 
available (Schukken et al., 1989a; 1989b; Barkema et al., 1999), in addition to the results 
obtained from experimental infection models, which can be used to generate practical 
conclusions. However, the specific experimental model used, i.e. E. coli vs. endotoxin, has a 
tremendous effect on the results obtained from pathogenesis studies. The inflammatory reaction 
in multiparous dairy cows has extensively been studied throughout the last decade (Heyneman 
and Burvenich, 1992; Vandeputte-Van Messom et al., 1993; Kremer et al., 1993a; 1993b; 1993c; 
van Werven et al., 1997; Dosogne et al., 1997; Hoeben et al., 2000). However, taking into 
account the present turn-over of high-yielding dairy cows (approximately 25 to 30% per year) in 
modern dairy herds, a relatively large population of primiparous cows is present, from which no 
data on resistance or susceptibility towards E. coli mastitis are available.  
Although the influence of stage of lactation has extensively been studied, until now, 
little information on the effect of parity is available. Younger cows (2nd parity) have been 
postulated to be more resistant to intramammary E. coli infection, mainly based on the lower 
bacterial count and the higher number of peripheral circulating leukocytes during experimentally 
induced E. coli mastitis (van Werven et al., 1997). Evaluation of impairment of periparturient 
neutrophil function revealed a significantly lower superoxide anion production in cows in their 
4th or greater lactation than in cows in the first three lactations (Gilbert et al., 1993). Superoxide 
formation plays an important role in the intracellular killing of E. coli inside the PMN. A 
longitudinal study of PMN viability and functions in primiparous and multiparous dairy cows 
around calving showed significant differences between both groups (Mehrzad et al., 2002). 
Although a periparturient decrease in PMN viability occurred in both groups, overall PMN 
viability was much higher in primiparous cows (Mehrzad et al., 2002). It seems logic that 
animals in their first lactation have markedly different pre-inflammatory parameters, which may 
result in differences in inflammatory kinetics following intramammary E. coli challenge (Gilbert 
et al., 1993; van Werven et al., 1997; Mehrzad et al., 2002).  
Normal milk contains a heterogeneous cell population, with its composition dependent 
on the stage of lactation. The normal proportion of PMN in the clinically healthy mammary 
gland is low (< 15%). During inflammation, due to for instance mastitis, the proportion of PMN 
increases to more than 90%. Therefore, inflammation should be considered a PMN related 
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condition with a well-controlled cell functionality. In this thesis, milk sample collection under 
pre-infection conditions was validated in relation to composition of the cell population and PMN 
functionality in milk, collected under different aseptical and non-aseptical conditions, because 
external bacterial contamination was thought to activate the PMN functionality in vitro. In low 
SCC milk, the number of PMN was only 13% and the average cell viability was decreased 
(40%). This observation was in accordance to Mehrzad et al. (2001), which also reported 
decreased PMN viability and functionality during early lactation. Validation of aseptical milk 
sample collection revealed no significant effect of bacterial contamination on milk PMN 
functionality under basal pre-infection conditions, and therefore, manual milk sampling was 
preferred to perform milk sample collection in the subsequent experimental E. coli challenges.   
 Number and composition of the somatic cell population could be considered as an 
important determining factor in the immunological status of the mammary gland. Numerous 
studies have been performed in order to identify the various cell populations present in the 
mammary gland, however, most of these studies have focused on bovine high SCC milk 
(Hageltorn and Saad, 1986; Östensson et al., 1988; Redelman et al., 1988; Saad and Östensson, 
1990). Moreover, most techniques were complicated and labour-intensive, and therefore without 
practical applicability. In epidemiological studies, low SCC has been demonstrated as an 
important risk factor for the occurrence of clinical coliform mastitis (Schukken et al., 1989a; 
1989b; Barkema et al., 1999). In this thesis, a rapid, simple and accurate bovine low SCC milk 
differentiation technique was developed using flow-cytometry (Dosogne et al., 2003). With this 
technique, PMN, macrophages, lymphocytes and apoptotic cells could easily be distinguished. 
Questions can arise to what extent the isolation method could influence the proportional 
composition of SCC, but this problem occurs in all published differentiation techniques. The 
present method could limit preparative manipulations to a minimum, but obligatory 
centrifugation for the removal of fat, interfering with flow cytometric analysis, could in fact bias 
the proportional distribution of cell types obtained in differentiation. However, compared to 
previous differentiation procedures, milk sample collection and preparation, cell staining and 
flow cytometric analysis were validated.  
As proposed in the study objectives, inflammatory kinetics and severity of the 
experimentally induced intramammary E. coli challenge were described using an inoculum dose 
of 1 x 104 and 1 x 106 CFU of E. coli P4:O32 per quarter (Vangroenweghe et al., 2004a). 
Primiparous cows generally appeared to react as moderate responders, based on their quarter 
milk production in the right uninfected quarters on d+2 post-infection. Moderate responders had 
a higher number of circulating PMN (Heyneman et al., 1990; Sordillo and Peel, 1992; Kremer et 
al., 1993c; van Werven et al., 1997), and the functionality of circulating blood PMN pre-
General discussion 
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infection, such as chemotactic differential (Kremer et al., 1993a; van Werven et al., 1997) and 
oxidative burst activity (Heyneman et al., 1990), was clearly increased. Some of these aspects, 
such as circulating number of PMN, were also observed in this thesis (Vangroenweghe et al., 
2004a). Therefore, an effect of parity or age can be concluded from the present experiment.  
Comparison of historical data of quarter milk production in the uninfected quarters at 
d+2 with data obtained in this thesis showed that primiparous cows had a remarkably higher 
average milk production in their uninfected quarters following intramammary challenge as 
compared to multiparous cows. Several animals already exceeded their pre-infection milk 
production at d+2 post-infection (Vangroenweghe et al., 2004a). Following E. coli challenge, 
primiparous cows exhibited a moderate inflammatory reaction, which could not be altered 
through an increase (1 x 104 → 1 x 106 CFU per quarter) in intramammary inoculum dose. The 
inflammatory reaction was characterised by a rapid onset of clinical symptoms, such as rectal 
temperature increase, udder swelling, and changes in milk composition, which also disappeared 
rather fast, resulting in a complete resolution of the functionality of the affected mammary 
quarters. To better diversify between different clinical responses, a severity scoring system, used 
to score cases of clinical mastitis in practice (Wenz et al., 2001), was adapted for use in the 
experimental infection model. Evaluation of clinical responses through this system neither 
revealed any severe responses in the challenged primiparous cows (Vangroenweghe et al., 
2004a). The severity scoring system could therefore be used as an additional scoring tool, 
besides the established measurement of quarter milk production in the uninfected quarters at d+2 
post-infection.  
 Literature data revealed a wide diversity of inoculum doses and strains used to provoke 
experimental E. coli mastitis in the bovine. However, strain diversity could not be held 
responsible for variations in clinical outcome of E. coli mastitis, because several researchers 
were unable to characterise specific virulence factors, which might be associated with severity or 
virulence following intramammary E. coli challenge (Lehtolainen, 2004). Differences in 
inoculum dose have been shown to result in variable inflammatory kinetics. Following 
inoculation of low doses (~ 30 CFU), bacterial growth preceded subsequent elimination (Shuster 
et al., 1996). Inoculation of high doses (~ 10,000 CFU) resulted in rapid bacterial elimination 
(Hoeben et al., 2000). However, studies in which inoculum doses were randomised have rarely 
been performed (Jain et al., 1969; Carroll et al., 1973; Bramley and Neave, 1975; Frost et al., 
1980). The variation in inoculum dose in primiparous cows, performed in this thesis, could 
modulate the inflammatory response, which was characterised by an earlier onset (approximately 
3 h) of clinical signs and chemotactic activity in the animals inoculated with the highest 
inoculum dose (1 x 106 CFU E. coli P4:O32) (Vangroenweghe et al., 2004b). These results seem 
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to confirm that a minimal number of bacteria should be present in the mammary gland to trigger 
the innate immune response in its activation of several defence mechanisms, such as activation 
of the mammary gland epithelium to produce chemotactic factors (IL-8) or macrophage 
activation with inflammatory cytokine production (Bannerman et al., 2003).  
Therapeutic and prophylactic strategies are claimed to modulate the course of an 
inflammatory reaction. Administration of an inhibitor of prostaglandin synthesis before or during 
experimentally induced LPS mastitis has been shown beneficial in reducing the clinical episode, 
characterised by the absence of fever or a shorter or lower fever peak (Burvenich and Peeters, 
1982; Anderson et al., 1986; Lohuis et al., 1989; 1991; Banting et al., 2000), mainly through the 
interaction with fever inducing mechanisms, such as central PGE2 production in the 
thermoregulatory centre (Burvenich and Peeters, 1982). In primiparous cows, the modulatory 
effect of carprofen treatment following experimentally induced E. coli mastitis was limited to a 
reduced peak fever and a shorter episode of reticulorumen motility depression. Moreover, 
eicosanoid (PGE2 and TXB2) production in the affected quarters decreased following carprofen 
treatment. The inflammatory reaction mounted in these animals, therefore, seems to be on the 
edge of clinically detectable inflammation, especially as increased rectal temperature is only 
present for 12 h (from PIH 6 until PIH 18). Furthermore, mammary gland functionality, as 
quantified by quarter milk production, is rapidly resolved.  
From a prophylactic point of view, vaccination against the endotoxin, using a J5 vaccine, 
has not been able to reduce the incidence of clinical coliform mastitis (Tyler et al., 1993), 
although a shift in clinical response from severe to moderate has been observed (Gonzales et al., 
1989; Tyler et al., 1993). To show efficacy in an experimental model, it is known that a severe 
inflammatory reaction is needed (Hogan et al., 1992). The present study with primiparous cows 
resulted in a homogenous population of moderate responders (Vangroenweghe et al., 2004a; 
2004b), and it is therefore not surprising that little modulatory effects of vaccination against the 
endotoxin were observed.  
Prognostic evaluation of clinical severity before treatment, combined with rapid 
etiological diagnosis, is difficult to achieve under practical conditions. However, based on 
experimentally induced intramammary E. coli challenge, several severity determining and risk 
factors have been identified, which could be associated with the potential occurrence of a severe 
inflammatory response (Burvenich et al., 2003). One of these factors could be age or parity of 
the affected animal (Gilbert et al., 1993; van Werven et al., 1997). The inflammatory reaction in 
primiparous cows following intramammary E. coli challenge has been shown mild to moderate 
based on clinical severity scoring (Vangroenweghe et al., 2004a). Therefore, primiparous cows 
with acute clinical mastitis during the early post-partum period should be considered low risk 
General discussion 
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candidates for a severe clinical response due to E. coli. Moreover, prophylactic and therapeutic 
interventions have been shown unable to modulate the already moderate inflammatory reaction, 
resulting in a maximal resolution of original functionality of the affected quarters. In case of 
clinical mastitis in primiparous cows, antibiotic treatment should be focused on combating 
Gram-positive infections, because infection with Gram-negative bacteria does not seem to cause 
a potential risk for severe inflammatory reactions. In contrast, high-yielding multiparous cows in 
negative energy balance during the early post-partum period are striking potential candidates for 
a severe clinical response (Kremer et al., 1993c; Hoeben et al., 1997; van Werven et al., 1997), 
and treatment should therefore be focused on these animals, providing them antimicrobial and 
anti-inflammatory therapy, eventually in combination with other additional treatments.  
 
CONCLUSION 
In conclusion, validation of milk sample collection under aseptical conditions to 
establish basal pre-infection values has revealed no effect of minor bacterial contamination on 
the milk PMN functionality in vitro. Therefore, manual milk sample collection was performed in 
the subsequent experimental E. coli challenges. Moreover, flow cytometric differentiation of the 
milk cell population present in bovine low SCC milk was validated. Following intramammary E. 
coli challenge during the periparturient period, primiparous cows reacted as moderate responders 
with a rapid and efficient inflammatory reaction and short-lasting depression in milk production. 
Variation of the inoculum dose could modulate the inflammatory reaction and a higher inoculum 
dose (1 x 106 CFU per quarter) resulted in a faster innate immune response. Inhibition of the 
prostaglandin synthesis through NSAID administration at PIH 9, when clinical symptoms were 
present, improved general clinical condition by rapid defeverescence and restoration of 
depressed reticulorumen motility. In addition, eicosanoid production (PGE2 and TXB2) 
decreased following NSAID treatment. Pre-calving prophylactic vaccination against the 
endotoxin could slightly alter the clinical course of the moderate inflammatory reaction in 
primiparous cows. Although vaccinated animals had favourable RT and blood leukocyte 
kinetics, no major clinical improvement could be observed following intramammary E. coli 
challenge. Therefore, primiparous cows can be considered low risk candidates for severe clinical 
mastitis following experimental intramammary E. coli challenge. Care should be taken with 
respect to generalisation of the obtained results of experimentally induced mastitis to the field 
situation, especially due to some major differences, such as the inoculum dose, which exist 
between experimental models used in research and field cases.  
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Figure 1. Schematic drawing of the hypothesis and objectives of this thesis. Left pathway: 
external bacterial contamination has no effect on cellular response of resident cells in milk (*) 
(p. 69). Right pathway: following intramammary E. coli infection, bacterial growth and lysis 
leads to the release of LPS, which interacts with the resident cells in milk. Binding of LPS by 
LBP/sCD14 induces a cellular response, which changes resident milk cell characteristics and  
elicits an inflammatory response resulting in changes in milk secretion. (**) Primiparous cows 
mainly react as moderate responders following intramammary E. coli challenge (p. 125), (***) 
inoculum dose can modulate the kinetics of the moderate inflammatory reaction in primiparous 
cows (p. 145), whereas inhibition of prostaglandin synthesis only affects general clinical 
condition and eicosanoid production in milk (p. 167), vaccination against the endotoxin could 
slightly alter the clinical course of the moderate inflammation in primiparous cows (p. 189). 
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PRACTICAL IMPLICATIONS AND FUTURE RESEARCH 
 
1. Until now, milk quality and immune status of the mammary gland are assessed through 
quantification of the cells in milk (SCC measurement). However, in the future, 
functional examination of the resident cells in milk will become an additional tool in the 
study of mammary gland immunity and milk quality. In this thesis, manual milk 
collection has been shown sufficient for these purposes. 
2. Questions will arise concerning the future approach of E. coli mastitis, especially in 
relation to treatment or prevention/prophylaxis. Focusing on prevention, one or more 
stable immune parameters should be available that can be measured throughout the 
transition period, in order to obtain quantitative feedback about the currently performed 
farm management practices. Therefore, the immune status of the dairy cows should be 
measured through the assessment of specific markers in the population. Besides the 
preventive approach, treatment of clinical mastitis will still be performed. The present 
work contributes, together with other data of our laboratory and world-wide mastitis 
research groups, to the knowledge of the physiological limits and the scientific basis of 
disease severity during clinical E. coli mastitis. This knowledge helps to answer the 
question: “which animals should not be treated ?” or rather: “should we treat with broad 
spectrum antibiotics or antibiotics with a Gram-positive spectrum ?”. Due to the high 
degree of self-curing, it is clear that all animals in mid-lactation and the primiparous 
cows during early lactation are low risk candidates for a severe clinical response due to 
E. coli mastitis and should therefore not be treated. Moreover, EU directives will also 
determine use of antimicrobials in the near future. However, until now, rapid etiological 
diagnosis is still difficult. Therefore, mild to moderate clinical mastitis occurring in 
primiparous cows during early lactation, which could be caused by Gram-positive 
bacteria, should be treated with antimicrobials with a unique Gram-positive spectrum. In 
contrast, primiparous cows exhibiting a severe clinical response following naturally 
occurring mastitis can be treated with an antibiotic with broad spectrum.   
3. Under practical circumstances, the use of a severity scoring system will help to obtain a 
good prognostic evaluation in animals suffering from clinical mastitis. A mild or 
moderate response in primiparous cows during early lactation may be due to E. coli or 
coagulase-negative staphylococci, which do both not require antimicrobial treatment. In 
practice, severe cases of clinical mastitis can occur in primiparous cows during the 
periparturient period. Under these circumstances, bacteriological diagnosis is an 
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essential tool in etiological diagnosis to differentiate between E. coli, which is 
predominantly self-curing, and S. aureus, which should efficiently be treated to omit 
chronic pathogen survival into the mammary gland. Moreover, differences in the clinical 
picture can occur between experimentally induced E. coli mastitis and naturally 
occurring cases of E. coli, which are observed under field circumstances.  
4. Clinical and subclinical mastitis should clearly be distinguished. Primiparous cows are 
susceptible to coagulase-negative staphylococci, whereas they react mild to moderate 
following intramammary E. coli challenge. However, clinical E. coli mastitis is mainly 
determined by the host (Burvenich et al., 2003), whereas subclinical mastitis by 
coagulase-negative staphylococci is rather a problem of the bacteria (De Vliegher, 
2004). Veterinary clinicians should therefore be forced to perform an etiological 
diagnosis of mastitis, especially because the term 'mastitis' is rather broad and more 
specifications should be made in terms of 'environmental mastitis' or 'contagious 
mastitis' to diversify between the two major groups of etiological bacteria. The more 
correct description of mastitis problematics does not discharge the veterinary clinician 
from his duty to perform an etiological diagnosis, because inventarisation of various 
bacteria, causing mastitis, present at the farm is advisable in good dairy farm 
management.  
5. Primiparous cows suffering from mild to moderate clinical mastitis due to E. coli should 
not be treated with antimicrobials or anti-inflammatory drugs, but care should be taken 
towards the potential risk to develop a chronic E. coli mastitis problem, although this is a 
rare disease. The presence of multiple cases of clinical E. coli mastitis in primiparous 
cows may be indicative for more fundamental problems in relation to a decreased 
immunological status of the cows during the early lactation period. This can eventually 
spread to the population of multiparous cows on the farm, which are far more susceptible 
to severe clinical coliform mastitis. 
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Escherichia coli, involved in bovine coliform mastitis, is part of the normal intestinal 
flora of animals. The strains isolated from bovine mastitis are essentially not different from 
strains isolated from bovine faeces. The bacteria do not possess specific virulence factors 
contributing in its pathogenesis. Several risk factors and severity determining factors, such as 
PMN number and functionality, and stage of lactation, have already been studied in relation to 
severe clinical mastitis. Many information is available on the inflammatory response following 
intramammary E. coli challenge in multiparous cows, although little is known on the 
susceptibility and reactivity towards E. coli mastitis of primiparous cows, which are an important 
population at dairy herd level.  
The objective of this study was to characterise the inflammatory reaction following 
experimentally induced E. coli mastitis in primiparous cows during the periparturient period. 
Therefore, milk sample collection under aseptical conditions was validated in order to establish 
the effect of external bacterial contamination on pre-infection PMN functions assessed in vitro. 
Primiparous cows were intramammarily challenged with E. coli and the inflammatory reaction 
was studied. Furthermore, modulatory effects of variation of the inoculum dose, inhibition of 
prostaglandin synthesis and vaccination against the endotoxin were studied in the same 
experimental infection model.  
In the chapter 'Validation of Milk Sample Collection under Aseptical Conditions' three 
different milk sampling techniques were compared with respect to the degree of external 
bacterial contamination obtained during sampling and its effect on pre-infection PMN functions 
in vitro. Limited external bacterial contamination during sampling did not interfere with PMN 
functionality assays and therefore, manual milk sample collection was preferred for further use 
in the subsequent experimental E. coli infections. 
The chapter 'Materials and Methods Experimental Infections' contains all details on 
materials and methods used in the different experimentally induced E. coli challenges using 
primiparous cows. This chapter also contains pre-infection values of all measured parameters 
with the respective variation (expressed as SEM).  
In the chapter 'Influence of Parity on Severity of Inflammation' primiparous cows are 
intramammarily challenged with high inoculum doses of E. coli and the inflammatory reaction is 
studied. Primiparous cows react as moderate responders, based on their quarter milk production 
in the uninfected quarters on d+2 post-infection. Decreased quarter milk production in 
primiparous cows is very short-lasting and resolution of local inflammation appears rapidly. A 
clinical severity scoring, using rectal temperature, reticulorumen motility, skin turgor and 
general attitude, is established to score the inflammatory reaction during clinical examination 
under practical conditions. 
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'Modulation of the inflammatory reaction' contains three chapters respectively studying 
variation of the inoculum dose, inhibition of prostaglandin synthesis and vaccination against the 
endotoxin.  
In the chapter 'Variation of the inoculum dose' primiparous cows are randomly 
inoculated with 2 different inoculum doses (1 x 104 and 1 x 106 CFU E. coli per quarter) and 
inflammatory reaction is studied by quantification of cytokines and markers of the innate 
immune response (IL-8, C5a, sCD14 and LBP). All primiparous cows react with a moderate 
inflammatory reaction. However, intramammary inoculation of the highest dose (1 x 106 CFU) 
results in an earlier activation of the innate immune response, although recovery of milk 
production does not differ between both inoculum doses.  
 In the chapter 'Inhibition of prostaglandin synthesis' an inhibitor of inducible enzymes of 
the cyclo-oxygenase pathway (COX-2) is administered to primiparous cows, intramammarily 
challenged with E. coli, when first clinical symptoms appear (9 h post-infection). Carprofen, a 
COX-2 inhibitor, treatment results in an improvement of general clinical condition, by rapid 
defeverescence and restoration of the reticulorumen motility, which is depressed during E. coli 
mastitis. The COX-2 inhibitor decreases eicosanoid production (PGE2 and TXB2) in the affected 
mammary quarters, but no effect on the inflammatory mediators of the innate immune response 
(IL-8, C5a, sCD14 and LBP) is observed.  
 Chapter 'Vaccination against the endotoxin' studies the effect of pre-calving vaccination 
with a J5 vaccine on subsequent experimentally induced E. coli mastitis in primiparous cows. No 
improvement in clinical condition could be observed in vaccinated animals, although favourable 
blood leukocyte kinetics were present in these animals. Vaccination against the endotoxin could 
barely modulate the inflammatory response following moderate inflammation in primiparous 
cows.  
 Primiparous cows during the periparturient period can be considered low risk candidates 
for severe clinical mastitis due to E. coli. The inflammatory reaction following experimentally 
induced E. coli mastitis is short-lasting, limited and self-curing. Only limited modulation is 
possible through the variation of the inoculum dose or inhibition of prostaglandin synthesis, 
whereas prophylactic vaccination against the endotoxin barely showed any effects on the 
moderate inflammatory reaction.  
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Acute mastitis, tengevolge van Escherichia coli, is van praktisch en economisch belang 
voor de melkveesector en de zuivelindustrie. De kiem, die geen specifieke virulentiefactoren met 
een rol in de pathogenese van de aandoening bezit, is een reguliere darmbewoner bij dieren en 
wordt dan ook in grote aantallen met de feces in de omgeving uitgescheiden. In de voorbije jaren 
zijn reeds verschillende risicofactoren en determinerende factoren in verband met de ernst van 
een intramammaire E. coli infectie, zoals het aantal en de functionaliteit van de neutrofielen en 
het lactatiestadium, bestudeerd. De ontstekingsreactie na intramammaire E. coli inoculatie is bij 
multipare koeien al uitgebreid onderzocht, doch de gevoeligheid en reactiviteit tegen E. coli 
mastitis van primipare koeien, een belangrijk deel van de populatie op een melkveebedrijf, is tot 
op heden nauwelijks bestudeerd.  
De doelstelling van dit proefschrift was de karakterisatie van de ontstekingsreactie bij 
experimenteel geïnduceerde E. coli mastitis bij primipare koeien tijdens de peripartum periode te 
bestuderen. Hiervoor diende eerst de melkstaalname onder aseptische omstandigheden 
gevalideerd te worden met betrekking tot het effect van externe bacteriële contaminatie op de in 
vitro gemeten pre-infectie neutrofiel functionaliteit. Vervolgens werden primipare koeien 
intramammair besmet met E. coli om de ontstekingsreactie, en de vroege gastheer 
immuunrespons in het bijzonder, nader te bestuderen. Verder werden modulerende effecten van 
een variatie van de inoculum dosis, inhibitie van de prostaglandine synthese en vaccinatie tegen 
het endotoxine in hetzelfde experimentele infectiemodel onderzocht. 
In het hoofdstuk 'Validatie van de melkstaalname onder aseptische omstandigheden' 
werden drie verschillende melkstaalname technieken, met name een aseptische, een manuele en 
een machinale techniek, vergeleken met betrekking tot de graad van externe bacteriële 
contaminatie tijdens de bemonstering en het effect van deze externe bacteriële contaminatie op 
de verschillende klassieke in vitro functietesten op boviene neutrofielen. Hieruit bleek dat een 
beperkte bacteriële contaminatie tijdens de bemonstering geen significante invloed had op deze 
in vitro functietesten. Tevens bleek dat de manuele melkstaalname voldoende garanties zou 
bieden voor een representatieve staalname tijdens de E. coli experimenten.  
 In het hoofdstuk 'Materiaal en methoden experimentele infecties' zijn alle details omtrent 
de gebruikte materialen en methodes in de verschillende E. coli experimenten bij primipare 
koeien opgenomen. In dit hoofdstuk zijn eveneens de pre-infectie waarden van alle gemeten 
parameters met hun respectievelijke variatie (uitgedrukt als SEM) opgenomen. 
 In het hoofdstuk 'Invloed van pariteit op de ernst van de ontsteking' werden primipare 
koeien intramammair geïnoculeerd met hoge inoculum doses E. coli en werd de 
ontstekingsreactie onderzocht. De ernst van de intramammaire infectie werd geëvalueerd door 
het meten van de kwartiermelkproductie in de niet-geïnfecteerde kwartieren op d+2 na infectie. 
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Daarnaast werd de ernst van de infectie gekwantificeerd door gebruik van een klinisch 
scoresysteem, rekening houdend met de rectale temperatuur, de voormagenmotiliteit, de 
huidturgor en de algemene indruk, die tijdens het klinisch onderzoek werden gemeten. Primipare 
koeien reageerden als 'moderate responders' op basis van beide scoresystemen. Op d+2 na 
infectie was de kwartiermelkproductie van de niet-geïnfecteerde kwartieren steeds > 50% van de 
productie voor infectie. Bovendien was de daling van de kwartiermelkproductie bij deze 
primipare koeien zeer kortstondig en trad vrij snel herstel van de locale intramammaire 
ontsteking op. De eenduidige 'moderate' klinische respons bij deze dieren stond in sterk contrast 
met de wijde variatie van het klinisch ziektebeeld dat bij multipare koeien in vorige studies kon 
worden waargenomen.  
Het hoofdstuk 'Modulatie van de ontstekingsreactie' bevat drie onderdelen: de variatie 
van de inoculum dosis, de inhibitie van de prostaglandine synthese en de vaccinatie tegen het 
endotoxine. 
 In het onderdeel 'Variatie van de inoculum dosis' werden primipare koeien at random 
met 2 verschillende hoge inoculum doses (1 x 104 en 1 x 106 kolonievormende eenheden (KVE) 
per kwartier) E. coli geïnoculeerd. De ontstekingsreactie werd vervolgens bestudeerd aan de 
hand van een kwantificatie van cytokines en merkers van de vroege immuunrespons (IL-8, C5a, 
sCD14 en LBP). Alle primipare koeien reageerden opnieuw met een 'moderate' 
ontstekingsreactie. Intramammaire inoculatie met de hoogste dosis (1 x 106 KVE) resulteerde 
niettemin in een vroegere activatie van de immuunrespons. Hierbij trad een duidelijke 
verschuiving van de activeringskinetiek van IL-8, C5a, sCD14 en LBP op tijdens de vroege fase 
van de immuunrespons. Niettegenstaande de vroegere activatie van de afweer bij dieren 
geïnoculeerd met de hoge inoculum dosis, verschilde het herstel van de kwartiermelkproductie 
niet tussen beide inoculum doses. Uit dit experiment blijkt duidelijk dat een variatie in de 
inoculum dosis een beperkte modulatie van de ontstekingsreactie kan veroorzaken.   
 In het onderdeel 'Inhibitie van de prostaglandine synthese' werd een inhibitor van de 
induceerbare enzymen van de cyclo-oxygenase weg (COX-2) toegediend aan primipare koeien, 
die intramammair geïnoculeerd waren met E. coli. De toediening van het therapeuticum 
gebeurde op het ogenblik van het verschijnen van de eerste klinische symptomen (9 h na 
infectie). Carprofen, een COX-2 inhibitor, leidde tot een verbetering van de algemene klinische 
conditie door het sneller verdwijnen van de koorts en een vlotter herstel van de 
voormagenmotiliteit. De eicosanoid productie (PGE2 en TXB2) in de geïnfecteerde kwartieren 
werd door de COX-2 inhibitor onderdrukt. Niettemin had het niet-steroidale anti-inflammatoire 
product geen positief effect op de ontstekingsmediatoren van de vroege immuunrespons (IL-8, 
C5a, sCD14 en LBP), daar geen wijzigingen in de kinetiek tussen beide behandelingsgroepen 
Samenvatting 
  - 227 - 
konden vastgesteld worden. Een inhibitor van de prostaglandine synthese blijkt dus in staat te 
zijn tot een beperkte modulatie van de ontstekingsreactie bij primipare koeien, vooral door het 
verbeteren van de algemene klinische conditie van het behandelde dier. Een vroege behandeling, 
op het ogenblik van het verschijnen van de eerste klinische symptomen, is hierbij van essentieel 
belang. 
 In het hoofdstuk 'Vaccinatie tegen het endotoxine' werd het effect van vaccinatie met een 
J5 vaccin tijdens de dracht op een daaropvolgende experimenteel geïnduceerde E. coli mastitis 
bij primipare koeien bestudeerd. Het vaccin werd tweemaal toegediend tijdens het laatste deel 
van de dracht (56 en 28 dagen voor de verwachte afkalfdatum) en éénmaal tijdens de eerste 
week na het afkalven. Vervolgens werden de primipare koeien intramammair met E. coli 
geïnoculeerd en werden een aantal klinische en laboratoriumparameters verzameld. Vaccinatie 
tegen het endotoxine liet weinig verbetering van de klinische conditie zien, hoewel een gunstige 
evolutie in de kinetiek van de bloedleukocyten waargenomen werd. De kwartiermelkproductie 
keerde in beide behandelingsgroepen vrij snel terug tot het pre-infectie niveau. Vaccinatie tegen 
het endotoxine was vrijwel niet in staat om de ontstekingsreactie bij primipare koeien te 
moduleren.  
 Primipare koeien tijdens de peripartum periode kunnen als laag risico kandidaten met 
betrekking tot ernstige klinische mastitis, te wijten aan E. coli, aanzien worden. De 
ontstekingsreactie bij experimenteel geïnduceerde E. coli mastitis is kortdurend, afgelijnd en 
geneest zonder behandeling. Een beperkte modulatie van de ontstekingsreactie is mogelijk door 
variatie van de inoculum dosis of inhibitie van de prostaglandine synthese. Vaccinatie tegen het 
endotoxine had vrijwel geen effect op de 'moderate' ontstekingsreactie.   
De extrapolatie van de resultaten van dit experimenteel onderzoek naar de praktijk toe 
moet met de nodige voorzichtigheid gebeuren, daar onder praktijkomstandigheden het optreden 
van een ernstige klinische reactie bij E. coli mastitis niet steeds kan worden uitgesloten. In dit 
opzicht is en blijft een bacteriologisch onderzoek voor het stellen van de etiologische diagnose 
van cruciaal belang om een duidelijk onderscheid te kunnen maken tussen de verschillende 
mastitisvormen.  
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 De resultaten van dit doctoraal proefschrift zijn de bekroning van ongeveer 5 jaar 
wetenschappelijk onderzoek, dat onmogelijk zou zijn geweest zonder de steun, de hulp en het 
vertrouwen van vele mensen. Ik wil dan ook iedereen die rechtstreeks of onrechtstreeks met dit 
werk betrokken was van harte bedanken. Niettegenstaande namen noemen onvermijdelijk 
impliceert dat er mensen vergeten worden, doe ik toch een poging om enkele mensen speciaal te 
bedanken.  
 Vooreerst wil ik mijn promotor Prof. Dr. C. Burvenich bedanken voor zijn waardevol 
advies ("Eerst nadenken met sigaarke en cognac, pas dan in actie schieten") en zijn voortdurende 
interesse in mijn wetenschappelijk werk. Hoewel de resultaten initieel merkwaardig leken, 
bracht het onvermijdelijke 'rijpingsproces' steeds meer duidelijkheid in de bekomen resultaten, 
waardoor de rode draad van dit werk zich vormde. Christian, bedankt voor de goede 
wetenschappelijke en fysiologische opleiding die ik onder uw vleugels genoot, ik zal er in de 
toekomst vast en zeker nog vaak naar teruggrijpen.  
 Je voudrais également remercier mon co-promoteur, Dr. P. Rainard, pour l'hospitalité 
avec laquelle il m' a toujours reçu au laboratoire à Nouzilly. Il m' a appris beaucoup pendant ces 
stages scientifiques et en discutant sur le contenu de cette thèse. J'espère qu'on puisse continuer 
cette coopération au futur. 
 De leden van de begeleidingscommissie, Prof. Dr. A. de Kruif, Prof. Dr. F. 
Haesebrouck, Prof. Dr. E. Cox, Prof. Dr. L. Duchateau en Prof. Dr. C. Hanzen, wens ik te 
bedanken voor het kritisch nalezen van dit proefschrift en de constructieve opmerkingen. Jullie 
verbeteringen zorgden voor een ver-beter-ing van dit proefschrift.  
 Zonder de doordachte statistische benadering van Prof. Dr. L. Duchateau zou dit werk 
slechts een onoverzichtelijke opeenhoping van cijfers en gemiddelden zijn. Luc, hartelijk dank 
voor de ontelbare statistische analyses en heranalyses, het opmaken van de figuren, maar ook 
voor het luisterend oor en de niet aflatende steun.  
 I would also like to thank Dr. M.J. Paape for his constructive comments and his help 
with my work on sCD14 and LBP.  
 De mensen van het eerste uur, Prof. Dr. A. Massart-Leën, Prof. Dr. R. Heyneman en Dr. 
H. Dosogne, mogen in dit dankwoord zeker niet ontbreken. Ze hielpen me op weg in de 
wetenschappelijke jungle. Annemie, ge zijt en blijft mijn wetenschappelijke 'moeder', dankzij 
jouw wijze raad hield ik vol, ook als het eens wat minder vlotte. 
 Nonkel en tante, ook jullie wil ik betrekken in dit dankwoord voor het onderhoud van 
'mijn' koetjes, de nachtelijke koffie, de 'stevige kost' die ons recht hield op de drukke challenge 
dagen. Nonkel, de helderheid waarmee uw 'klinisch oog' de behandelingen kon onderscheiden 
was opzienbarend.     
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Experimenten doe je nooit alleen. Achter de schermen stond een gans team van mensen 
klaar om mij in de stal of op het labo bij te staan met het afnemen van bloed- en melkstalen en 
het verwerken van plasma, serum en melk. Etienne, Hubert, Luc, Ann, Kristel, Valérie, Bart en 
Klaartje, bedankt voor jullie deskundige hulp. Collega's dierenartsen, Valérie en Bart, er was 
steeds 'ambulance' in de stal als jullie in de buurt waren. De nachtelijke uren werden draaglijk 
door het aanstekelijk enthousiasme waarmee jullie doorgingen met melken, ook als de koe bijna 
droog stond door het frequent melken. De andere mensen van het labo bedank ik eveneens voor 
hun interesse in mijn werk. Special regards go to Jalil and Cheli, who kept my spoken English in 
good shape.  
Een deel van het onderzoek werd financieel gesteund door het Ministerie van 
Middenstand en Landbouw, waarvoor dank. In het bijzonder wil ik Ir. J. Weerts en Dr. X. Van 
Huffel bedanken voor hun vertrouwen in dit onderzoek. 
Ook de medewerkers van de Dierengezondheidszorg - Vlaanderen, in het bijzonder Dr. 
L. De Meulemeester, en van het Melk Controle Centrum - Vlaanderen, Ir. R. Bossuyt en Ir. J. 
Van Crombrugge, wens ik van harte te bedanken voor de vlotte samenwerking. Tevens een 
speciaal woord van dank aan Dr. H. Deluyker en Dr. C. McLaughlin voor de samenwerking en 
hun interesse in mijn werk. 
Zonder kaft zou dit boek niet hetzelfde geweest zijn. Nonkel Roger, hartelijk dank voor 
de vele uren artistiek werk die je aan het kaftontwerp besteedde. We zaten vanaf het eerste 
ogenblik op dezelfde ‘artistieke golflengte’. Het finale resultaat mag er wezen. Bedankt. 
Dit dankwoord zou onvolledig zijn zonder een oprecht woord van dank aan mijn ouders. 
Pa, ma, bedankt voor jullie steun in mijn keuze om dierenarts te worden. Jullie wijze raad ("Doe 
wat ge graag doet, en maakt da ge erdoor zijt") heb ik steeds in mijn achterhoofd gehouden. 
Jullie steun en blijvende interesse in mijn werk met de 'uiers' was voor mij een drijfveer om door 
te gaan. Pa, ik wil jou in het bijzonder bedanken voor de hulp tijdens de staalnamen van de 
laatste experimenten. Eén man meer of minder maakt soms toch het verschil uit tussen het vlot 
of stroef verlopen van de staalnamen.  
 En last but not least ... Ellen, je bent mijn rots in de branding. Zonder jouw steun was dit 
proefschrift nooit geworden wat het nu is. Je stond altijd voor mij klaar als er helpende handen 
tekort waren tijdens de challenge dagen. Bedankt voor je onvoorwaardelijke hulp. Je onmetelijk 
geduld en begrip, tijdens de vele uren, avonden en weekends die de finalisatie van dit 
proefschrift met zich meebrachten, hebben heden hun vruchten afgeworpen. Ik hoop voor jou 
evenveel te kunnen betekenen wanneer jij dezelfde 'beproeving' moet doorstaan. Oprechte dank 
voor alles! 
Frédéric
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